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ABSTRACT
The perinatal immune system is highly tolerogenic and is phenotypically and functionally
distinct from the adult immune system. This tolerogenic nature is a double-edged sword for
newborns. While it is beneficial to prevent excessive inflammation against the vast array of
foreign antigens encountered after birth, it also causes a lack of immune responses to lifethreatening infections. My dissertation research aims to investigate the mechanisms by which
perinatal T cells contribute to immune tolerance in infants. A deeper understanding of the nature
of the perinatal immune system will provide pivotal knowledge to develop safe and effective
strategies to protect infants from infection and to establish immune homeostasis with commensal
microbes.
Using umbilical cord blood (UCB) T cells as a model to study perinatal immunity, we
found that antigen receptor stimulation of T cells in UCB leads to the development of Foxp3+ T
cells in both CD4+ and CD8+ T cell subsets. These UCB-derived Foxp3+ T cells are
phenotypically and epigenetically distinct from canonical thymus-derived Tregs (tTregs) in
adults, but they carry immune regulatory functions in vitro and in vivo. The development of
Foxp3+ T cells requires CD36hi monocytes. Adult blood contains a group of lymphocytes that
inhibits monocyte-induced Foxp3+ T cell development, showing how perinatal blood differs
from adult blood. Foxp3+ T cell development also requires IL-2. Alcohol, which is known to
cause immunological defects, reduces the expression of CD25, a component of the high affinity
IL-2 receptor, and blocks Foxp3+ T cell development. The result suggests that immunological

xvii

dysfunctions found among infants born from alcoholic mothers may be in part due to the
impaired development of these Foxp3+ T cells during their fetal life.
To further elucidate the mechanisms that contribute to perinatal immunological tolerance,
we investigated the expression of Helios, another transcription factor known to be expressed by
tTregs along with Foxp3. We found that Helios is expressed significantly more frequently by
UCB and neonatal peripheral blood T cells than adult T cells. Similar results were observed in
mice. The expression frequency decreased rapidly after birth. The data suggested that T cells
from fetal/perinatal origin express Helios. Indeed, we found that most gut-associated T cells,
which are known to originate from the fetal thymus, express Helios in the fetus and maintained
Helios expression throughout adulthood. Additionally, human T cells that matured in mice that
received UCB hematopoietic stem cells also express Helios. Gene knockout of Helios in UCB T
cells showed a significant increase in expression of multiple effector cytokines, suggesting that
one of Helios’ functions is to suppress effector cytokine production by activated T cells.
Together, these data demonstrated multiple mechanisms by which T cells can contribute
to immune tolerance in neonates. First, the perinatal peripheral environment promotes T cells to
differentiate into a unique group of Foxp3+ T cells that carry suppressive functions. Second,
perinatal T cells express high levels of Helios, which suppress activated T cells to produce
effector cytokines. Together, both intrinsic (Helios) and extrinsic (CD36hi monocytes)
mechanisms promote the tolerogenic nature of the perinatal immune system.
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CHAPTER ONE: REVIEW OF LITERATURE
T Cell Development
The mature immune cells originate from bone marrow-resident hematopoietic stem cells
(HSCs) that differentiate through a highly hierarchical developmental progression. This
differentiation process progresses with increasing restricted lineage potential, ultimately leading
to the different mature blood cell lineages. The Weissman group was pioneers in identifying two
critical progenitor cells: the common myeloid progenitor (CMP), which eventually develops into
erythrocyte-megakaryocyte progenitors or granulocyte-monocyte progenitors, and the common
lymphoid progenitor (CLP), which ultimately differentiates into the different lymphocyte
subsets, including T cells1,2.
While most of hematopoiesis occurs in the bone marrow, T cell development takes place
in the thymus to yield mature, self-tolerant, functional T cells3,4. T cell development does not
happen cell-autonomously but requires signals from stromal cells, including thymic epithelial
cells and mesenchymal fibroblasts5. Although the thymus provides the niche that supports T cell
development, the thymus-resident T cell progenitor has limited self-renewing potential.
Therefore, sustained T cell production requires continual seeding of blood-borne bone marrowderived progenitors from the periphery6,7.
The Bleul group identified the most immature precursors, thymic multipotent precursor
(TMP), within the early T lineage progenitors in the thymus. These TMPs can give rise to T, B,
and dendritic cells on the single-cell level under respective lineage permissive conditions8.
However, TMPs respond to Notch signals provided by the thymus microenvironment to induce

1

2
T cell lineage commitment and rapidly lose their B cell lineage potential. Their finding suggests
that bone marrow-derived hematopoietic precursors only commit to T cell lineage after seeding
the thymus9.
αβ T Cell Development
Two lineages of T cells generated in the thymus can be identified by the expression of αβ
or γδ T cell receptor (TCR) complexes. Within the αβ T cell lineage, two major subsets were
distinguished by surface expression of CD4 and CD8 in the 1980s 10. T cells undergo a series of
differentiation steps defined based on their surface expression of CD4 and CD8 in a spatialtemporal manner in the thymus11,12. The most immature subset of thymocyte precursors does not
express CD4 and CD8, thus denoted as double-negative (DN). DN is the critical stage that
progenitors are committed to either αβ or γδ T cell lineage13. During the DN stage, immature
thymocytes undergo rearrangement in the TCRβ, TCRγ, and TCRδ genes14,15. Successful
rearrangement of the TCRβ chain will be complex with a germline-encoded pre-TCRα, forming
the pre-TCR complex16,17. Signaling via the pre-TCR complex subsequently led to a burst of
proliferation, upregulation of CD4 and CD8 co-receptors, initiation of TCRα gene
rearrangement, and the silencing of the TCRγ gene18. αβ T cell lineage thymocytes then progress
to the CD4+ CD8+ double-positive (DP) stage, where they complete TCRα gene rearrangement
and subsequently undergo positive and negative selection19.
Both positive and negative selection process involves the engagement of TCR with a
major histocompatibility complex (MHC) molecule with a self-peptide. The goal of positive
selection is to select thymocytes that express TCR that recognize self-MHC molecules. Positive
selection occurs in the thymus cortex mediated by cortical thymic epithelial cells (cTECs) that
express MHC class I or MHC class II with a self-peptide. A peptide-MHC complex that induces
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weak TCR signaling promotes thymocyte survival during positive selection and does not induce
TCR-mediated apoptosis20–22. After positive selection, DP thymocyte that recognizes MHC class
I in the context of self-peptide further differentiate into CD4-CD8+ single-positive (SP) T cells,
while those that recognize self-peptide in the context of MHC class II differentiate into
CD4+CD8- SP T cells23(Figure 1).
Conversely, thymocytes that express TCR that binds self-peptide bound to MHC too
strongly undergo activation-induced apoptosis24. This process is known as negative selection,
where the goal is to remove T cells that will recognize self5. Negative selection occurs in the
medulla and is mediated by medullary thymic epithelial cells (mTECs) and dendritic cells (DC).
Positively selected thymocytes migrate from the thymic cortex to the medulla via CCR7mediated attraction by mTECs25,26. In the thymic medulla, mTECs express numerous tissuerestricted self-antigens promiscuously through the autoimmune regulator protein(AIRE)27–3034,35.
mTECs can directly and indirectly, in cooperation with thymic dendritic cells, present these
tissue-specific self-antigens to eliminate self-reactive T cells and promote the generation of
regulatory T cells (Tregs)31–33. AIRE-expressing mTECs mediates Treg generation when
thymocytes bind MHC-self peptides at high-avidity34,35. The generation of thymic Tregs (tTreg)
aids in controlling self-reactive T cells that have escaped the negative selection in the thymus
into the periphery. Subsequently, the Foxp3+CD25+ thymocytes can be found mainly in the
medullary region of the thymus36,37. Therefore, mTECs play an essential role in establishing selftolerance in T cells through both negative selection and generation of tTregs.
After the completion of both positive and negative selection, SP thymocytes undergo
final functional maturation that involves the upregulation of cell surface markers CD62L,
sphingosine-1-phosphate receptor 1 (S1P1), and chemokine receptor CCR725,38. These markers
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facilitate the emigration of SP thymocytes from the thymus into the circulation known as recent
thymic emigrants. Once in the periphery, these recent thymic emigrants continue their postthymic education with progressive maturation of both surface phenotype and immune function
ultimately into fully mature naïve CD4+ and CD8+ T cells39,40.

Figure 1: αβ and γδ T Cell Development in the Thymus. The diagram depicts simplified stages
of αβ and γδ T cell thymopoiesis from thymocyte precursors to CD4-CD8- double-negative (DN),
CD4+CD8+ double-positive (DP), and CD4+ or CD8+ single-positive (SP) stage.
γδ T Cell Development
γδ and αβ T cells arise from a common progenitor cell in the thymus where they commit
to either αβ or γδ T cell lineage in the DN stage13. Progenitors that productively rearrange TCRγ
and TCRδ chain will express γδ TCR on the cell surface and undergo a burst of proliferation.
However, the majority of them avoid progression through the SP stage and egress to the
periphery with a CD4-CD8- DN phenotype (Figure 1). Molecular events leading to αβ or γδ T
cell lineage decision is not resolved, but several factors that can contribute to γδ T cell lineage
commitment has been identified. For instance, the expression of transcription factor SOX13
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promotes γδ T cell development while opposing αβ T cell development41. Expression of inhibitor
of DNA binding 3 (Id3) also regulates the adoption of the γδ T cell fate in the thymus42. TCR
signal strength is also implicated in determining lineage choice where DN cells receiving a
stronger TCR signal adopts a γδ T cell fate while DN cells receiving weaker TCR signals
committing to the αβ lineage43.
Early genetic work of γδ TCR rearrangement during fetal, neonatal and adult thymocyte
development revealed an organized and sequential rearrangement of specific γ and δ gene
segments in developing γδ T cells during ontogeny44,45. These studies showed that upon thymic
egress, most γδ T cells localized to non-lymphoid peripheral tissues, and the tissue localization
segregates with the surface expression of specific TCR Vγ chains46,47. This ordered
rearrangement resulted in timed production of defined γδ T cell population with specific
combinations of Vγ and Vδ chain, appearing in waves during development and populate
different tissues in the adult animal.
The first wave of thymocytes bearing γδ TCR encoded by Vγ5 and Vδ1 gene segments
appear early (E14.5) in embryonic life and populates the skin epidermis 48. Subsequently, Vγ6+
γδ T cells are generated and localize to tissues such as the uterine, tongue, and lungs49,50. Next,
Vγ7+ γδ T cells that mainly populate the gut mucosal tissue are generated, even though their
development timeline is still under debate. Vγ7 chain can be detected in the thymus as early as
E13, with the highest expression between E17-E19. However, Vγ7 chain is detected in the fetal
gut and liver at E11, before developing thymic lobes are colonized by T cell progenitors 51.
Lastly, Vγ1+ and Vγ4+ expressing γδ T cells are generated and found in the periphery (blood,
spleen and lymph nodes)44,52,53. In summary, γδ T cells with different Vγ chain usage appeared in
waves during ontogeny and localized to different anatomical sites in mice (Figure 2).
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Figure 2: Successive Waves of γδ T Cells of Different Vγ Chain Usages Across
Development in the Thymus. Diagram depicts the developmental timing of specific Vγ chain
expression in the thymus and their corresponding anatomical localization after thymic egression.
Figure adapted from Ribot et al.54 using Tonegawa nomenclature.
αβ T Cell Subsets
Within the adaptive arm of the immune system, αβ T cells can elicit immune responses,
maintain immune homeostasis, and establish immune memory. Peripheral αβ T cells subset (also
commonly referred to as conventional T cells) can be classified by surface expression of CD4 or
CD8 coreceptors, representing T helper and cytotoxic T lymphocytes, respectively. CD4+ T cells
recognize antigen bound to MHC class II, while CD8+ T cells recognize antigen bound to MHC
class I55. CD4+ and CD8+ T cells can be further distinguished into different subsets based on
their function, unique defining transcription factor, and cytokine profile discussed in the
following sections.
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CD4+ T Cell Subsets
CD4+ T cells play a central role in immune protection mainly by producing cytokines to
help B cells make antibodies, induce macrophages to increase microbicidal activity, or
chemokines to recruit immune cells to the site of infection, etc. Upon activation, naïve CD4+ T
cells can differentiate into different T helper (Th) subsets such as Th1, Th2, Th17, and Tregs
depending on the cytokine milieu of the microenvironment produced by antigen presenting cells
(APCs) or other neighboring cells (Figure 3).
T helper type 1 (Th1). Th1 cells were first discovered along with Th2 cells by the
Coffman group back in 1986, where they observed that CD4+ T cells is divided into two distinct
populations with different cytokine profiles56. Cytokines interleukin-12 (IL-12) and interferon-γ
(IFN-γ) initiates the signaling cascade to generate Th1 cells 57,58. These cytokines promote the
expression of the master transcription factor for Th1 differentiation, T-box transcription factor
(T-bet), and suppress the development of other Th subsets59,60. Th1 produces cytokines such as
IFN-γ, IL-2, and tumor necrosis factor (TNF) which mainly functions to aid in eliminating
intracellular bacteria and viruses by other immune cells type such as macrophages61–63.
T helper type 2 (Th2). CD4+ T cells activated in the presence of IL-4 and IL-2 give rise
to Th2 cells64. Th1 cytokine IFN-γ can inhibit Th2 responses65. Th2 cells express the master
transcription factor GATA-binding protein 3 (GATA3) and produce IL-4, IL-5, IL-10, and IL1356,66,67. The expression of GATA3 leads to the production of IL-4, IL-5 and inhibits Th1
differentiation66,68,69. Th2 cytokines mainly play a role in the elimination of extracellular
pathogens as well as mediating airway hypersensitivity by acting on B cells, mast cells, and
eosinophils70–74.
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T helper type 17 (Th17). For the longest time, Th1 and Th2 comprise the main effector
population of CD4+ T cells differentiated from naïve CD4+ T cells in the periphery. In 2003, a
third major CD4+ effector T cell population differentiated from naïve CD4+ T cells was
identified75. These cells were designated as Th17 and characterized by their production of IL17A, IL-17F, and IL-22. Th17 mediate immune responses against extracellular bacteria and
fungi. They are also involved in various autoimmune disorders such as rheumatoid arthritis,
psoriasis, and Crohn’s disease76–80. While Th1 and Th2 cytokines inhibit Th17 differentiation,
IL-6, TGF-β, IL-21, and IL-23 promote Th17 differentiation from activated CD4+ T cells76,81.
IL-6 and low concentrations of TGF-β induce the Th17 master transcription factor retinoidrelated orphan receptor γ-t (RORγt)82. IL-21 and IL-23, on the other hand, promote stabilization
and maintenance of Th17 cells83,84.
Regulatory T cells (Tregs). Th1, Th2, and Th17 mainly generate inflammatory responses
to fight pathogens. On the other hand, Tregs are specialized for immune suppression by
preventing aberrant or excessive inflammation and promoting self-tolerance.
Gershon and Kondo started the concept of suppressor T cells in 1970 when they found
that T cells can also dampen immune responses85. Active research of these suppressor T cells and
markers to identify them went on for several years but quickly collapsed in the mid-1980s. In
parallel with the study of suppressor T cells above, different researchers investigated how
breaching self-tolerance can lead to autoimmune disease development. This approach eventually
led to the finding of T cells and thymocytes with autoimmune-suppressive activity86. Nishizuke
and Sakakura demonstrated in 1969 that neonatal thymectomy (NTx) three days after birth
resulted in autoimmune destruction of the ovaries87. Others further showed that thymectomy in
conjunction with sublethal radiation resulted in autoimmune thyroiditis and type 1 diabetes
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development in adult rats88,89. Subsequently, they discovered that the transfer of syngeneic T
cells protected rats from developing diabetes and thyroiditis induced by adult thymectomy and
sublethal irradiation90,91. These results suggested that the thymus produces a subset of T cells
with suppressive function to prevent T cell-mediated autoimmune disease, prompting the
investigation to identify specific markers expressed by these suppressive T cells.
In 1995, Sakaguchi et al. discovered CD4+ T cells that carry suppressive functions
express the IL-2 receptor α chain, CD2592. The depletion of CD4+CD25+ T cells led to
autoimmune disease development and heightened immune response when foreign antigens were
introduced. Reconstitution of CD4+CD25+ T cells prevented autoimmune disease development
and normalized the response against foreign antigens92. The frequency of CD4+CD25+ T cells in
the periphery correlated well with the NTx model findings. CD4+CD25+ T cells can be detected
in the periphery of neonates from around three days after birth93,94. NTx at day 3 eliminates the
presence of these cells in the periphery and causes autoimmune disease. Subsequently, the
transfer of syngeneic CD4+CD25+ immediately prevents autoimmune disease93. These results
demonstrated that the thymus produces CD4+CD25+ T cells with suppressive function, later
known as Tregs.
The master transcription factor for Tregs, forkhead box P3 (Foxp3), was initially
discovered in 2001. A single Foxp3 mutation in the X-chromosome is the disease-causative gene
in Scurfy mice, where they develop severe autoimmunity spontaneously95. Mutation of the
human Foxp3 (the ortholog of murine Foxp3) causes a similar human disease called IPEX
(immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)96,97. The
autoimmune phenotype observed in Scurfy mice and IPEX patients closely resembled mice
deficient in CD4+CD25+ Tregs, giving rise to the hypothesis that Foxp3 is crucial for Treg

10
development and function. By 2003, several studies supported the role of Foxp3 in the
generation of Tregs and their suppressive function. Peripheral CD4+CD25+ T cells and
CD4+CD8-CD25+ thymocytes express Foxp3 mRNA. Overexpression of Foxp3 in CD4+CD25T cells converted them into phenotypically and functionally Treg-like cells in vitro and in vivo98–
100.

While Foxp3 expression in mice is limited to Tregs, human T cells can transiently
upregulate Foxp3 expression upon TCR activation101. This transient Foxp3 induction after TCR
activation may be an inhibitory feedback mechanism to prevent hyperactivation of T cells as they
are hyporesponsive and have reduced cytokine production such as IFN-γ, TNF, and IL-10.
However, these activated effector T cells that transiently upregulate Foxp3 are not Tregs as they
do not carry suppressive function and still produce higher levels of IFN-γ, TNF-α, and less IL-10
compared to Tregs upon PHA restimulation102.
While Tregs can be generated from the thymus (tTregs), Tregs can also be generated in
the periphery (pTregs) or in vitro (iTregs) from naïve CD4+ T cells upon TCR activation. As
discussed previously, tTregs are generated in the thymus when thymocytes bind MHC-self
peptides at high-avidity to maintain self-tolerance34,35. On the other hand, naïve CD4+ T cells in
the periphery can differentiate into pTregs when stimulated with cognate antigen in the presence
of TGF-β, retinoic acid, and IL-2103,104. TGF-β signaling induces the expression of Foxp3 by
CD4+ T cells in the presence of IL-2 and inhibits Th17 differentiation through the actions of
transcription factors, Smad3 and STAT5105–108. IL-2 signaling is required for TGF- to convert
naïve CD4+CD25- T cells into CD4+CD25+Foxp3+ Tregs105.
Since the development mechanism for pTregs and tTregs is different, it is proposed that
the development of tTregs is essential to maintain self-tolerance and prevent autoimmunity. In
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contrast, pTregs are generated in the periphery to control immune response against
environmental challenges. Several reports demonstrated that pTregs accumulate at tissue sites
constantly exposed to foreign antigens such as the intestine and the placenta109–111. Furthermore,
tissue severely damaged by inflammatory effector responses against pathogens subsequently
produces anti-inflammatory cytokines such as TGF-β to induce Tregs specific for foreign
antigens112,113.

Figure 3:Naïve CD4+ T Cell Differentiation into the Different T Helper or Regulatory
Subsets. Diagram depicting the differentiation of stimulated naïve CD4+ T cells by APC into
different Th subsets depending on the cytokine milieu. The master transcription factor is denoted
within each Th and Treg subset.
Mechanisms of regulatory and suppressive functions by Tregs. Tregs themselves have
to be TCR-activated in the presence of IL-2 to be suppressive114. Once activated, Tregs can
suppress conventional T cells independently of an antigen, a phenomenon known as the
bystander effect115. Tregs possess regulatory and suppressive functions mediated via several
mechanisms, some of which include: 1) Tregs can inhibit TCR-induced proliferation by
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inhibiting IL-2 production by conventional T cells in a cell-contact dependent manner in the
absence of APCs. 2)Tregs can modulate the function of APCs through the expression of
coinhibitory molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is
constitutively expressed by both murine and human Tregs116–118. CTLA-4 expression by Tregs
suppresses the proliferation of conventional T cells in the presence of APCs by downregulating
costimulatory molecules CD80/86 on APCs119. Blockade of CTLA-4 both in vitro and in vivo
abrogated suppression of conventional T cell proliferation and protective effects of Tregs in
murine colitis models116,117,120. 3) Tregs can produce immunosuppressive cytokines, including
TGF-β and IL-10. Tregs can produce high amounts of soluble or membrane-bound TGF-β, and
blocking TGF-β is shown to abrogate suppression of T cell proliferation by Tregs partially121,122.
Immunoregulatory effects of IL-10 production by Tregs have been demonstrated in several
inflammatory disease models 123–125. 4) Tregs may also suppress by expressing hallmark effector
T cell transcription factors such as T-bet. Treg subset has been shown to upregulate Th1
transcription factor T-bet in the presence of IFN-γ, subsequently promoted the expression of
chemokine receptor CXCR3 to promote T-bet+ Tregs accumulation at Th1 inflammatory sites126.
Therefore, it is well appreciated that Tregs can suppress immune responses to maintain
homeostasis and tolerance using many different mechanisms.
Epigenetic regulation of Foxp3. Tregs are characterized by Foxp3 expression, which has
been shown to mediate its differentiation, maintenance, and function99,100,127,128. Because Foxp3
plays such a critical role in Treg biology, extensive studies have been conducted to understand
the molecular mechanisms that govern and regulate the induction of this transcription factor. In
addition to the promoter, three conserved non-coding DNA sequence (CNS) intronic enhancer
element at the Foxp3 gene locus has been identified129. These enhancer regions are designated as
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CNS 1, 2, and 3 and have been shown to contribute differentially to tTreg and pTreg
differentiation. CNS1 region is shown to be essential for iTreg/pTreg development while CNS2
is crucial for the maintenance of Foxp3 expression and CNS3 controls de novo Foxp3 expression
and tTreg differentiation (Figure 4)129.
CNS1 enhancer region contains binding sites for transcription factors such as the nuclear
factor of activated T cells (NFAT), activator protein-1 (AP-1), retinoic acid receptor (RAR), and
Smads (Figure 4)130,131. Smad2/3 binding to CNS1 is responsible for TGF-β mediated induction
of Foxp3 in pTregs132. The deletion of CNS1 led to abrogation of Foxp3 induction in naïve T
cells and pTreg differentiation but did not affect tTreg differentiation in the thymus129. Deletion
of CNS1 is similar to the phenotype of TGF-β1-and Smad2/3-deficient mice, where tTreg levels
were relatively normal, but pTregs were significantly reduced in numbers132,133. CNS1-deficient
mice demonstrate mucosal inflammation and abortion of fetuses, highlighting the importance of
pTregs in maintaining mucosal homeostasis and in pregnancy111,134.
The CNS2 enhancer region contains Stat5, NFAT, RUNX1/Cbfβ, CREB, and Foxp3
binding sites (Figure 4)135. CNS2 region is highly enriched with CpG sites that can be
epigenetically regulated through methylation. This region is also known as one of the Tregspecific demethylated regions (TSDRs). Methylation of CpG islands is generally accepted as an
epigenetic mechanism to repress gene transcription136. The fully demethylated CpG sites on
CNS2 contribute to the stable expression of Foxp3 by tTregs 137,138. Foxp3 protein binds to
demethylated CNS2 and enhances its expression via a positive feedback loop129. The CNS2 CpG
islands are highly methylated in both Foxp3- effector T cells and in vitro generated Tregs
(iTregs), leading to a non-permissible chromatin configuration at the CNS2 enhancer
region135,138,139. Consequently, Foxp3 expression in iTregs is highly unstable and is lost during
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restimulation in the absence of TGF-β135. Additionally, this region’s complete methylation
prevents abnormal Foxp3 induction in non-Tregs such as Th1, Th2, Th17, CD8 T cells, and NK
cells140–142.
The commitment of a stable Treg lineage is established early during tTreg development,
where the TSDR demethylation occurs continuously throughout its tTreg maturation process.
The most immature CD24hi subset among thymic Foxp3+ Tregs started with a substantially
methylated TSDR, and demethylation frequency increases as they mature, identified as CD24 lo
population143. The CpG demethylation of CNS2 in Tregs were controlled by the ten-eleventranslocation (Tet) family of the demethylation factor144. Downregulation of Tet2 prevented
TSDR demethylation in tTregs145. Methyl-binding domain (Mbd) proteins-deficient tTregs had a
marked impairment of Tet2 binding at the TSDR region, leading to a decrease in TSDR
demethylation and Foxp3 expression in tTregs146.
The CNS3 enhancer region contains binding sites for c-Rel, an NFkB family member,
and plays a vital role in tTregs and pTregs differentiation (Figure 4). c-Rel directly binds to
CNS3 and promotes Foxp3 transcription by the formation of a Foxp3-specific
enhanceosome147,148. CNS3-deficient mice demonstrate a significant decrease in the frequency of
tTregs, as well as impairment in TGF-β-mediated Foxp3 induction in peripheral naïve T cells129.
c-Rel deficient mice exhibit a similar reduction in Foxp3 induction as CNS3-deficient mice129.
Kitagawa et al. recently identified a region approximately 8-kb upstream of the
transcriptional start site (TSS) of Foxp3 that is also important for Foxp3 expression regulation.
This region is defined as CNS0 (8.5kb upstream of TSS) and contains binding sites for Satb1
(Figure 4)149. Satb1 is a global genome organizer that induces transcriptional and epigenetic
regulation via forming a novel nuclear architecture150. The binding of Satb1 to CNS0 is predicted
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to be the pioneering element that is required for subsequent activities of the other CNS elements
for Treg lineage commitment. T cell-specific Satb1 deficiency impaired Treg-specific superenhancer activation and decreased expression of Treg signature genes151. Genetic ablation of
Satb1 leads to autoimmunity due to impaired tTreg development152. Although Satb1 deletion
impairs tTreg development, it enhances the development of pTregs in the periphery in mice149.
These data suggest that Satb1 has differential effects on tTreg and pTreg cell development.

Figure 4: Schematic Diagram of Transcriptional Regulation of the Foxp3 Locus. Regulatory
regions within Foxp3 locus, including the promoter, CNS0, CNS1, CNS2, and CNS3 with the
binding of transcription factors and the function of each regulatory region were depicted. Figure
adapted from Lee et al. 153.
CD8αβ+ T Cell Subsets
Upon recognizing its cognate antigen in the context of MHC class I, naïve CD8+ T cells
undergo clonal expansion and subsequent effector differentiation to generate cytotoxic T
lymphocytes (CTL) in the presence of IFN-α/β or IL-12154–156. CD8+ T cells specialize in the
eradication of acute viral or intracellular bacterial pathogens and malignant cells. Like Th1 cells,
CD8+ T cells can generate robust amounts of IFN-γ and TNF157,158. In addition to the release of
proinflammatory cytokines, CD8+ CTL mediates target cell killing by granule exocytosis
pathway or FasL/Fas pathway159. CTL can release secretory granules containing perforin and
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granzyme protein to lyse neighboring cells directly160. Perforin deficient mice cannot clear
lymphocytic choriomeningitis virus (LCMV) in vivo and have lower efficiency in eliminating
tumor cells161–163.
While research mainly focuses on CD4+ Tregs, descriptions of CD8+ Tregs are scarce. In
humans, thymic CD8+ Tregs is described to express markers and function similar to their CD4+
tTreg counterpart164. CD8+ Tregs have been implicated in inflammatory disorders, including
inflammatory bowel disease (IBD), type 1 diabetes, and multiple sclerosis 165–167. CD8+ Tregs
have been shown to inhibit CD4+ Th1 and CD4 follicular T helper (Tfh) cells 168,169.
CD8αα+ T Cells
An important component of the intestinal immune system is the intraepithelial
lymphocytes (IEL), which directly contacts enterocytes and serve as the frontline T cells in the
gut. Within the mouse IEL fraction, there is a sizeable unconventional subset of αβ T cells that
express CD8αα molecules instead of co-receptors CD4 or CD8αβ170. The frequency of these IEL
varies among species where 10% of mouse small intestine IEL consists of these CD8αα+ αβ T
cells but is undetectable in human intestines171,172. CD8αα+ T cells have been detected in the
mouse small intestine lamina propria lymphocyte (LPL) fraction although this study did not
differentiate if they are αβ or γδ T cells173. Unlike conventional CD8αβ+ αβ T cells that have
high TCR repertoire diversity, analysis of both human and mouse IEL repertoire diversity
revealed that TCRα and β chain are oligoclonal in the gut174,175. Furthermore, CD8αα+ αβ T cell
also undergoes self-antigen-dependent agonist selection process in the thymus176,177.
CD8αα+ αβ T cells carry immunoregulatory functions in the gut. Using TCRαβ specific
for lymphocytic choriomeningitis virus (LCMV)-derived peptide gp33 transgenic mice, selfantigen stimulation led to a decrease in IL-2, IFN-γ, and IL-10 production by CD8αα+ αβ IELs.
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Furthermore, in the presence of LCMV infection in the intestinal mucosa of these mice, CD8αα+
αβ IELs do not exhibit cytotoxic activity albeit being activated178. Additionally, CD8αα+ αβ
IELs can prevent CD4+CD45RBhi mediated colitis in severe combined immunodeficiency
(SCID) mice in an IL-10 dependent manner179. These data highlight how CD8αα+ αβ T cells
differ phenotypically and functionally from conventional CD8αβ+ αβ T cells.
γδ T Cells
γδ T cells were discovered in the mid-1980s, but their biological functions and antigens
they recognize are still poorly understood180–182. This T cell lineage blurs the traditional
boundaries between the innate and adaptive immune systems. γδ T cells exert an innate-like
rapid immune response by recognizing a broad spectrum of molecules, including non-peptide
antigens in a classical MHC or MHC-like molecule dependent183–186 and independent
manner187,188. Unlike conventional αβ T cells, which reside primarily in secondary lymphoid
organs, γδ T cells are enriched in mucosal sites of the body such as the skin 189, intestinal
epithelium47,190,191, lung, tongue, and uterus50. γδ T cells express a CD3-associated heterodimeric
T cell receptor (TCR) molecule on their surface, but their diversity of Vγ/Vδ chains appears to be
limited and dictated by their anatomical localization (Figure 2)46,47.
The biology of γδ T cells has been extensively studied in mouse models. They are among
the first T cells to develop in the murine thymus. Their differentiation and effector functions are
developmentally pre-programmed and occur at distinct waves during development. In mice, γδ
thymocytes were detected in the thymus as early as gestation day 14.5 (E14.5), where their
frequency and numbers outnumbered that of αβ thymocytes192. The frequency of γδ thymocytes
reaches its peak at E16.5 then gradually decreases through the first postnatal week until it
reaches adult levels of about 0.3-0.5% around ten days after birth192. This early emergence of γδ
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T cells is also reflected in the periphery, where they are highly represented in fetal and neonates
of many different species. γδ T cells can be detected as early as 6-9 gestational weeks in the
human liver and primitive gut193.
γδ T Cells in the Gut
Most of γδ T cells in the intestine IEL fraction express CD8αα homodimer but not CD8β
chain170. γδ IEL is implicated to be of fetal origin as the transfer of fetal liver from E15-16 can
generate γδ T cells in the IEL compartment173. Vγ7 chain can be detected in the thymus at E13,
and in the fetal gut and liver as early as E11, before T cell progenitors colonize the developing
thymic lobes51.
The developmental route of IEL γδ T cells has been the subject of controversy for many
years as several studies showing γδ IEL from thymus-dependent and thymus-independent origin.
In athymic mice, γδ T cells are still present in the IEL compartment, albeit at a lower number
than euthymic mice173. γδ T cells development and maintenance in the gut are independent of the
microbiota, as the cell numbers isolated from germ-free and conventionally raised mice were
similar194,195.
The importance of γδ IEL in maintaining gut tissue homeostasis is evident by the
reduction of epithelial cell proliferation in both the small intestine and colon in TCRδ-/- mice196.
These γδ IEL express keratinocyte growth factor (KGF), a potent intestinal epithelial cell
mitogen, and are important to preserve the integrity of damaged epithelial surfaces in Dextran
Sulfate Sodium (DSS)-induced colitis model system197. Large numbers of γδ T cells localized at
DSS-induced epithelial cell damage sites and TCRδ-/- mice demonstrated more DSS-induced
mucosal injury and delayed tissue repair after the termination of DSS treatment197. TCRδ-/- mice
also have increased gut permeability attributed to a decrease in intestinal tight junctional
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complexes198. This perturbation correlates with increased susceptibility to the development of
spontaneous colitis in aged TCRδ-/- mice around eight months of age199. The lack of γδ T cells is
also correlated with increased levels of IFN-γ in the intestinal epithelium in different
inflammatory bowel disease animal models200. The transfer of γδ IEL ameliorated colitis with
decreased IFN-γ and increased TGFβ1 production199. In patients with celiac disease, individuals
on a gluten-free diet and not experiencing active celiac disease have a higher frequency of CD8+
γδ IEL that express inhibitory NK receptor NKG2A and intracellular TGFβ1. Crosslinking of
NKG2A or γδ TCR of these CD8+ γδ IEL led to secretion of TGFβ1 in vitro, suggesting the
regulatory potential of CD8+ γδ IEL in celiac disease patients 201.
In addition to maintaining intestinal homeostasis, γδ IEL may carry effector roles against
pathogens. In the presence of intestinal microbiota, γδ IEL can produce antimicrobial protein
regenerating islet-derived (Reg) protein family, C-type lectins, including RegIIIγ, which kills
Gram-positive bacteria194,202. Gene expression profile analysis of γδ IEL shows that they
constitutively express effector function genes such as Granzyme A, B, and RANTES even
without the presence of an infection203. Indirectly, IEL γδ T cells can protect against pathogens
by promoting intestinal epithelial barrier function to restrict epithelial transmigration of
pathogens such as Toxoplasma and Salmonella typhimurium198.
γδ T Cells and Tolerance
The role of γδ T cells in tolerance induction was initiated when McMenamin et al.
demonstrated that OVA exposure in the respiratory mucosa activates splenic CD8+ γδ T cells
that specifically suppressed OVA-specific IgE antibody response in rats and mice204,205. The
depletion of γδ T cells in vivo and in vitro abolished the induction and maintenance of orally
induced-systemic tolerance against OVA, reflected in the production of anti-OVA antibody and
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OVA-specific T cell proliferative responses206. Mechanistically, γδ T cells inhibit the priming of
CTL precursors, IL-2 production and inhibit humoral responses207.
To further investigate how γδ T cells can contribute to the establishment of oral tolerance,
Kapp et al. isolated and generated γδ T cell clones from small intestine IEL fraction. These γδ T
cell clones express IL-10 and transforming growth factor-β1 mRNA and can potently inhibit the
generation of CTL response in vitro208. Locke et al. demonstrated that CD8+ γδ IEL is
required for self-tolerance using a NOD mouse model of spontaneous type 1 diabetes. Transfer
of CD8 γδ IEL prevented the development of diabetes in a 3-day old neonatal thymectomy
(NTX)-NOD mouse model similar to CD4+CD25+ Tregs transfer. The induction of
CD4+CD25+ Tregs via oral insulin in euthymic mice also requires CD8+ γδ IEL in the gut to
prevent diabetes in NOD mice209.
γδ T Cell Cytokine Production
Depending on the source and conditions of activation, γδ T cells can produce a variety of
cytokines including IFN-γ, TNF-α, IL-4, IL-5, IL-6, and IL-10210–212. Many studies generated γδ
T cell clones to study their function and cytokine production due to the low frequency of γδ T
cell. CD4+ and CD4-CD8- γδ T cell clones isolated from TCRα-/- mice conformed to the typical
Th2 phenotype: high levels of IL-4, IL-5 and IL-10 and undetectable levels of IFN-γ, or to the
typical Th1 phenotype, displaying high levels of IFN-γ, respectively. These Th1 and Th2
associated γδ T cell clones could generate appropriate Th1 and Th2 associated IgG production
when cultured with naïve B cells212. Primary γδ T cell clones from noninflamed human skin
tissue produce IFN-γ and TNF after 24-hour stimulation with PMA and ionomycin213. γδ T cell
clones established from the small IEL fraction are shown to produce large amounts of IL-10 and
little to no IL-2, IL-,4, and IFN-γ214. On the other hand, γδ T cell clones established similarly
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from the spleen produces high levels of type 1 cytokines such as IFN-γ and TNF215. Freshly
isolated lamina propria γδ T cells produce IL-10 and IL-17 after PMA ionomycin activation, but
not those isolated from the spleen, payer’s patches, mesenteric lymph nodes, and peripheral
blood216. These data suggest that the cytokine profile of γδ T cells varies depending on their
cellular localization.
T Cell Signaling and Activation
T cell activation initiates when the TCR binds to its cognate antigen presented by the
MHC molecule (pMHC). This TCR/pMHC engagement subsequently led to the phosphorylation
of tyrosine residues on the immunoreceptor tyrosine-based activation motifs (ITAMs) on the
CD3 complex by Src family kinases, Lck217. CD4 and CD8 are both associated with Lck and acts
as co-receptors to augment antigen receptor responses218.
The phosphorylated tyrosine molecules on CD3 ITAMs led to the recruitment of a
protein tyrosine kinase (PTK) known as the zeta-associated protein of 70kDA (Zap-70). Zap-70
binds to these phosphor-tyrosine molecules via their SH2 domain219,220. Upon ITAMs binding,
Zap70 is released from its autoinhibitory conformation. This exposes its regulatory
phosphorylation sites to be phosphorylated by Lck or Zap70 itself (via
transphosphorylation)221,222. Activated Zap70 can now further activate downstream substrates,
including linker for activation of T cells (LAT) and SH2 domain-containing leukocyte
phosphoprotein of 76kDA (SLP-76)223,224.
LAT and SLP-76 served as essential adapters for subsequent signaling factors to bind and
activate multiple signaling pathways. LAT deficient of critical tyrosine residues inhibits T cell
activation224. The loss of LAT or SLP-76 results in a near-complete loss of TCR signal
transduction225,226. Phosphorylation of tyrosine residues on LAT led to the recruitment of

22
downstream signaling molecules such as Grb2 family proteins, SLP-76, and phospholipase Cγ1227,228. Grb2 family of proteins can bind LAT via their SH2 domain while binding other
downstream proteins via their SH3 domains.
One well-known target in the Grb2 complex is the son of sevenless (SOS) that
subsequently led to Ras activation and its downstream signaling pathway229,230. SLP-76 can bind
both Grb2 and PLCγ, serving as an important functional link of the RAS and calcium signaling
pathway223. The recruitment and activation of PLCγ1 catalyze the hydrolysis of
phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol-1,4,5-triphosphate (IP3) and
diacylglycerol (DAG)231. IP3 leads to calcium release from intracellular calcium stores in the
endoplasmic reticulum via the IP3 receptor. This deprivation of intracellular calcium storage
leads to the opening of cytoplasmic calcium release-activated calcium (CRAC) channels leading
to the influx of calcium from the extracellular environment232,233. Calcium regulates calcineurin,
which dephosphorylates and induces the nuclear localization of NFAT transcription complexes
from the cytosol, ultimately leading to NFAT-dependent gene transcription such as IL-2234,235.
The increase of DAG leads to activation of its downstream target RasGRP, a Ras activator, that
subsequently mediates the activation of the Ras signaling pathway downstream236. DAG also
activates protein kinase C-θ, which eventually leads to the activation of the NF-kB pathway
(Figure 5)237.
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Figure 5: Simplified Schematics of the TCR Signaling Pathway. Image adapted from
Biorender.
Immune Tolerance
Our immune system is developed to generate protective immune responses against
foreign antigens and tolerate self-antigens to preserve the integrity of our tissue. Tolerance can
be defined as a state of unresponsiveness against a specific antigen by a fully competent immune
system that is still capable of eliciting protective responses against foreign antigens.
Ray Owen first demonstrated the concept of immunological tolerance in 1945. He
observed that nonidentical, dizygotic twin cattle shared red blood cells that persist into adult
life238. It was known that mixing red blood cells during regular blood transfusions would trigger
a severe immunological reaction. Still, the lack of immune response against dizygotic red blood
cells in these calves suggested that immune tolerance is generated in response to foreign cells
acquired before birth. Furthermore, the majority of these dizygotic cattle twins are entirely
tolerant of each other’s skin allograft239,240. In 1953, Billingham, Brent, and Medawar
demonstrated that injection of allogeneic tissue into mice in utero led to tolerance against
subsequent skin allografts from the same allogeneic strain in adulthood. They showed that the
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establishment of tolerance is dependent on a critical time window when alloantigens are exposed.
Mice that were injected with foreign cells after birth demonstrated a lack of tolerance against
subsequent skin allografts241. These seminal studies laid the groundwork for the concept of
acquired immunological tolerance, for which Burnet and Medawar were awarded the Nobel
Prize in Physiology or Medicine in 1960.
Immune tolerance can be divided into central and peripheral tolerance. Central tolerance
occurs when newly generated T and B cells test their receptors to recognize self-antigens in the
thymus or bone marrow, respectively. Strongly autoreactive T and B cells are censored by clonal
deletion or receptor editing mechanism24,242. Autoreactive T cells developing in the thymus can
also undergo “clonal diversion” where T cells expressing self-reactive TCR differentiate into
tTregs35. tTregs can then exit into the periphery to suppress other autoreactive T cells to maintain
self-tolerance. Therefore, autoreactive T cells can get deleted through the negative selection that
eliminates self-reactive clones from the repertoire (clonal deletion) or gets imprinted into selfreactive clones with suppressive and regulatory functions (clonal diversion).
While central tolerance mechanisms are efficient, they cannot eliminate all self-reactive
lymphocytes. Autoreactive lymphocytes that escaped these mechanisms and entered the
periphery can encounter new self-antigens in secondary lymphoid organs such as lymph nodes
and the spleen. Therefore, the tolerance state of the immune system is further maintained by
multiple peripheral tolerance mechanisms. One of the mechanisms is clonal anergy. It was first
described by Nossal, who discovered the presence of mature, autoreactive B cells in the
circulation that failed to respond to antigen stimulation243. This phenomenon is observed in T
cells activated in the absence of costimulatory signals (e.g., CD28 co-stimulation) or presence of
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coinhibitory signals (e.g., CTLA-4 mediated inhibition), resulting in their unresponsiveness to
subsequent stimulation244.
Another mechanism of peripheral tolerance is the presence of tolerogenic antigenpresenting cells (APCs). DCs can modulate T cell response based on the costimulatory or
coinhibitory signals they provide. DCs can promote tolerogenic response by delivering
coinhibitory signals or not provide adequate costimulatory signals for T cell activation and
proliferation. Healthy cells do not activate resting DCs, whereas direct stress, virally induced
cytokines, and necrotic signals can activate them245. Tolerogenic DCs are not confined to a single
DC subset but may be generated by incomplete maturation or induced in the presence of antiinflammatory cytokines such as IL-10 and TGF-β246. Furthermore, repetitive stimulation of
human naïve T cells with immature DCs can convert naïve T cells into IL-10 producing
regulatory T cell subset, Tr1 cells, that do not express high levels of CD25 or canonical Treg
transcription factor, Foxp3247.
Of note, in addition to tTregs and pTregs, other Foxp3 negative regulatory T cell
populations have been characterized to contribute to peripheral tolerance. A population of
CD4+CD25-Foxp3- T cells was detected in the mesenteric lymph node and spleen when oral
tolerance is induced and mediates suppression via TGF-β dependent mechanism. These cells
express latency-associated peptide (LAP) on their surface and suppress T cell-mediated colitis
and autoimmune encephalomyelitis248,249. Another subtype of peripherally induced Treg is the
IL-10 producing type 1 regulatory T (Tr1) cells that are Foxp3 negative250. Foxp3 is not required
for Tr1 induction or function since suppressive Tr1 cells can be generated and isolated from
peripheral blood of IPEX patients, a disease due to Foxp3 mutations 251. IL-10 producing Tr1
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cells have been demonstrated in various immune-mediated diseases such as diabetes and celiac
disease252,253.
In summary, immune tolerance can be achieved by multiple mechanisms (both central
and peripherally) to prevent excessive inflammation and autoimmune disease development.
Perinatal Immunity
According to the World Health Organization, the perinatal period (comprises both fetal
and neonatal stages) is defined as the period before and a short period after birth. In humans, it
starts during gestational week 22 up to 1 week after birth254. Using conserved key stages of
neurodevelopment during fetal brain formation, the perinatal period in mice starts from
embryonic day 9 (E9) and up to 7 days after birth255,256 (Figure 6).

Figure 6: Perinatal Period in Human and Mice.
The perinatal immune system is phenotypically and functionally distinct from the adult
immune system, which is highly tolerant. During development, the fetus is programmed to exist
in a semi-allogeneic environment in utero. Postnatally, newborns must rapidly develop a
functional system capable of tolerating non-harmful commensal microbes and antigens while
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fighting off harmful pathogens. Therefore, the primary goal of the perinatal immune system is to
attain tolerance, with reduced alloantigen recognition and poor responses against foreign
antigens238,241,257–259. This tolerogenic propensity is important for preventing excessive
inflammation when neonates are first exposed to benign antigens such as commensal microbes,
maternal and food antigens. However, increased tolerance renders newborns highly susceptible
to life-threatening infections, contributing to 40% of the 3 million annual worldwide neonatal
deaths260. Many of these deaths are attributed to vaccine-preventable illnesses, but neonatal
immunity’s tolerant nature reduces vaccine efficacies such as measles, malaria, and polio in
infants261,262. Transplacentally transferred maternal antibodies can provide some early protection
against pathogens in neonates. Maternal antibodies against measles, rubella, and varicella can be
detected in infants up to 4 months after birth263. However, this passive protection mechanism is
short-lived and decays when the child is about six months of age.
Tolerance Establishment
In 1953, Billingham, Brent, and Medawar demonstrated tolerance against non-self can be
established if introduced within a critical time window 241. Failure to establish tolerance during
this critical time window is reflected in the development of allergic disease or inflammation in
adulthood.
In humans, the development of tolerance likely begins in utero. Maternal exposures to the
farming environment increase Treg abundance and suppressive function in UCB 264,265.
Production of allergy-associated Th2 cytokines IL-5 and IL-13 are also lower in neonates from
farming mothers265. Childhood exposure to the farming environment is correlated with the
protection against allergic disease development in adult life266,267. Exposure of children younger
than one year to stables and farm milk consumption is associated with lower frequencies of
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asthma, hay fever, and atopic sensitization compared to those aged 1-5 years266. Subjects that
lived on a farm during the first five years of life had the lowest prevalence of allergic rhinitis
even among the oldest age group (61-75 years), suggesting the lifelong protective effect of
childhood farm living267.
The establishment of tolerance in utero is also essential to tolerate maternal antigens
when the fetuses are developing in a semi-allogeneic host. Several studies have observed that
hematopoietic cells of maternal origin can be found in the developing fetus. Maternal DNA can
be detected in both the cellular and plasma fractions of UCB268. Further, maternal cells have also
been detected to cross the placenta and reside in fetal lymph nodes 257. This micro-chimerism can
persist into adulthood where human leukocyte antigen (HLA)-disparate maternal cells have been
detected in healthy adults269.
Fetal exposure to non-inherited maternal alloantigens (NIMAs) induces the development
of Tregs that suppress anti-maternal immunity and persist into adulthood. These fetal T cells
proliferate substantially in mixed leukocyte reactions with another non-related adult APCs but
have lower proliferation against maternal APCs. These differences were abrogated when fetal
Tregs are depleted from the culture, demonstrating that fetal Tregs suppress proliferation against
maternal alloantigen in an antigen-specific manner257. Tolerance towards NIMAs was observed
in organ transplant recipients with higher graft survival if they received organs expressing
maternal HLA antigens rather than paternal HLA antigens not inherited by the recipient270,271.
Interestingly, newborns exclusively breastfed have a higher frequency of Tregs, reduced NIMAinduced T cell proliferation, and inflammatory cytokine production than those who were
formula-fed. These data indicated that exposure of newborns to maternal cells through
breastfeeding could also increase Treg frequency and promote tolerance against NIMA 272. These
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studies suggest a human equivalent of murine actively acquired tolerance demonstrated by
Billingham, Brent, and Medawar back in 1953.
Tolerance against skin commensal microbe is established during the first to the second
week of life in mice. Adult colonization of the skin commensal microbe (S. epidermis) led to
subsequent skin inflammation, while at seven days after birth, colonization led to tolerance. This
phenomenon coincides with the rapid influx of Tregs to the skin between six and thirteen days
after birth. Blocking Treg migration to the skin abrogates tolerance establishment against S.
epidermis in neonates273.
In summary, establishing tolerance against harmless foreign antigens needs to occur
within a critical development time window to prevent inflammation and atopic disease
development.
Perinatal Immune System is Functional
Experiments demonstrating qualitative and quantitative differences in fetal and adult
immune response demonstrated that the impaired newborn immune responses persist up to 18
months after birth274,275. The perinatal immune system is initially thought to be different from the
adult immune system because it is inert, functionally impaired, or compromised due to limited
antigen experience leading to insufficient immune response. It is now clear that the perinatal
immune system is highly active but biased towards achieving a state of tolerance due to its
developmental requirement.
In neonatal mice, it has been shown that protective CTL responses can be generated by
murine retrovirus276. Furthermore, neonatal T cells can be activated in vivo if the antigen is
presented by professional APC isolated from adult mice277. These data suggest that neonatal T
cells are not intrinsically tolerant biased but became tolerant when non-costimulatory neonatal
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APCs activate them. Lastly, depending on the immunization method, murine neonatal T cells can
generate Th1 or Th2 T cell responses278.
In humans, fetal thymocytes respond to PHA activation as early as 14 gestational weeks,
providing evidence of immune competence in the fetus279. The human fetus can mount T cell
response to some pathogens but result in antigen-specific tolerance towards others. For instance,
fetuses exposed to mumps virus in utero developed persistent cellular immune responses as they
developed delayed hypersensitivity towards inactivated virus skin test280. Neonatal T cells can
elicit a Th1 type response like adult levels in certain vaccinations or maternal infections. Bacillus
Calmette-Guerin (BCG) vaccinations at birth trigger a Th1 memory response of a similar
magnitude compared to when it is given later in life281. CD4+ T cells from infants vaccinated
with BCG at birth produced similar concentrations of IFN-γ as compared to immune adults282.
UCB from helminth infected or mycobacterial-sensitized mothers produced more antigenspecific cytokines (IL-5, IL-10, and IFN-γ) than those from uninfected or non-sensitized
mothers283. Infants exposed to malaria in utero have elevated frequencies of CD4+ effector
memory T cells. Higher frequency of their CD4+ and CD8+ T cells express IFN-γ and TNF in
response to malaria antigens284. These findings suggest that fetuses and neonates can generate
functional and protective pathogen-specific T cell responses like adults under certain infections
and vaccination.
In contrast, T cells from babies with congenital toxoplasmosis failed to proliferate and
produce IFN-γ and IL-2 when cultured with toxoplasma lysate antigens compared to T cells from
infected adults. This lack of response by these neonatal T cells is antigen-specific because they
achieve similar or greater response to concanavalin A activation or mixed leukocyte reaction as
adult T cells285. These data demonstrate that perinatal T cells can generate an immune response
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depending on the pathogen. It is still unclear why specific pathogens can elicit a response while
others do not.
Perinatal versus Adult Immune System
While the perinatal immune system is functional, some critical differences between the
perinatal and adult immune systems contribute to the tolerant biased response by fetuses and
newborns.
Innate Immunity
Several studies indicated that antigen-specific priming in the fetus could occur from
around 20-22 gestation weeks286,287. However, circulating monocytes at all gestational ages
express reduced levels of MHC class II molecules compared to adults, leading to impaired
antigen-presenting activity288. DCs are professional APCs required for the initiation of an
immune response. In their immature form, DC capture, process, and presents antigens on MHCpeptide complexes at their surfaces upon activation289. While APB and UCB DCs have
comparable immature phenotypes, the upregulation of surface HLA-DR and CD86 costimulatory
molecules was significantly diminished in UCB DCs upon LPS activation290. The surface
expression of CD80, CD86, and HLA-DR did not reach until adult levels around 6-9 months
after birth for monocytes and plasmacytoid DC (pDC)291,292.
In addition to antigen presentation, APCs can modulate the immune response generated
to be inflammatory or anti-inflammatory by cytokines they produced after activation293. CD8α+
DC promotes Th1 responses in vivo, while CD8α- DC promotes a Th2 type profile. This
phenomenon was due to the high levels of IL-12 production by CD8α+ DCs294. The induction of
Th1 CD4+ T cells by UCB DCs was significantly lower compared to their adult counterparts 290.
The lower Th1 induction is due to a decrease in IL-12 and IFNα/β production by UCB DCs290,292.
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LPS stimulation of UCB mononuclear cells demonstrates hyperproduction of IL-6, IL-8, and IL10 while IL-12, IFN-γ, and TNF were significantly lower. This hypoproduction of IL-12, IFN-γ,
and TNF persist up to the first six months after birth compared to adults291. Additionally, while
human fetal classical dendritic cells 2 (cDC2) are capable of migrating to lymph nodes, respond
to toll-like receptor ligation and induce adult CD4+ T cell proliferation like adult cDC2s, they
limit the ability of adult CD4+ T cells to produce inflammatory cytokines through the
upregulation of arginase-2 in a coculture set up295.
Another component of the innate immune system is natural killer (NK) cells. NK cell
functions are tightly regulated in the presence of activating and inhibitory receptors. For
instance, CD94/NKG2A is an inhibitory receptor, while CD94/NKG2C is an activating receptor
capable of binding the same human leukocyte antigen-E (HLA-E) molecule296. Neonatal NK
cells express higher levels of the inhibitory receptors CD94/NKG2A and lower capacity to lyse
cognate target cells without undergoing differentiation compared to adult NK cells297,298.
Furthermore, UCB NK cells also have diminished degranulation ability and IFN-γ
production299,300.
γδ T cell compartment. Another difference between the perinatal and adult immune
systems is the γδ T cell compartment. γδ T cells are highly represented in young animals in many
animal species and are disproportionately crucial for immune protection48,301. γδ T cells are
essential for effective primary response against E. vermiformis and Cryptosporidium parvum in
younger mice but not as prominent when adult mice were infected302,303. γδ T cells deficient
weanlings showed a delayed acquisition of immune resistance to E. vermiformis and
Cryptosporidium parvum compared to their wild-type counterparts. The requirement for γδ T cell
for immune protection is no longer observed when adult mice were challenged302,303.
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The γδ V gene usage has been reported to differ between human neonates and adults as
well. UCB γδ T cells predominantly express Vδ1 while adult PBMC predominantly expresses
Vδ2 304. Overrepresentation of Vγ9Vδ2+ γδ T cells in adults was previously thought to reflect an
antigen-specific selection process resulting from postnatal exposure to pathogens. Surprisingly, it
is found that Vγ9Vδ2+ are the predominant circulating γδ T cell subset in the second-trimester
fetus, and its frequency decreases with gestation age. These fetal circulating Vγ9Vδ2+ γδ T cells
were phosphoantigen reactive and showed a preprogrammed effector potential with the
capability to produce Granzyme A, Granzyme K, and IFN-γ305. These data suggest that different
γδ T cell subsets can become predominant at different developmental stages and may carry
important functions that remain to be elucidated.
In humans, γδ T cell clones from UCB and pre-term peripheral blood produce higher
levels of IL-4, IL-5, IL-10, and lower levels of proinflammatory cytokine IFN-γ compared to
adult γδ T cell clones upon antigen receptor stimulation. On the other hand, IFN-γ production by
neonatal γδ T cell clones achieved similar levels to adult γδ T cell clones when the clones were
stimulated with PMA and ionomycin306. These data suggest that neonatal γδ T cell clones can
produce adult levels of effector cytokines depending on the type of stimulation. Gibbons et al.
further dissected if the differences in cytokine production between neonates and adult γδ T cells
is due to the proportion of γδ T cells with different TCR v gene usage. They found that adult
Vγ9Vδ2+ and Vδ1+ clones produce none or very low levels of IL-10 in comparison to neonatal
Vγ9Vδ2+ and Vδ1+ clones, suggesting some age-dependent change in function regardless of V
gene usage306.
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In summary, while perinatal and adult γδ T cells carry specific differences, γδ T cells are
well positioned before and during birth to contribute to both immuno-protection and immunoregulation properties.
Adaptive Immunity
The perinatal immune system is generally considered to produce a Th2 biased response
upon antigen stimulation. In murine studies, neonatal T cells produce higher levels of IL-4 in
response to TCR stimulation compared to adult T cells307. This group subsequently demonstrated
that this Th2 biased response rapidly declines five days after birth to levels similar to adult T
cells308. In contrast, human perinatal T cells do not predispose to a Th2 response but a more
defective Th1 response. UCB naïve T cells produce significantly lower levels of IFN-γ in
comparison to adult naïve T cells under neutral conditions309. UCB T cells also secrete higher
levels of anti-inflammatory cytokine IL-10 upon TCR stimulation under neutral conditions while
their adult counterparts do not310. However, under Th1/Th2 polarizing conditions or in a TCRindependent manner, UCB and murine T cells can elicit Th1 and Th2 cytokine production
similar to or higher than adult-levels309,311.
Studies in both humans and mice demonstrated a deficiency in CD8+ T cell functionality
and magnitude of T cell responses during the perinatal stage. In mice, neonatal CD8+ T cells are
deficient in their in vivo response against influenza, herpes simplex virus, and respiratory
syncytial virus (RSV)312–314. This defect is also observed in humans, where infants with fatal
RSV and influenza virus show a near absence of CD8+ CTL response315. Neonatal CD8+ T cells
produce significantly less granzyme B, IFN-γ, and IL-2 than adult CD8+ T cells316. Additionally,
neonatal CD8+ T cells failed to differentiate into memory T cells but preferentially gave rise to
short-lived effector T cells317. CD8+ T cells by neonates proliferate and differentiate more
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rapidly and demonstrate increased death compared to their adult counterparts following
infection318. These data highlight intrinsic cell differences in the division and differentiation
program by neonatal CD8+ T cells. CD8+ T cells in neonates displayed a distinctive
transcription and chromatin landscape, enriched with gene expression signatures characteristic of
innate immunity316.
Increase propensity for Treg development by perinatal T cells. The contribution of
perinatal tolerance by Tregs has been shown in humans where maternal alloantigen can promote
Treg development and subsequent tolerance that persists into adulthood257,270,271. Treg-mediated
peripheral tolerance is required during fetal development as the initiation of autoimmunity in
IPEX coincides with the emergence of T cells in the second trimester of fetal development 319.
Tregs comprise a significantly greater percentage of total peripheral CD4+ T cells in fetuses (at
25th gestational weeks) than healthy infants and adults (~15% vs. ~5%)320. tTregs were detected
as early as the 13th gestational week along with the first mature T cells, while extrathymic
CD4+CD25+ Tregs were present from the 14th gestational week onwards in human321,322.
Naïve T cells that are isolated from fetal lymphoid organs preferentially differentiate into
functional Tregs upon antigen stimulation are more responsive to allogeneic stimulation than
adults, where they proliferate and adopt a Treg fate257,323. This enhanced propensity could be due
to the elevated expression of various TGF-β family members in fetal lymph nodes compared to
adult lymph nodes257. However, a higher frequency of naïve T cells isolated from fetal lymphoid
organs differentiate into Tregs and express higher Foxp3 than adults upon antigen receptor
stimulation324. The addition of exogenous TGF-β further enhanced Treg differentiation in both
fetal and adult T cells populations. Still, a higher frequency of fetal T cells differentiates into
Treg in all conditions324. This enhanced Treg differentiation may partly be due to having a higher
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sensitivity to TGF-β as indicated by higher levels of SMAD2/3 phosphorylation and the
increased expression of Lin28b, a repressor of microRNAs that target TGF- β signaling
mediators by fetal naïve T cells 324.
UCB naïve CD4+ T cells also differentiate into Foxp3+ Tregs at a higher frequency than
adult naïve CD4+ T cells after antigen receptor stimulation325. The Foxp3+ Treg induction is
further increased in UCB but not APB naïve T cells in the presence of progesterone. This
hormone is implicated in dampening immune responses against fetal and maternal antigens 326.
Furthermore, gene microarray analysis between fetal and adult naïve CD4+ T cells demonstrate
substantial differences323,327. Fetal naïve T cells share a partial transcriptome and epigenome like
adult tTregs, further suggesting that fetal naïve T cells are more poised for tolerance327.
In mice, the increased propensity of perinatal CD4+ T cells to differentiate into Foxp3+ T
cells upon TCR stimulation is also observed. Wang et al. demonstrated a higher frequency of
sorted CD4+ Foxp3-/GFP- from neonatal thymus and spleen converted into Foxp3+/GFP+ Treg
cells upon TCR stimulation than adults without the addition of exogenous TGF-. They
demonstrated that this intrinsic default of Treg generation by neonatal T cells inversely correlates
with age, decreasing to adult levels by two weeks after birth328.
Together these studies suggest both cell-intrinsic and extrinsic mechanisms promote Treg
generation from perinatal T cells to establish tolerance.
Soluble Factors
Soluble plasma factors appeared to carry immunosuppressive effects in infants. The
blood plasma of newborns contains significantly higher levels of adenosine compared to adults.
Adenosine is shown to inhibit toll-like receptor-mediated TNF production by newborn
monocytes while preserving IL-6 cytokine production, a cytokine with anti-inflammatory and
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Th2 polarizing properties329,330. Thus, high adenosine levels may further promote an overall antiinflammatory milieu in neonates.
Relative to adult plasma, neonatal plasma demonstrated a gestational-age-dependent
inadequacy in multiple anti-microbial proteins and peptides. The release of
bactericidal/permeability-increasing protein (BPI) by neonatal polymorphonuclear leukocytes is
significantly lower than adults331. Anti-microbial proteins and peptides such as BPI levels,
calprotectin, LL37, and secretory phospholipase A2 (sPLA2) of full-term newborns are also
significantly lower than their maternal counterparts332.
Thymus differences
During gestation in the mouse, the thymic rudiment is first colonized by hematopoietic
precursors originating from the fetal liver or the aorta-gonad-mesonephros around E12-14333–336.
T cells leaving the thymus during the first two weeks of life appeared to be derived from the first
wave of lymphoid precursors that seeded the fetal thymus around E10-12337. The thymus is
colonized by a second wave of precursor cells sometime after 12 days of fetal life, subsequently
giving rise to the second generation of thymocytes two weeks after birth337. These suggest that
the peripheral T cell pool can arise from different waves of lymphoid precursors seeding the
thymus during ontogeny, which could be another potential mechanism contributing to perinatal
tolerance.
Peripheral CD4+ T cells derived from fetal versus adult thymic precursors are
functionally and phenotypically different. Adkin et al. generated thymic chimera by implanting
fetal thymic lobes in adult host mice and found that fetal-derived T cells produce higher levels of
both IFN-γ and IL-4 than adult-derived T cells in an antigen-specific manner338. In contrast,
antigen response of CD4+ T cells comparing intact neonatal and adult mice demonstrate the
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typical neonatal response where they are Th2 biased and produce fewer IFN-γ compared to
adult338. These data suggest that the combination of fetal precursors and fetal thymic stroma are
necessary to produce cells with fetal-like properties339.
There are differences in cTECs and mTECs proportions between the first week of
postnatal life versus the adult thymus. Quantification of cytokeratins, K5 expressed by mTECs,
and K8 expressed by cTECs allowed the cTECs/mTECs ratio analysis. There is a predominance
of cTEC in neonates in contrast to mTEC predominance in adults340. Histologic analysis revealed
that the neonatal thymus has minimal medullary areas and unique vascular architectures than the
adult thymus. This observation is consistent with immature thymocyte predominance in
neonates340. Transcriptional diversity is also observed within mTEC and cTEC isolated from the
fetus (from different gestational days), newborns, adults, and aged mice341. Age-dependent
thymic microenvironment changes in the peptide repertoire, antigen processing, and presentation
are thought to influence the negative selection and Treg development342,343.
Furthermore, it is suggested that negative selection in neonates is inefficient344,345.
Thymic selection threshold is higher in neonates and young versus adult mice, where thymocytes
bearing TCRs with low affinity for self-peptide are not efficiently selected into the neonatal T
cell repertoire346. Alternately, thymocytes with high reactivity against self-peptide MHC will be
positively selected, leading to a skewed TCR repertoire in neonates with higher self-reactivity.
Increased self-reactivity subthreshold has been linked to higher binding affinity and promiscuity
against multiple foreign antigens347–349. The strength of TCR signaling during thymic selection is
correlated with the cell surface expression of CD5350. Both neonatal conventional T cells and
tTregs had significantly higher CD5 expression than their adult counterparts in mice346. Thus,
increasing the thymic selection threshold in neonatal T cell development may endow the limited
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TCR repertoire with a more remarkable ability to respond to multiple foreign antigens.
Additionally, NTx one to four days after birth led to maintenance of TCR repertoire from early
neonatal life that was usually deleted in the adult thymus. These thymectomized mice contain
autoreactive T cell clones in the periphery that can expand, ultimately leading to autoimmune
disease development344.
Differences in Progenitor Cells
Previous work has suggested that the ontogeny of the immune system does not progress
linearly from fetal to adulthood but rather stratified into layers of distinct immune cell
development arising from different waves of hematopoietic stem cells351. This concept has been
applied to observing different murine  T cells lineages and B cells that differ in their ontogeny
and arise in succession352,353. Accumulating evidence proposes that neonatal T cells are a distinct
T cell population with unique functional properties suited for their perinatal life requirements. It
is hypothesized that they arise from a different pool of progenitor cells from adult T cells.
Fetal and adult thymocyte precursors can give rise to mature T cells that differ in life
span and proliferative capacity in the periphery. Intra-thymic injection of fetal thymocyte
precursors generated a different ratio of CD4+ to CD8+ T cells compared to those derived from
adult thymocyte precursors354,355. Adkins et al. demonstrated that E14 and E17 fetal CD4-CD8thymocyte produce similar outcomes with low CD4:CD8 mature T cell ratio. In contrast, E20
(approximately at birth) fetal progenitors produce more CD4+ T cells in the periphery, bringing
the CD4:CD8 ratio closer to that produced by adult progenitors. This study further suggests a
switch of CD4-CD8- thymocyte precursor potential at or near birth355.
HSCs from fetal vs. adult can also give rise to cells that differ in their function and
phenotype. Peripheral CD4+ T cells derived from fetal thymic precursors produce more IFN-
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and IL-4 than adult-derived cells in an antigen-specific manner338. Human HSC from 18-22
gestational week fetuses has an increased capacity to generate Tregs during thymic maturation
than adults323. Neonatal CD8+ T cells derived from fetal liver HSCs are inherently more
proliferative and preferentially become short-lived effectors, while adult-derived CD8+ T cells
form long-lived memory cells after infection356. Using a time-stamp method, this group
subsequently observed that naïve CD8+ T cell population consists of a heterogeneous population
distinguished by their developmental origin, transcriptional and epigenetic profiles 357. Lastly,
Vγ5 γδ T cells are the first wave of γδ T cells is detected in the thymus48. Ikuta et al.
demonstrated that only thymic lobes repopulated with HSCs from the fetal liver can generate
Vγ5 γδ T cells but not HSCs from adult bone marrow358. Altogether, these observations suggest
that there are cell-intrinsic differences in progenitor cells between fetal and adult.
Transcriptome and Epigenetic differences
Epigenetic processes partly contribute preferential neonatal CD4+ T cell differentiation
into Th2 effector cells. It was demonstrated that human UCB naïve CD4+ T cells have
differential methylation patterns at their IFN-γ promoter regions than adult naïve CD4+ T cells.
UCB CD4+ T cells carry a hypermethylation pattern in their IFN-γ promoter regions, and this is
reflected with a 5 to 10-fold decrease in IFN-γ production compared to their adult counterparts.
In contrast, there was little to no evidence of non-CpG methylation in the IL-4 promoter region
in both UCB and adult naïve T cells359.
Fetal naïve T cells have an increased propensity to differentiate into Tregs even in the
absence of high levels of exogenous TGF- suggestive of additional cell-intrinsic mechanisms
such as a poised epigenome for Treg differentiation324. Fetal naïve T cells express higher levels
of Helios and display higher chromatin accessibility at the Helios locus compared to adult naïve
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T cells327. Ablation of Helios in fetal naïve T cells subsequently results in poor Treg
differentiation and function, suggesting that fetal naïve T cells may have a poised predominant
epigenome programmed for immune tolerance.
Recent studies have shown that neonatal CD8+ T cells are poised for rapid effector cell
differentiation. CD8+ T cells of early developmental origins displayed increased chromatin
accessibility to genes that favor effector cell differentiation such as Tbx21, Id2, Il2ra, Il15ra, and
decreased accessibility to genes promoting naïve and memory cell development even without the
presence of infection357. Furthermore, CD8+ T cells of early developmental origins also express
a higher proportion of genes associated with short-term effectors, late effectors, and memory
cells. CD8+ T cells of adult origin have a higher expression that characterizes naïve and late
memory cells seen in RNA-sequencing357. This study corroborated the finding that neonatal T
cells generate a comparable lung-localized response against influenza infection as adult T cells
but subsequently reduce developing tissue-resident memory cells after the infection360. This
response is T cell-intrinsic as neonatal T cells highly express transcription factors associated with
effector T cell differentiation and function (Blimp1, Id2, and Tbet) as demonstrated using RNAseq. Neonatal lung effector CD4+ T cells also revealed a T-bet signature, known to drive the
generation of terminally differentiated, short-lived effector cells361.
Ikaros Family of Transcription Factors
The Ikaros (Ikzf1) transcription factor was first cloned and characterized in search of a
master regulator for T-cell development in 1992 by Georgopoulos et al.362. Subsequently, the
other family members, Helios (Ikzf2), Aiolos (Ikzf3), Eos (Ikzf4), and Pegasus (Ikzf5), were
isolated and found to be functionally diverse. The Ikaros family of proteins are zinc-finger
transcription factors. They contain conserved zinc-finger motifs consisting of a zinc atom in
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specific coordination with four amino acids that are predominantly cysteine and histidine. This
family of transcription factors is characterized by two sets of highly conserved C2H2-type
(Cysteine-2-Histidine-2) zinc-finger motifs363. The first set of zinc-fingers are the aminoterminal (N-terminal) DNA binding zinc-finger domains, which facilitates the binding to specific
DNA sequences throughout the genome. The next set of zinc-fingers are the carboxyl-terminal
(C-terminal) zinc-finger domains for homo- and heterodimeric protein interaction with other
Ikaros family members as well as other transcriptional regulators364,365. These proteins can both
positively and negatively regulate gene expression through direct interactions with DNA and
form transcriptional complexes with other proteins366. Ikaros, Aiolos, Helios, and Eos contain
four DNA-binding zinc-fingers and are shown to recognize canonical sequence “GGAAA” while
Pegasus has been found to recognize distinct DNA sequences “GNNNGNNG” due to its
divergent N-terminus zinc finger domains 363,367.
Helios
Helios (IKZF2) was cloned in 1998 as a novel dimerization partner of Ikaros. At the
chromosomal level, Helios is found to be in complex with Ikaros at centromeric heterochromatin
regions of the T cell nuclei368. At the nucleosomal level, Helios is also found to associate with
proteins of the nucleosome remodeling and histone deacetylase (NuRD) complex in a thymocyte
cell line369.
Helios expression. Helios was detected in all hematopoietic sites of the developing
embryo, in adult HSCs, earliest lymphoid progenitors, and subsequently restricted to a subset
within the T cell lineage368. Using Northern blot, Kelley et al. tracked Helios expression in
different fetal organs throughout ontogeny. Helios is first detected in the yolk sac blood islands
on day 8 of gestation (E8). Subsequently, Helios is detected in the fetal liver by E11. At E13,
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Helios is detected in the epithelial lining of the gut and within the liver. Helios is expressed near
the center of the thymus, epithelial linings of the esophagus, and the trachea at E16. By E17,
Helios expression is found in several epithelial tissues such as the lungs, mouth, salivary glands,
and skin but no longer detected in the fetal liver368. Although Helios is expressed in the lungs,
liver, kidney, and brain at different stages of embryogenesis, it is not detected in adult tissues368.
During hematopoietic development, Helios, Ikaros, and Aiolos have an overlapping but
distinct pattern of expression that might underscore their specific regulatory roles during
differentiation368,370,371. Helios mRNA is detected in CD4-CD8- DN to CD4+CD8+ DP subsets
and declines as these become CD4+ and CD8+ SP thymocytes. Mature T cells in the periphery
also have lower IKZF2 mRNA expression compared to immature thymocytes. However, Helios
mRNA is highly detected in skin and gut γδ T cells368.
Helios was initially thought of as a specific marker for tTreg identification372. This
conclusion is reached due to the identification of the earliest Foxp3+ T cells in the thymus during
the first week of life exclusively express Helios, Foxp3+Helios- cells do not appear in the
periphery until after the first week of life. Lastly, iTregs and pTregs do not express Helios.
However, Helios is upregulated in both human and mouse CD4+ and CD8+ T cells after
activation regardless of Foxp3 status373. Another study demonstrated that Helios is expressed by
CD4+ T cells differentiating into Th2 and T follicular helper cells (Tfh) without parallel
upregulation of Foxp3374. Helios is also induced in iTregs generated in vitro in the presence of
APC and pTregs in vivo following antigen-specific immunization375. These studies demonstrate
that Helios is not specific as a marker to distinguish tTregs from other T cell subsets.
Helios is also expressed by other T cell subsets such as CD8+ T cells and γδ T cells.
About 50% of CD8+ Tregs (CD44+CD122+Ly49+) are shown to express Helios in mice376.
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They demonstrate that CD8+ but not CD4+ Tregs displayed reduced numbers in IKZF2 deficient
mice with no apparent signs of autoimmunity until 6-8 months of age. CD8+ Tregs target T
helper cells through a Qa-1/peptide-T cell receptor interaction that prevents autoantibodymediated autoimmune disease169. Helios deficient CD8+ Tregs failed to inhibit Tfh cells as
demonstrated by increased antigen-specific IgG1 response, increased dsDNA, and Tfh cell
number376. In addition to that, Helios binds mainly at promoter regions of target genes in both
CD4+ and CD8+ Tregs376. Roughly one-third of freshly isolated γδ T cells from human
peripheral blood express Helios but are Foxp3 negative. However, if Helios is directly involved
in the immunoregulatory functions of γδ T cells is still unclear377. While the precise role of
Helios in γδ T cells remains to be fully characterized, it is observed that the up-regulation of
Helios in γδ T cells depends on the cytokine milieu and was more pronounced in response to
TCR stimulation as compared to phosphoantigen377.
The Function of Helios. Initial functional analysis of Helios in tumor cell lines
suggested that Helios was a tumor suppressor. Human T cell leukemia and lymphoma cell lines
and patients with T-cell acute lymphoblastic leukemia overexpressed short isoforms of Helios,
which lacked three of the four N-terminal zinc finger domains378,379. Characterization of this
short Helios isoform (Hel-5) reflects the loss of repressor function. It also carries dominantnegative effects by associating with full-length isoforms of Ikaros, Aiolos, and Helios,
subsequently inhibit their DNA-binding activity380. Overexpression of the short Helios isoform
lacking the N-terminal DNA binding domain in hematopoietic progenitor cells led to aggressive
and transplantable T cell lymphoma in mice.
On the other hand, overexpression of full-length Helios in this model inhibits αβ T cell
development at the DN stage within the thymus, resulting in increased frequencies of γδ T cells
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and NK cells in the periphery381. Overexpression of the full-length Helios isoform in T cells also
results in cell death382. Studies using the in vivo Helios-null mutation system demonstrate that the
germline deletion of Helios is embryonically lethal on a B6 background but only almost entirely
lethal if the mice were generated on a mixed background (129/Sv: B6)383. These Helios deficient
mice live at least 22 months of age without overt signs of ill health, defects in T cell function, or
Treg development383. Overall, these studies suggest that Helios is vital in maintaining normal
homeostasis in T cell development.
Helios is important to maintain Treg stability and function372,384–386. Helios+ Tregs
demonstrated more superior suppressive capability than Helios- Tregs in antigen-specific
manner387. Treg-specific Helios deficiency led to lower levels of Foxp3 expression and increased
effector cytokines such as IFN-γ, TNF, and IL-17 by these cells following immunization376. The
transfer of Helios deficient Tregs failed to abrogate inflammatory bowel diseases (IBD) induced
by effector T cells transfer into Rag2-/- mice376. Surprisingly, Treg-specific Helios knockout did
not exhibit autoimmunity early like Treg defective mice. However, they eventually develop
progressive systemic immune activation and hypergammaglobulinemia by 5-6 months of age385.
Helios regulates IL-2 production by suppressing IL-2 gene transcription in Tregs through the
cooperation of Foxp3388. Helios does not bind to the Foxp3 locus in both CD4+ and CD8+ Tregs,
while Foxp3 is found to occupy the Ikzf2 locus in CD4+ Tregs376,389. T cell-specific Helios
deletion did not affect Foxp3 expression, demonstrating that Helios is not required for Foxp3
expression372. Ectopic co-expression of Foxp3 and Helios in CD4+ and CD8+ T cells led to
superior suppressive function and delayed xenogeneic graft-versus-host disease compared to
Foxp3 alone390.
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Additionally, Helios is implicated in Treg differentiation by being a part of the epigenetic
and transcriptional program that lowers the threshold for Treg differentiation and functional
commitment. Helios is highly expressed by fetal naïve T cells, and CRISPR-Cas9 mediated
deletion of Helios impaired fetal naïve T cell’s intrinsic ability to differentiate into iTregs upon
TCR activation in the absence of exogenous TGF-β327. Helios upregulates Treg-specific genes
such as Il10 and downregulates proinflammatory genes in fetal iTregs. Fetal iTregs deficient in
Helios produce lower levels of IL-10 and concurrently increased levels of IFN-γ and IL-2327.
Microarray data have shown that Foxp3 alone is insufficient to induce a complete Treg gene
signature in mouse CD4+ T cells391. Expression of full-length Helios can further alter Treg
signature and gene expression in cellular pathways390. Overall, these data highlight the role of
Helios in Treg differentiation, function, and stability. However, mice with Helios deficiency in
all T cells do not immediately exhibit autoimmunity (developed at 5-6 months of age) despite the
defective suppressive effect of their Treg population376. These data suggest that Helios also
carries essential functions in non-Treg subsets.
Ikaros
Ikaros is the founding as well as the most studied member of the Ikaros transcription
factor family. It is abundantly expressed during early embryonic hematopoiesis, including HSCs,
lymphoid, erythroid, and myeloid precursors, as well as various lymphoid and myeloid lineages
in mice362,392–394. Ikaros can repress and activate gene expression by forming higher-order
chromatin binding complexes such as histone deacetylase complexes (HDAC) and SWI/SNF
complexes395,396.
The critical role of Ikaros in hematopoiesis has been investigated in different transgenic
mouse models and is implicated to be a lymphocyte-specific lineage factor. In mice that lack all
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Ikaros isoforms, demonstrated a devoid of all fetal and most adult lymphoid lineages. Aberrant T
cell development after birth and subsequent T cell lymphoma development was observed in these
mice397. This selective defect in fetal and adult lymphoid compartments suggests that Ikaros are
required for fetal HSCs development or differentiation into lymphoid lineages. At the same time,
they are partially redundant for adult HSCs differentiation into some lymphoid compartments. In
mice that express dominant-negative form of Ikaros (DNA-binding domain deficient) show more
severe defects with complete absence of αβ and γδ T cells and NK cells, while their erythroid
and myeloid lineages remained intact370. These data suggest that the unique pattern of Ikaros
expression provides positive signals for lymphocyte differentiation and negative signals for other
hematopoietic lineages.
Within mature T cells, Ikaros is known to play a role in CD4+ T cell differentiation.
Ikaros inhibits Th1 differentiation by suppressing T-bet and IFN-γ gene expression398,399. Ikaros
deficiency decreased Th2-specific transcription factors such as GATA-3 and cMAF and a
subsequent increase in T-bet and STAT1 expression under Th2 polarizing conditions398. T celldeficient in Ikaros also express lower levels of IL-10, and overexpression of Ikaros restore IL-10
production. Ikaros also directly binds to conserved regulatory regions of the Il10 locus in Th2
cells, further supporting a role in IL-10 expression400. Ikaros is shown to play a role in cytokine
responsiveness within CD8+ T cells. Expression of a dominant-negative Ikaros isoform within
CD8+ T cells increases CD25 (IL-2Rα) expression and survival in the presence of IL-12401.
Ikaros also suppresses CD8+ T cells autocrine IL-2 production and subsequent differentiation
into IFN-γ producing CTL402.
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Aiolos
Cloned by the Georgopoulos group in 1997, Aiolos has the highest sequence homology to
Ikaros and can heterodimerize with Ikaros. However, in contrast to Ikaros, Aiolos expression was
not detected in HSCs or precursor cells371. The earliest stage where Aiolos was detected was in
the pre-B cell and CD4-CD8- DN thymocyte stage. Aiolos expression is subsequently
upregulated as these cells terminally differentiate403. Loss of Aiolos increases pre-B and
immature B cell precursors and subsequent B cell lymphomas while T cell development is
relatively unaffected in mice404.
In mature T cells, Aiolos is implicated in Th17 differentiation by promoting Th17
associated genes, including IL-17a and IL-17f, in part by silencing IL-2 production405. Aiolos
interacts with a known Il10 regulator, Ikaros, which has been reported to regulate IL-10
expression in CD4+ T cells371,400. Furthermore, Aiolos is required for IL-10 production by CD4+
T cells upon TCR stimulation. However, overexpression of Aiolos did not further upregulate IL10 production. These data suggest that Aiolos is associated with but not sufficient for IL-10
production by CD4+ T cells406.
Eos
Eos and Pegasus were cloned around 1999367,407. Eos is highly related to Helios and can
form heterodimers with the other Ikaros family members and homodimers with itself 367. Eos
expression is not confined to the hematopoietic system as it can also be detected in the liver and
the developing nervous system407. In the hematopoietic system, Eos is express in myeloid and
megakaryocyte cell lines367. Within CD4+ T cells, Eos may play a negative role in Th17
polarization as its inhibition by microRNA, miR-17, enhances Th17 differentiation408. Eos is a
critical mediator of Foxp3-dependent gene silencing in Tregs. Mechanistically, Eos directly
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interacts with Foxp3 and induces chromatin modification to suppress Foxp3-dependent gene
expression in Tregs. Knocking down Eos in Tregs abrogates their suppressive function in vivo
and increases effector cytokine gene expression409.
Pegasus
Pegasus is the most divergent member of the Ikaros family and the least studied among
them. Its expression is not restricted to only mature hematopoietic cells but also broadly
expressed in the brain, skeletal muscle, heart, liver, and kidney in mice367. Pegasus recognizes
specific DNA-binding sites from the other Ikaros family of proteins and represses gene
expression367.
Interleukin-10 (IL-10)
IL-10 was initially termed cytokine synthesis inhibitory factor (CSIF) when it was
discovered to be produced by Th2 cells and suppress Th1 cytokine production67. It was
subsequently discovered that IL-10 could be produced by both innate and adaptive immune cells
in addition to Th2 CD4+ T cells, such as DC, monocytes, macrophages, B cells, CD8+ T cells,
Th1 CD4+ T cells, Tregs, and Th17410.
Irrespectively of the cellular source, IL-10 is generally accepted as an anti-inflammatory
cytokine. IL-10 can inhibit CD4+ effector T cells differentiation and proliferation by
downregulating MHC, intracellular adhesion molecule-1 (ICAM-1), and costimulatory
molecules CD80/86 on APCs411–414. Downregulation of these costimulatory molecules can
significantly affect the T cell activating capacity of the APC413,415. IL-10 can suppress the
production of proinflammatory cytokines, including IL-1α, IL-1β, IL-6, IL-8, M-CSF, IL-12,
GM-CSF, TNF, G-CSF by APCs416–419. Furthermore, IL-10 can also inhibit IFN-γ production by
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Th1 cells by acting on APC420. On the other hand, IL-10 can directly act on T cells by inhibiting
T cell proliferation and cytokine production421–423.
The anti-inflammatory role of IL-10 is important in maintaining immune tolerance in the
gut. Mutations in IL-10 and its receptors were the first causal genetic defects discovered in very
early onset-inflammatory bowel disease (VEO-IBD) pathogenesis424,425. VEO-IBD is a subset of
IBD patients that developed IBD under six years of age424. IL-10 deficient mice developed
spontaneous enterocolitis due to a hyperactive immune response against gut microbes426.
Notably, IL-10 treatment in weanlings prevents IBD development but was not as effective when
the same regimen was given in adult mice, suggesting that IL-10 production is vital to maintain
tolerance early in life427.
Alcohol Effects on the Immune System
It is well established that alcohol consumption alters both the innate and the adaptive
immune systems in both human and animal models. However, the effects of alcohol are not as
clear-cut and are dependent on the duration and the amount of alcohol consumed. Moderate
alcohol consumption is associated with immune-stimulatory effects, while heavy or binge
drinking results in impaired immune function. Based on the Dietary Guidelines of Americans by
the U.S. Department of Health and Human Services and the U.S. Department of Agriculture,
moderate alcohol consumption is defined as up to one drink per day for women and up to two
drinks per day for men428. The Substance Abuse and Mental Health Service Administration
(SAMHSA) defines binge drinking as four or more alcoholic drinks for women and five or more
alcoholic drinks for men on the same occasion on at least one day in the past month. They further
define heavy alcohol use as binge drinking on at least five days or more in the last 30 days429.
Alcohol can modulate the immune system in a biphasic manner, but these effects remain poorly
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understood due to a lack of systematic studies that examine the effects of multiple doses and
duration of alcohol intake on the different aspects of the immune system.
Modulation of the Innate Immune System
Monocytes express toll-like receptor 4 (TLR4), a pattern recognition receptor (PRR)
capable of recognizing endotoxin LPS on the surface of Gram-negative bacteria430,431. Upon TLR
activation, monocytes get activated, differentiate, and produce inflammatory cytokines such as
IL-1β, IL-12, IL-6, and TNF at the site of infection432–434. These events are dependent on the
translocation of NFkB into the nucleus, subsequently leading to the production of these
proinflammatory cytokines 433,434. Studies have shown that alcohol can modulate LPS response
by monocytes in a dose-dependent manner. Acute treatment of alcohol produces an
immunosuppressive response by monocytes. For instance, pre-incubation of human monocytes
with 25mM alcohol (~0.1g/dL blood alcohol concentration) for 24 hours inhibits NFkB
activation in the presence of LPS, subsequently decreasing the production of TLR4-induced IL1β, IL-6, and TNF435. Acute alcohol exposure led to increased IL-1R-associated kinasemonocyte (IRAK-M) expression, a negative regulator for IRAK-1 in human monocytes, and
decreased NFkB activity in human monocytes436. Additional studies in monocytes and
macrophages demonstrate that acute alcohol exposure induces the expression of heat shock
protein 70 (hsp70) in the presence of LPS activation, which subsequently binds NFkB subunit
p50 and decreases NFkB activity by inhibiting its nuclear translocation435. Overall, acute alcohol
exposure of monocyte and macrophages in vitro decreases TLR-4 mediated proinflammatory
cytokine production by inhibiting the NFkB pathway. Additionally, acute alcohol exposure can
also inhibit other PRR signaling pathways such as TLR-8 mediated TNF production while
increasing anti-inflammatory cytokine IL-10 by human monocytes437.
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These in vitro findings of acute alcohol exposure were recapitulated in vivo using mouse
models. Serum cytokine levels 2 hours after a single administration of 6g/kg ethanol showed a
decrease in IL-6, IL-12, and an increase in IL-10 in response to TLR2/6, TLR4, TLR5, TLR7,
and TLR9 agonists administered intraperitoneal or intravenous at the same time as oral gavage of
alcohol438. Using the same regimen, administering a single dose of alcohol also decreased host
resistance to E.coli-induced peritonitis438. Consumption of 10% (w/v) ethanol ad libitum for two
days in mice resulted in suppressed DC function by reducing bone marrow DC generation, IL12 production, costimulatory molecule expression, and impaired capability to promote T cell
proliferation439.
In contrast to immunosuppressive effects by acute alcohol exposure, prolonged alcohol
exposure increased inflammatory response. Prolonged incubation (7 days) of human monocytes
with alcohol in vitro increases LPS-induced TNF production while maintaining IL-10 levels
compared to acute exposure437. Prolonged alcohol exposure of monocytes and macrophages
reduces hsp70 and IRAK-M expression in the presence of LPS activation, which subsequently
increases NFkB activity and TNF production435,436. In a chronic drinking rodent model, ingesting
6.3% (v/v) ethanol for four weeks increased the serum's proinflammatory cytokines, IL-6 and
TNF levels. This response is reflected by increased NFkB activation and subsequent IL-6 and
TNF production by hepatic macrophages after LPS challenge in vitro440. In humans, peripheral
monocytes isolated from alcoholic hepatitis patients also demonstrated a significant increase in
TNF production in response to LPS challenge in vitro compared to healthy controls441.
Finally, the dose of alcohol also modulates immune function differently. Primary murine
alveolar macrophages cultured in increasing amounts (25mM-100mM) of ethanol for 24 hours
before the addition of apoptotic cells demonstrated a dose-dependent decrease in efferocytosis,
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the process of clearing dead cells442. Human monocytes isolated from a 30-day moderate alcohol
drinking regimen exhibit increased phagocytic and intracellular bactericidal activity when
incubated with fluorescence-labeled E.coli443.
In summary, alcohol can modulate the function of innate immune cells in a dose and
time-dependent manner. Acute exposure led to the suppression of innate immune cell function,
while prolonged exposure to alcohol led to increased proinflammatory responses by innate
immune cells (Figure 7).

Figure 7: Modulation of Innate Immune System by Alcohol.
Modulation of the Adaptive Immune System by Alcohol
Alcohol can also modulate cell-mediated and humoral immunity in a dose- and timedependent manner, although studies with systemic comparison across doses and durations are
scarce. Moderate consumption of beer for 30 days in a human study resulted in a significant
increase in the number of leukocytes and mature T cells in women444. Moderate alcohol
consumption is implicated in enhancing the immune response against infection where it is
associated with a lower incidence of common cold and better vaccination response 443,445–449. A
cross-sectional study of heavy (90-249 drinks/month), moderate (30-89 drinks/month), or light
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(<10 drinks/month) male drinkers demonstrated a dose-dependent effect on both cellular and
humoral immunity450. In this study, as alcohol consumption increases, there is a decrease in B
cells and CD8+ T cell frequency while CD4+ T cell frequency, CD4/CD8 ratio, and IgA and
IgM level increase450. Another human study across men and women alcohol drinkers
(abstainers, light, moderate and heavy drinkers) also found a dose-dependent increase in serum
IgA levels451. Treatment of a mouse hybridoma cell line with increasing doses of ethanol for 48
hours demonstrated a dose-dependent increase in IgM production452.
Chronic alcoholics without liver disease demonstrated a decreased CD4/CD8 ratio in
their periphery453. Multiple chronic drinking rodent models revealed a reduction in total T cell
frequency and a progressive loss of both CD4+ and CD8+ T cells454,455. In addition to the effects
on lymphocyte frequency, chronic alcohol abuse also affects the T cell phenotype. Chronic
alcohol users demonstrate a decreased percentage of naïve CD4+ and CD8+ T cells and an
increase in memory T cell subsets456,457. This phenomenon is recapitulated in a rodent model
where chronic ethanol consumption (20%) for up to 6 months causes a decrease in naïve T cell
frequency and subsequent increase in memory T cell frequency458. Subsequently, the change in T
cell subsets by chronic alcohol consumption led to elevated IFN-γ and IL-4 production by these
T cells independent of a second costimulatory signal 458. This shift from naïve to memory
phenotype is due to homeostatic-induced proliferation in vivo as chronic alcohol consumption
can induce lymphopenia459,460. The loss of naïve T cells could impair the development of
effective response towards vaccines and against infectious pathogens, which may explain the
increased susceptibility of chronic alcohol users to different infectious diseases 461–466.
In rodent models of chronic alcohol abuse, there is also an increase in morbidity and
mortality against infectious diseases. Mice that consumed 20%(w/v) ethanol for 4-8 weeks

55
demonstrated impaired immune response against pulmonary influenza as seen in a decrease in
pulmonary influenza-specific CD8+ T cell responses, increased mortality and morbidity, as well
as virus titers467. This phenomenon was also seen in a Listeria monocytogenes infection
model468.
In addition to the shift from naïve to memory phenotype, chronic alcohol abuse also led
to a significant increase in activated T cell frequency. Adult males who chronically use alcohol
increased activated CD8+ T cell frequency as measured by increased HLA-DR expression457,469.
This observation is recapitulated in rodent models where consumption of 20% (w/v) ethanol for
up to 6 months displayed an increased percentage of activated T cells as measured by CD43,
Ly6C expression, increased sensitivity to TCR stimulation, and a more robust IFN-γ response
upon stimulation458,459.
In summary, chronic alcohol exposure induces T cell lymphopenia, a shift from naïve to
memory T cell phenotype, and increased immunoglobulin production. In contrast, moderate
alcohol consumption is implicated in boosting the immune response and causes an increase in
lymphocyte frequencies (Figure 8).

Figure 8: Modulation of Adaptive Immune Cells by Alcohol.
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Alcohol Effects on T cell Signaling
Alcohol-related immunosuppression of cell-mediated immunity includes a higher
incidence of sepsis, pneumonia, and tuberculosis461–464. Alcohol can also suppress T cell
proliferation and IL-2 production in response to mitogen, suggesting possible impairment in
transmembrane signal-transduction pathways during T cell activation470–472. In vitro ethanol
incubation of human T cells led to decreased proliferative response to anti-CD3 and anti-CD2
accompanied by a decrease in intracellular Ca2+ mobilization and IP3 production473. This
phenomenon is also observed in T cells isolated from alcoholic liver cirrhosis (AC) patients473.
Furthermore, human primary CD4+ T cells and Jurkat T cells exposed to ethanol led to a dosedependent decrease in PHA-stimulated IL-2 mRNA and protein levels. The reduction of IL-2
production by CD4+ T cells is due to the inhibition of NFAT upon anti-CD3/CD28
stimulation474. Pretreatment of Jurkat and primary CD4+ T cells with ethanol also decreased T
cell stimulation mediated phosphorylation of early signaling molecules PLCγ1, Zap70, LAT, and
Lck without changing total protein levels. The decrease activation of early TCR signaling
molecules may be partly due to a decrease in TCR-activation mediated lipid raft colocalization of
PLCγ1, Zap70, LAT, and Lck474. These data suggest that ethanol blocks early TCR signaling
pathways and subsequently decreases IL-2 production.
Fetal Alcohol Exposure
Despite the well-known teratogenic effects of alcohol on the developing fetus, CDC
reported 1 in 9 pregnant women drank alcohol in the past 30 days between 2015-2017. Among
these pregnant women, one-third reported their engagement in binge drinking (defined as four or
more alcoholic drinks on the same occasion on at least one day in the past month) with an
average of 4.5 binge-drinking episodes in that 30-day period475. The teratogenic effects of

57
alcohol on fetuses were first described back in 1967. Lemoine et al. described a pattern of
congenital disabilities including growth deficiency, low IQ, and psychomotor retardation476,477.
The term “fetal alcohol syndrome” (FAS) was introduced to the medical community after several
publications by Jones et al. describing patterns of birth anomalies, including craniofacial
abnormalities, growth, and mental deficiencies due to prenatal alcohol exposure478–480. However,
after years of research, it has become clear that FAS lies near the end of a spectrum of diseases
and disorders, resulting in the new term, fetal alcohol spectrum disorders (FASD). The exact
number of people with FASD is unknown, but CDC studies have identified that about 0.2 to 1.5
infants in every 1000 births have FAS in the United States481. Estimates for FASD based on
National Institutes of Health-funded community studies predicted as high as 1-5% of school
children in the United States482–484. While the most profound and widely known consequences of
fetal alcohol exposure (FAE) encompass identifiable neurobehavior and overt dysmorphia
outcomes, more recent reporting has uncovered subtle and long-term effects of alcohol on
immune function.
FAS children have a higher autoimmune disease, infection, and malignancies rate,
implicating significant impairments in cellular immune functions. Children exposed to alcohol in
utero were associated with an increased risk of developing atopic eczema485. In animal models,
FAE increases susceptibility to autoimmune diseases such as rheumatoid arthritis and type 2
diabetes486,487. Limited alcohol use during gestation increases the risk for neonatal infection by
2.5 fold, while excessive alcohol abuse further increases this predisposition another 3-4 fold488.
Children exposed to alcohol prenatally have an increased incidence of bacterial infections such
as otitis media, meningitis, pneumonia, gastroenteritis, sepsis, urinary tract, and upper respiratory
tract infection489,490. Case studies also demonstrated an association of FAE with cancer
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development, such as ganglioneuroblastoma, neuroblastoma, adrenal carcinoma, and
hepatoblastoma491–494. FAS children also showed a lower proliferative response of their T cells,
lower B and T cell numbers, and hypogammaglobulinemia490.
Animal models recapitulate the immune deficit associated with FAS in humans as
demonstrated by delayed T cell development and function. Marked retardation of thymus
development in fetuses exposed to alcohol in utero is observed with a reduced thymus size and
cellularity495. There is also a reduction in thymocyte and T cell proliferative response against
mitogen and a decrease in T cell frequencies in both the spleen and the thymus 496–499. These
immune deficits have been shown to persists into adolescence and adulthood. Young adult mice
exposed to alcohol in utero have decreased contact hypersensitivity and graft-vs-host
responses500. Several studies also indicated that lymphocyte number and function in response to
mitogen stimulation are also reduced in adult rats previously exposed to alcohol in utero501,502.
Similarly, human adolescents exposed to alcohol in utero demonstrate impaired immune
responses and an increased rate of atopic, hypersensitivity reactions such as skin rashes, asthma,
and allergic rhinitis503. Adult mice exposed to alcohol only during gestation and nursing period
displayed increased subsequent influenza virus infection severity during adulthood, which
decreased influenza-specific CD8+ T cells in the lungs504.
FAE can also modulate cytokine production in the fetus, generating an overall
inflammatory cytokine profile. Chronic alcohol usage led to an increase in IL-1β, IL-6, and TNF
in both the serum of the fetus and the mother505. TNF and IL-6 levels are upregulated in the
placenta of pups exposed to alcohol in utero506. The pattern of cytokine milieu can determine Th
differentiation. Therefore, alteration of cytokine profile due to FAE can alter the regulation of Th
differentiation and maturation.
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In summary, alcohol exposure during development can produce significant alterations in
the immune system that can be detrimental and persists throughout life.
Purpose of Dissertation
It has been established that both the innate and adaptive arms of the perinatal and adult
immune systems are phenotypically and functionally distinct507–510. The overall response of the
perinatal immune system is highly tolerogenic, with reduced alloantigen recognition and poor
responses against foreign antigens238,241,257–259. This tolerant nature is found to be a double-edged
sword for infants and newborns. While it allows them to tolerate benign antigens such as food
and commensal microbes, newborns are highly susceptible to life-threatening infections as they
have low vaccination efficiency261,262,511. These life-threatening infections cause 40% of the 3
million annual worldwide neonatal deaths260. Therefore, it is essential to understand mechanisms
underlying perinatal tolerance to generate better vaccines for infants. As reviewed above,
multiple factors can contribute to perinatal tolerance, such as the increased propensity of
perinatal T cells to differentiate into Foxp3+ Tregs and intrinsic properties of perinatal T cells
that promote an anti-inflammatory response overall. The purpose of my dissertation is to
investigate the mechanism by which perinatal T cells can contribute to immune tolerance in
infants.
In our lab, we use umbilical cord blood as a model to study the fetal immune system. Our
lab demonstrated that UCB T cells differentiate into Foxp3+ T cells upon antigen receptor
stimulation. It is unknown if these ex vivo generated UCB Foxp3+ T cells carry suppressive
functions in vivo. Furthermore, these ex vivo generated UCB Foxp3+ T cells have stable Foxp3
expression up to 62 days in culture512. It is unknown if these ex vivo generated UCB Foxp3+ T
cells have similar Foxp3 epigenetics status to adult tTregs with stable Foxp3 expression137,138.
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We seek to characterize the Foxp3 epigenetic status of UCB-derived Foxp3+ T cells and
determine their in vivo function utilizing a xenogeneic-graft-versus-host disease model. Alcohol
consumption during pregnancy is known to cause immune dysfunction in infants. Since Foxp3+
Tregs are important for maintaining tolerance and preventing autoimmune diseases, we
hypothesized that alcohol impairs the immune functions of neonates by blocking the
development of these Foxp3+ T cells and enhancing proinflammatory conditions among infants.
Our lab also demonstrated that UCB naïve CD4+ T cells highly express surface antigen
molecules such as CD26 and CD31, while APB naïve CD4+ T cells do not309. These data
suggest that there are intrinsic differences between UCB and APB naïve CD4+ T cells. To
further elucidate other mechanisms contributing to perinatal tolerance, we investigated
transcription factors that regulate T cell function and may be differentially expressed between
perinatal and adult T cells. We found that Helios, a member of the Ikaros transcription factor
family, is significantly upregulated in newborn T cells compared to adult T cells in humans and
mice. As reviewed above, Helios is typically associated with Foxp3+ Tregs and is required for
Foxp3 stability and suppressive functions. Our findings demonstrated that the majority of
perinatal Helios+ T cells do not express Foxp3. Therefore, we seek to characterize the origin and
function of these Helios+Foxp3- perinatal T cells.

CHAPTER TWO: MATERIALS AND METHODS
Mononuclear Cell Isolation
Whole Umbilical cord blood (UCB) was kindly donated from Loyola University Medical
Center from donors that meet our collection criteria. Donors are excluded if: 1. Evidence of
active malignancies; 2. Use of medication that affects the immune system such as
glucocorticoids and immunosuppressants; 3. Uncontrolled hyper or hypothyroidism; 4. Presence
of autoimmune disease; 5. Presence of active infection. Total UCB was collected into blood
collection bags containing a citrate phosphate dextrose solution. Mononuclear cells were
enriched by density centrifugation using Lymphopure density gradient medium (Biolegend, San
Diego, CA) and red blood cells were lysed with RBC lysis buffer (Biolegend). Pre-term neonate
PBMC samples were collected in collaboration with Loyola University Health Center NICU
department. The samples were processed similarly as UCB described above.
Antibodies
Antibodies used for flow cytometry were anti-human CD4, CD8, CD25, Foxp3, Zombie
Aqua Fixable Viability dye, anti-mouse CD45, CD4, CD8α, CD8β, TCRγδ, TCRβ, Foxp3, IL10, IFN-γ, anti-human/mouse Helios, anti-human/mouse/rat Foxp3, anti-mouse Ikaros
(BioLegend), anti-mouse Foxp3, Eos (ebioscience, ThermoFisher Scientific, Waltham, MA),
anti-mouse/human Aiolos (Cell Signaling, Danvers, MA). Functional grade antibodies for cell
culture used were all obtained from BioLegend,: anti-human CD3 (clone OKT-3), anti-human
CD28 (clone 28.2), anti-mouse CD3 (Clone: 145-2C11), anti-mouse CD28 (clone 37.51), antimouse IL-4 (Clone: 11B11), anti-mouse IFNγ (Clone: AN-18), anti-mouse IL-12 (clone C17.8)
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Chemicals and Recombinant Proteins
Recombinant human IL-2 and recombinant mouse IL-4 were obtained from PeproTech
(Rocky Hill, NJ). Recombinant mouse IL-12 (p70) (BioLegend). Molecular biology grade 200
proof (absolute) Ethanol was obtained from Sigma-Aldrich (St. Louis, MO).
Flow Cytometry
Surface stains were performed using standard staining protocols as described by the
manufacturer. Intracellular transcription factor staining was performed using the True Nuclear
Transcription Factor Buffer kit (Biolegend) following the manufacturer’s protocol. Data were
collected on FACS Canto II (BD Biosciences, San Jose, CA) or FACS LSRFortessa (BD
Biosciences) and analyzed using FlowJo software (BD Biosciences).
Foxp3+ T cell Induction Culture
Total UCB mononuclear cells were stimulated with recombinant human IL-2
(10ng/ml; >100U/ml) and 0.2µg/ml anti-human CD3 in RPMI 1640 (GE Healthcare Hyclone)
supplemented with 10% fetal calf serum, essential- and non-essential amino acids,
penicillin/streptomycin and L-glutamine. Cells were split with a media change every 2-3 days,
maintaining IL-2 concentrations. In ethanol-treated cultures, indicated concentrations of ethanol
(200 proof for molecular biology) was added daily to obtain a final concentration of 50mM or
100mM for the first 5 days of culture. Foxp3+ T cell frequency was analyzed after 13-14 days of
culture. For bead-based restimulation, day 14 UCB-derived Foxp3+ T cells (containing both
CD4+ and CD8+ subsets) were cultured with polystyrene beads pre-coated with anti-human CD3
with or without anti-human CD28 antibodies (10µg/ml each) at a ratio of 4 beads per 1 T cell.
5x104 cells were cultured for 5 days total in the absence and presence of 10ng/ml IL-2 and other
cytokines (10ng/ml IL-4, 50ng/ml IL-6, 10ng/ml IL-1β, 10µM TGF-β receptor kinase inhibitor
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SB431542) where indicated. For EtOH total UCB 24-hour bead-based stimulation, total UCB
mononuclear cells were cultured in the presence of indicated EtOH with polystyrene beads precoated with 10µg/ml anti-human CD3 without IL-2. 24 hours later, cells were harvested and
stain for CD25 expression.
Cytokine Profile Analysis
Cell supernatants were collected and analyzed for the expression of major T helper
cytokines including IFN-γ, TNF, IL-2, IL-4, IL-5, IL-13, IL-6, IL-9, IL-10, IL-17a, IL-17f, IL21, IL-22 using LEGENDplex Human Th Cytokine Panel (Biolegend) on BD FACSCanto II
(BD Biosciences).
Suppression Assay
Suppressor cells were generated from UCB by stimulating them with anti-CD3 and IL-2
stimulation for 14 days as described above and Foxp3 expression was confirmed by flow
cytometry. CD4+ and CD8+ T cells were separated by FACS sorting. tTreg were purified from
the same UCB donor using CD4+CD127low CD25+ Regulatory T Cell Isolation kit STEMCELL
Technologies (Cambridge, MA) and expanded in vitro using Immunocult from STEMCELL
Technologies in the presence of 10ng/ml IL-2 for 14 days. Both ex vivo generated UCB Foxp3+
T cells and tTregs were labeled with 5µM carboxyfluorescein succinimidyl ester (CFSE,
Biolegend). For responder cells, unstimulated naïve CD4+ T cells were isolated from allogeneic
adult PBMC using naïve CD4+ T cell isolation kit and labeled with 5µM Tag-it violet
(Biolegend) proliferation and cell tracking dye. CD14+ enriched cells were isolated using
monocyte isolation kit (Biolegend) from the same adult PBMC donor and irradiate at 3000 rad to
serve as APCs. Responder cells were stimulated with 0.2µg/ml anti-human CD3 and APCs at a
1:1 ratio, in the presence or absence of indicated ratio of suppressor cells. After 5 days, flow
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cytometry was used to gate on all CFSE-negative CTV-positive responder cells to assess percent
of proliferation. The percent inhibition of proliferation by suppressor cells for each sample were
determined by [(percentage of cells divided without suppressor cells)- (percentage of cells
divided with suppressor cells)]/ (percentage of cells divided without suppressor cells).
Xenogeneic Graft versus Host Disease (xGVHD)
xGVHD was established in NSG-S mice by intravenous transfer of total UCB
mononuclear cells by tail vein injections. NSG-S mice were subjected to total body irradiation of
2.5gray, 24 hours before mixed CD4+, and CD8+ UCB-derived Foxp3+ T cells (1x10^6 cells in
200ul PBS) or PBS control injection. 48 hours later, autologous UCB mononuclear cells (1x10^6
cells in 200ul PBS) or PBS alone were injected intravenously by tail vein. Mice were monitored
for weight loss and sacrificed when weight dropped to <15% of the original weight or after 35
days post transfer if they did not reach criteria.
Bisulfite Sequencing
Only male donors were used as all female cells carry a methylated allele from one of the
X chromosomes. For adult PBMC Treg cells, cells were freshly isolated using the EasySep
human CD4+CD127low CD25+ Regulatory T Cell Isolation kit (STEMCELL Technologies).
UCB-derived Treg cells were induced by culturing total UCB in the presence of anti-CD3
antibody and IL-2 for a total of 14 days and sorted for CD4+CD25+ cells on day 14 (only donors
that achieved >80% CD25+Foxp3+ were used; data not shown). iTreg cells were generated by
using CD4+ T cells from UCB (CD4 enrichment kit BD iMags) cultured in the presence of IL-2,
TGF-β, and ImmunoCult CD3/CD28/CD2 T cell activators (STEMCELL Technologies) for 6
days and sorted for CD4+CD25+ (only donors that achieved >80% CD25+Foxp3+ were be used).
Effector T cells were cultured in the presence of IL-2 and ImmunoCult CD3/CD28/CD2 T cell
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activators (STEMCELL Technologies) for 14 days and sorted for the CD4+CD25- population.
DNA isolation was conducted using DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany)
and bisulfite conversion was conducted following the manufacturer’s protocol using Single-step
EZ DNA methylation-Direct Kit (Zymo Research, Irvine CA).
Assay for Transposase-Accessible Chromatin (ATAC)-Sequencing
Only male donors were used as all female cells carry a methylated allele from one of the
X chromosomes. UCB-derived Foxp3+ cells were induced by culturing total UCB in the
presence of anti-CD3 antibody and IL-2 for a total of 14 days and FACs sorted for CD4+CD25+
cells on day 14 (only donors that achieved >80% CD25+Foxp3+ were used; data not shown).
Sorted cells were transported to NuSeq Core Facility at Northwestern University for library
preparation and sequencing. Paired-end sequencing was conducted using NextSeq, 37x37bp
reads, 200M read pairs. 3’ adapter sequences are R1=
AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC and R2=
AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA. ATAC-seq reads pre-processing
were conducted using Galaxy. The quality of DNA reads in fastq format was evaluated using
FastQC, adapters were trimmed using Trim galore. Poor quality reads duplicated reads and reads
that aligned to mitochondrial DNA were filtered. The cleaned reads were aligned to Homo
sapiens genome (hg38) using Bowtie2. Peaks were called and annotated using MACS2. Adult
tTreg raw data were mined and process and analyze similarly as our UCB ex vivo generated
CD4+Foxp3+ samples from published work by Ng et al327.
Mice
C57BL/6 mice were obtained from Jackson Laboratories and bred in-house. Mice were
euthanized by CO2 if they are >10 days old or decapitated if <10 days old and dissected by
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sterilized scissors to obtain the spleen. Splenocytes were obtained from the different ages
indicated where day of birth was called day 0. The spleen was grinded by Frosted Microscope
Slides (Fisher Scientific, Waltham, MA) to obtain splenocytes. The cells were then washed once
with 2% FCS RPMI and filtered through a cell strainer (DOT Scientific, Burton, MI) to obtain a
single-cell suspension. Time pregnancies were set up to collect E17.5/18.5 fetal samples. The
day after time pregnancy set up was set as E0.5.
Naïve CD4+ T Cell Isolation
Naïve CD4+ T cells were isolated from UCB or APB mononuclear cells via negative
selection using EasySepTM Human Naïve CD4+ T cell Enrichment Kit (STEMCELL
Technologies). Naïve CD4+ T cells were isolated from total splenocytes via negative selection
using MojoSortTM Mouse CD4+ Naïve T Cell Isolation Kit (BioLegend)
CRISPR-Cas9 Editing
CRISPR-Cas9 editing was conducted using Neon transfection system (ThermoFischer
Scientific) according to manufacturer’s protocol. Briefly, UCB naïve CD4+ T cells were isolated
and activated with 5µg/ml anti-human CD3 and 5µg/ml anti-human CD28 in the presence of
10ng/ml IL-2 for 3 days. After 3 days of activation, cells were harvested and resuspended in
buffer R at 4x105 cells/10µl. 610ng of gRNA was incubated with 1µg Invitrogen TrueCut Cas9
Protein v2 (ThermoFischer Scientific) for 15-20 minutes, room temperature, before adding 5µl
of cell mixture to generate a final concentration of 2x105 cells per 10µl transfection reaction. The
cell and Cas9/gRNA complex mixture were pipette into Neon 10µl tip and transfected using
program #24 (1600V/10ms/3 pulses). After transfection, cells were immediately transferred into
a 48-well containing 1ml of pre-warmed antibiotic free RPMI 1640 supplemented with 10% fetal
calf serum, essential- and non-essential amino acids, and L-glutamine for 2 days. After 2 days,
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cells were checked for knockout efficiency and ready for downstream experiments. Human ikzf2
and non-target gRNA was designed using GUIDES. gRNA was then generated using Invitrogen
GeneArt Precision gRNA Synthesis Kit (ThermoFischer Scientific) according to manufacturer’s
protocol.
T Helper Cell Differentiation
Isolated human naïve CD4+ T cells from UCB or APB were maintained in IL-7 for 7
days in IL-7, then were stimulated with 5µg/ml anti-human CD3 and 5µg/ml anti-human CD28
and differentiated using human Th1 Differentiation Kit for 5 days (CDK001, R&D Systems,
Minneapolis, MN) according to manufacturer’s protocol. 5 days after Th1 polarization, the cells
were harvested, washed, and plated at 1x106/ml in the absence or presence of 50ng/ml phorbol
12-myristate 13-acetate (PMA, Fischer Scientific) and 1µM Ionomycin (Sigma-Alrich) for 4
hours. After stimulation, the supernatants were harvested and analyzed for cytokine expression
using Legendplex Human Th Cytokine Panel (BioLegend).
For CRISPR-cas9 gene editing experiments, isolated human naïve CD4+ T cells from
UCB were subjected to Th0 or Th1 culture conditions 48 hours after transfection. 2x105/ml cells
were cultured in IL-2 (10ng/ml; >100U/ml) for Th0 and Human Th1 Differentiation kit
(CDK001, R&D Systems) according to manufacturer’s protocol for 5 days. After 5 days in
culture, cells were harvested, washed, and restimulated with PMA and Ionomycin for 4 hours at
1x106 cells/ml.
Isolated mouse naïve CD4 T cells or total splenocytes (5-day old neonates) were cultured
at 1x106 per ml in 96 well flat bottom, non-treated plate (CELLTREAT, Fisher Scientific) coated
with 5µg/ml anti-mouse CD3 and 2µg/ml soluble anti-mouse CD28, under neutral, Th1 or Th2
conditions for the first three days. For the first three days of culture, neutral conditions: no
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additional cytokines or antibodies, Th1: 10ng/ml IL-12, 10µg/ml anti-IL-4, Th2: anti-IFNγ
10µg/ml, anti-IL-12 2µg/ml, IL-4 10ng/ml. After three days, the cells were equally divided into
96 round bottom tissue culture treated plate (DOT Scientific) uncoated with anti-CD3 and
continue culture for additional two more days. The cells were supplemented with these cytokines
for the rest of the culture, neutral conditions: 10ng/ml IL-2; Th1 condition: 10ng/ml IL-12 and
10ng/ml IL-2; Th2 conditions: 10ng/ml IL-4. At day 5, the cells were harvested, washed, and
subjected to PMA and Ionomycin stimulation for 5 hours. The cells were plated at 1x10 6 cells/ml
and 1X Monensin (Biolegend) was added at final two hours of the restimulation culture. After
restimulation, the cells were stained for intracellular IL-10 and Helios.
Intraepithelial Lymphocytes (IEL) and Lamina Propria Lymphocytes (LPL) Isolation
IEL were isolated from the mouse small intestine and colon as described by Yamamoto et
al with modifications513. Briefly, the small intestine and colon were removed, and fecal matter,
fat, mesentery lymph nodes and payer’s patches were removed. The intestinal tissues were open
longitudinally and cut into 1cm pieces. The tissues were incubated in calcium- and magnesiumfree 10% HBSS supplemented with fetal calf serum, 10mM HEPES and 1mM Dithiothreitol
(DTT, Sigma Alrich) rocking for 30 minutes in 37˚C. The tissues were then vortex vigorously
and intestinal IEL were obtained by filtration of the supernatant through 100µm filter. To isolate
LPL, the remaining tissues were further cut into smaller pieces, and incubated in 10% HBSS
supplemented with 0.1mg/ml DNAseI (Roche, Basel, Switzerland), 2mg/ml Collagenase D
(Sigma Aldrich) and 0.17U/ml Dispase (Gibco, Thermo Fisher Scientific), rocking for 30
minutes in 37˚C. The digest was stopped with 10% HBSS supplemented with 5mM EDTA and
cells were obtained by filtration of the supernatant through 100µm filter. Purified IEL were
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obtained by harvesting the cell interphase of 40/70% Percoll (Cytiva, Marlborough, MA)
centrifugation and LPL were obtained from 40/80% Percoll centrifugation.
Generation of Humanized Mice
NSG-S mice were subjected to total body irradiation of 2.5gray, 24 hours before
CD34+Lineage- HSCs (using anti-human lineage antibody cocktail: CD3, CD14, CD16, CD19,
CD20, CD56, Biolegend) FACS sorted from UCB were transferred via tail vein injection
intravenously. A total of around 10,000-100,000 HSCs were injected in 200µl PBS depending on
the donor and final sorted HSCs number. The mice were monitored and human CD45
reconstitution were checked 4 weeks after transfer. After human CD45 cells reconstitution is
confirmed, humanized mice were sacrifice between 10-21 weeks post UCB HSCs transfer.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism software (San Diego, CA).
The following designation was used throughout the dissertation: *p<0.05, **p<0.01, ***p<0.001
and ****p<0.0001.

CHAPTER THREE: RESULTS
Section I: Epigenetic and Functional Analysis of UCB-derived Foxp3+ T Cells.
The developing human fetus has a unique ability to tolerate benign and necessary
antigens, including self, environmental, and food antigens that are transferred across the
placenta511. Multiple mechanisms contribute to fetal tolerance, one of which is the strong
tendency of fetal CD4+ T cells to differentiate into Foxp3+ regulatory T cells (Treg) 258. The
tolerant nature of fetal immunity is beneficial to prevent excessive inflammation against the vast
array of foreign antigens that they encounter after birth. However, this also makes them
vulnerable to succumb to infections caused by invading pathogens514. For this reason, neonatal
immunity needs to adapt to the complex demands of tolerance against harmless environmental
antigens, while maintaining protective immune responses against pathogens 515. A deeper
understanding of the nature of the developing human immune system will provide pivotal
knowledge to develop safe and effective strategies to protect infants from infection.
Generation of Foxp3+ T cells from Human UCB
To understand the cellular mechanisms that establish fetal tolerance, our lab utilizes
umbilical cord blood (UCB) as a source of full-term fetal immune cells. In agreement with
previous reports, UCB and adult peripheral blood (APB) displayed similar frequencies of preexisting CD4+ T cells that express Foxp3, an essential transcription factor for the development
and maintenance of Tregs, at day 0 (Figure 9A)512,516. Since Foxp3 plays a pivotal role in the
establishment of immunological tolerance and the perinatal immunity is tolerant biased, and the
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majority of UCB T cells carry a naïve phenotype517–519, we hypothesized that UCB T cells
preferentially differentiate into Foxp3+ T cells upon stimulation.
We stimulated total UCB mononuclear cells with anti-CD3 antibodies in the presence of
IL-2. Activated human CD4+ T cells can transiently express Foxp3 up to one week after
stimulation and takes two weeks to lose Foxp3 expression102,520. Therefore, to assess stable
Foxp3 expression by UCB T cells, we continued this culture with IL-2 medium for 2 weeks. We
found that both UCB CD4+ and CD8+ T cells acquire prototypic Treg cell markers, CD25 and
Foxp3, while only a few APB CD4+ and CD8+ T cells under the same culture conditions acquire
them (Figure 9B, C). These Foxp3+ T cells are not expanded from pre-existing Tregs, as removal
of CD4+CD25+ T cells (majority of CD4+CD25+ cells also express Foxp3521,522) from UCB did
not reduce the frequency of Foxp3+ T cell induction after anti-CD3 stimulation (Figure 9D, E).
Furthermore, these UCB-derived Foxp3+ T cells also express Helios, a transcription
factor strongly associated with Foxp3+ Tregs and is important to maintain Treg stability and
function372,384–386 (Figure 9F). These data demonstrated that UCB T cells differentiate into
Foxp3+ T cells de novo upon antigen receptor stimulation. Further mechanistic studies found that
CD14+CD36hi monocytes in UCB provide TGF-β and retinoic acid to UCB T cells to promote
Foxp3+ T cell differentiation (conducted by Dr. Jessica Lee MD, Ph.D)512.
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Figure 9: Induction of Foxp3+ T Cells from UCB. A) Foxp3 expression among CD4 T cells
from freshly isolated UCB and APB mononuclear cells. B, C) Frequency of cells expressing
CD25 and Foxp3 by CD4 and CD8 T cells after anti-CD3 and IL-2 stimulation of UCB or APB
total mononuclear cells for 12-15 days. N=5-7, 2-tailed Student’s t-test. D, E) Frequency of cells
expressing CD25 and Foxp3 from stimulation of total UCB mononuclear cells or CD4+CD25+
depleted UCB with anti-CD3 and IL-2 for 12-15 days. F) Helios frequency within freshly
isolated APB CD4+Foxp3+ T cells and UCB-derived Foxp3+ CD4 and CD8 T cells. N=4-7.
UCB or APB mononuclear cells were subjected to anti-CD3 stimulation in the presence of IL-2
for 13-15 days. The culture was split throughout and replenish with IL-2 media to maintain IL-2
concentration. Data and Figures by Dr. Jessica Lee MD, Ph.D. from Lee et al. 512.
Regulatory Functions of Foxp3+ T Cells from Human UCB In Vitro
To determine if these ex vivo generated Foxp3+ T cells from UCB carry regulatory
functions, we conducted a standard in vitro suppression assay to assess if they can suppress
effector T cell proliferation by measuring CellTrace Violet dilution. Both ex vivo generated UCB
CD4+, and CD8+ Foxp3+ T cells can suppress effector T cell proliferation in a dose-dependent
manner, comparable to preexisting UCB isolated tTregs (Figure 10)512. These data demonstrated
that UCB-derived Foxp3+ T cells are functional regulatory T cells in vitro.
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Figure 10: Regulatory Function of UCB-Derived Foxp3+ T Cells In Vitro. UCB-derived
Foxp3+ T cells were induced as described in Figure 9 and used as suppressor cells. Preexisting
tTregs were isolated using a Treg isolation kit from the autologous donor of UCB-derived
Foxp3+ T cells and expanded in culture were also used as suppressor cells. CellTrace Violet
labeled allogeneic adult naïve CD4 T cells were used as responder cells and cultured with CFSE
labeled suppressor cells at indicated ratios in the presence of irradiated CD14+ enriched cells
from the same adult PBMC donor to serve as APCs. Figure from Lee et al. 512.
Regulatory Functions of Foxp3+ T cells from Human UCB In Vivo
To determine if these ex vivo generated UCB-derived Foxp3+ T cells also carry
regulatory function in an in vivo setting, we utilize a xenogeneic graft-versus-host disease
(xGVHD) in NSG-S mice. This is a well-established xGVHD model by adoptively transferring
human peripheral blood mononuclear cells (PBMC) into NSG-S immunodeficient mice523,524.
Since NSG-S mice lack T, B, and NK cells, xenogeneic transplants of human PBMC causes
acute GVHD-like syndrome that results in death by 20-50 days524. Others have shown that adult
tTregs can reduce lethal GVHD in this system525,526.
We utilized NSG-S mice, which share the background as NSG mice but provide human
growth factor support of myeloid lineages, allowing for a higher rate of engraftment527,528. We
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hypothesized that if UCB-derived Foxp3+ T cells are suppressive in vivo, we should see a delay
in xGVHD development using this system.
To test if these ex vivo generated UCB-derived Foxp3+ T cells are suppressive in vivo,
we intravenously injected sub-lethally irradiated (2.5Gy, day 0) NSG-S mice with a final volume
of 200µl with UCB-derived Foxp3+ T cells (1x10^6 cells) or PBS control (i.v. lateral tail vein).
48 hours later, an equal number of autologous UCB mononuclear cells in 200µl PBS or PBS
alone were injected. The development of xGVHD was monitored 5 days a week by observing
overall mouse health conditions such as body weight and general appearances (fur and skin
conditions). Mice were given xGVHD “scores” adapted from the scoring system developed by
Cooke et al529. The experiment model is depicted in Figure 11.

Figure 11: Xenogeneic Graft-Versus-Host Disease (xGVHD) Experimental Model. NSG-S
mice were sub-lethally irradiated at day 0 and allowed to rest for 24 hours. PBS alone or 1x106
UCB-derived Foxp3+ T cells were generated as described in Figure 9 and injected 24 hours postirradiation. 48 hours after the first injection, PBS alone or 1x106 autologous total UCB
mononuclear cells in PBS were injected. Mice were monitored for weight change and xGVHD
phenotype up to day 35 and sacrificed if they lost>15% of original body weight measured at day
0.
Using this xGVHD model, we found that the transfer of total UCB mononuclear cells led
to rapid xGVHD development. Mice lost weight approximately 10 days after total UCB transfer
and reached the criteria for euthanasia (>15% weight lost) no later than day 18 (day 16 ± 1.4).
Control mice that received PBS alone remained healthy throughout the experiment days

75
(observation stopped at day 35). The transfer of equal amounts of ex vivo generated UCBderived Foxp3+ T cells (CBT) alone did not cause xGVHD. Pretreatment of UCB-derived
Foxp3+ T cells (CBT) 48 hours before the transfer of autologous total UCB mononuclear cells
significantly delayed the onset of xGVHD in these mice (day 21.6 ± 3.1, Figure 12).
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Figure 12: The Effect of UCB-derived Foxp3+ T Cells Pre-Transfer on xGVHD Induced by
Autologous UCB. NSG-S mice were injected with 1x106 UCB-derived Foxp3+ T cells (Cord
blood-derived T cells, CBT) or PBS 48 hours before injecting 1x106 autologous UCB
mononuclear cells or PBS intravenously. Mice were monitored for xGVHD phenotype and
weight loss of more than 15% original weight as criteria. Data combined from two independent
experiments demonstrating percent of mice survive across indicated days post autologous UCB
injection, *p<0.05, Log-rank (Mantel-Cox) test.
In addition, mice that received UCB-derived Foxp3+ T cells alone or PBS control
gradually increased their weight throughout the experiment. Mice that received total UCB
mononuclear cells demonstrated weight loss around 10 days post transfer and then rapidly lost
weight until they hit criteria (>15% weight loss). Mice pretreated with UCB-derived Foxp3+ T
cells 48 hours before total autologous UCB injection had less weight loss on average (Figure 13).
Together these data demonstrated that ex vivo generated Foxp3+ T cells from UCB carry
suppressive functions in vivo.
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Figure 13: The Effect of UCB-Derived Foxp3+ T Cells (CBT) Pre-Transfer on xGVHD
Induced by Autologous UCB. NSG-S mice were injected with 1x106 UCB-derived Foxp3+ T
cells or PBS 48 hours before injecting 1x106 autologous UCB mononuclear cells or PBS
intravenously. Mice were monitored for xGVHD phenotype and weight loss of more than 15%
original weight as criteria. Data combined from two independent experiments.
The transfer of human PBMC in the xGVHD model leads to subsequent human
mononuclear cell infiltration in peripheral organs and elevation of Th1 pre-dominant cytokine
levels in the serum530,531. To determine if the delay of xGVHD development by UCB-derived
Foxp3+ T cell (CBT) transfer is accompanied by a decrease in circulating proinflammatory
cytokines produced by engrafted human PBMC, we measure cytokine levels in the serum of
mice collected when they hit criteria (immediately before sacrifice). We found that mice that
received PBS alone or CBT then PBS had little to no detection of Th1 and Th2 cytokine in their
serum. Mice that received PBS then UCB had elevated levels of Th1 cytokines as demonstrated
by others. Lastly, mice pretreated with CBT before UCB transfer also had similar levels of Th1
and Th2 cytokines in the serum. These data demonstrated that although CBT pretransfer
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enhanced survival and decreased weight loss, Th1 and Th2 cytokine production was similar to
UCB transfer alone (Figure 14).

Figure 14: Serum Cytokine Analysis for xGVHD. NSG-S mice were injected with 1x106
UCB-derived Foxp3+ T cells (CBT) or PBS 48 hours before injecting 1x106 autologous UCB
mononuclear cells or PBS intravenously. Mice were monitored for xGVHD phenotype and
weight loss of more than 15% original weight as criteria. Serum was collected by spinning down
peripheral blood collected via cheek bleed at the day of sacrifice and cytokine profile was
analyzed using LEGENDplex Human T Helper Cytokine panel. Data combined from two
independent experiments. One-way ANOVA, Tukey’s multiple comparisons test, *p<0.05.
Patients with GVHD have been reported to have elevated serum levels of the commonly
known anti-inflammatory cytokine, IL-10. High IL-10 levels were associated with fatal
outcomes in these patients532. We next assess if pretreatment of CBT will reduce serum levels of
IL-10 in our xGVHD model. We found that serum levels of IL-10 in mice pretreated with CBT
were significantly reduced compared to mice that received UCB alone (131.7±40.7pg/ml vs
53.1±21.2 pg/ml, Figure 15). These data suggest that CBT pretreatment may ameliorate xGVHD
by reducing IL-10 levels.
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Figure 15: Serum IL-10 Levels for xGVHD. NSG-S mice were injected with 1x106 UCBderived Foxp3+ T cells (CBT) or PBS 48 hours before injecting 1x106 autologous UCB
mononuclear cells or PBS intravenously. Mice were monitored for xGVHD phenotype and
weight loss of more than 15% original weight as criteria. Serum was collected by spinning down
peripheral blood collected via cheek bleed at the day of sacrifice, and cytokine profile was
analyzed using LEGENDplex Human T Helper Cytokine panel. Data combined from two
independent experiments. One-way ANOVA, Tukey’s multiple comparisons test, **p<0.01,
***p<0.001.
Epigenetic Regulation of Foxp3 in UCB-derived Foxp3+ T Cells
We demonstrated that UCB T cells differentiate into Foxp3+ T cells upon antigen
receptor stimulation without exogenous TGF-β addition and that they carry regulatory functions
comparable to pre-existing tTregs. Furthermore, these ex vivo generated UCB-derived Foxp3+ T
cells also significantly delayed xGVHD mediated by UCB transfer in vivo. Previous lab
members have shown that Foxp3 expression by UCB-derived Foxp3+ T cells is relatively stable,
where it was sustained up to 62 days in culture512. These UCB-derived Foxp3+ T cells also do
not express CD127, the IL-7 receptor α chain that is known to be absent on Treg cells533. The
majority of the preexisting Tregs are produced in the thymus (tTregs), but mature naïve T cells
can also differentiate into Foxp3+ Tregs in the periphery in the presence of TGF-β, retinoic acid,
and IL-2103,104. These ex vivo generated UCB-derived Foxp3+ T cells also express Helios; a
transcription factor initially thought to be a specific marker for tTreg identification (Figure 9)372.
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This prompted us to investigate if UCB-derived Foxp3+ T cells resemble pre-existing tTregs or
peripherally induced pTregs.
Foxp3 was discovered as the master transcription factor for Tregs. A single Foxp3 gene
mutation in the X-chromosome led to spontaneous autoimmune disease development in Scurfy
mice and IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)
disease in human95–97. Since the discovery of Foxp3 as the master transcription factor of Tregs
and plays such a critical role in Treg biology, extensive studies have been conducted to
understand the molecular mechanisms that govern and regulate the induction of this transcription
factor. Three CNS intronic enhancer element, CNS1, CNS2, and CNS3 at the Foxp3 locus has
been identified in addition to the promoter129. These enhancer regions have been shown to
differentially contribute to tTreg and pTreg differentiation. CNS1 region is shown to be
important for iTreg/pTreg development. CNS2 is crucial for the maintenance of Foxp3
expression where it is highly enriched with CpG sites that can be epigenetically regulated
through methylation136. It has been shown that the stable expression of Foxp3 by tTregs is
contributed by the fully demethylated CpG sites on CNS2137,138. Lastly, CNS3 controls de novo
Foxp3 expression and tTreg differentiation129.
Since we observed relatively stable Foxp3 expression by UCB-derived Foxp3+ T cells,
we asked if the CNS2 region of Foxp3 in UCB-derived Foxp3+ T cells is highly demethylated
like those of adult tTregs. To test this, we conducted genomic bisulfite sequencing to identify 5methylcytosine residues on a gene sequence534. We compared the Foxp3 CNS2 region of CD4+
UCB-derived Foxp3+ T cells (generated as described in Figure 9), adult CD4+ tTregs, UCB
CD4+ effector T cells as well as UCB in vitro induced iTregs (Treg generated in vitro in the
presence of TGF-β). Only male donors were used as female donors carry a methylated allele
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from one of the X chromosomes. As reported previously in the literature, we found that Foxp3
CNS2 CpG sites in adult tTregs (APB tTregs) are highly demethylated (high frequency of
demethylated CpG sites) and contained a range of demethylated frequencies based on donor
variability. Similarly, on our hands, we observe that the CNS2 enhancer region is highly
methylated (low frequency of demethylated CpG sites) in both Foxp3- effector T cells as well in
vitro generated Tregs (iTregs)135,138,139. Surprisingly, we found that although Foxp3 expression in
CD4+ UCB-derived Foxp3+ T cells (CD4 CBT) is relatively stable, their CNS2 enhancer region
is highly methylated (low frequency of demethylated CpG sites) as well, just like their UCB
effector T cells and iTreg counterparts (Figure 16). These data suggest that Foxp3 expression in
UCB-derived Foxp3+ T cells is regulated differently than adult tTregs.
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Figure 16: Frequency of Demethylated CpG Sites of Foxp3 CNS2 Region as Determined by
Bisulfite Sequencing. Bisulfite conversion was conducted on genomic DNA isolated by the
indicated T cell subsets. Each dot represents one donor (N=3-4), analyzed by One-way ANOVA,
Tukey’s multiple comparison test, *p<0.05.
To investigate how Foxp3 in UCB-derived Foxp3+ T cells may be regulated, we
conducted Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) to assess
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genomic chromatin accessibility of the Foxp3 region. It has been previously demonstrated that
there is greater chromatin accessibility at the Foxp3 locus in Tregs compared to effector T
cells149. Since we observed UCB-derived Foxp3+ T cells have differential methylated status in
CNS2 compared to adult tTregs, we sought to determine if CNS regions within the Foxp3 locus
have differential chromatin accessibility between the two populations.
UCB-derived Foxp3+ cells were generated as described in Figure 9. Only male donors
that achieved >80% CD25+Foxp3+ were sorted for CD4+CD25+ on day 14 post-induction and
transported to Northwestern University NuSeq Core facility for ATAC-Sequencing library
preparation and sequencing. Adult CD4+ tTreg ATAC-sequencing raw data were obtained from
a previously published source and analyzed with our sequencing samples using Galaxy and
mapped against homo sapien genome hg38327. After pre-processing, chromatin accessibility was
visualized using the Integrative Genomics Viewer (IGV) for ATAC signals at the gene of
interest535. CNS and promoter sequences of Foxp3 locus were obtained from Zheng et al and
blasted onto IGV for visualization129. ATAC-seq data show that UCB-derived CD4+ Foxp3+ T
cells (CBT) have less chromatin accessibility than adult CD4+ tTreg samples as demonstrated by
lower signal peaks at the promoter, CNS1, CNS2, and CNS3 (Figure 17).
Together, our bisulfite sequencing and ATAC-sequencing data further suggest that Foxp3
expression by ex vivo generated UCB-derived Foxp3+ T cells are epigenetically regulated
differently than preexisting adult tTregs.
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Figure 17: Chromatin Accessibility Within Foxp3 Locus by UCB-Derived CD4+ Foxp3+ T
Cells and Adult Ttreg Using ATAC-Seq. CD4+CD25+ cells were sorted from male UCBderived Foxp3+ T cells (CBT) after induction culture as described in Figure 9 was sent for
ATAC-sequencing transposase reaction, library preparation, and sequencing at NuSeq Core,
Northwestern University. Preprocessed sequencing data were visualized using the Integrative
Genomics Viewer for chromatin accessibility. Tracks show ATAC signals at the human Foxp3
locus and the promoter and CNS regions are indicated in colored boxes.
When we look at regions that are unique to UCB-derived Foxp3+ T cells (CBT) within
the Foxp3 locus, we found 3 regions that are more accessible in UCB-derived Foxp3+ T cells
than adult CD4+ tTregs as demonstrated by higher ATAC signals (Red boxes, Figure 18). These
regions are annotated in Figure 18 as region 1 (Chrx:49265521bp-49265983bp), region 2 (Chrx:
49255141-49256310bp) and region 3 (Chrx: 49252706-49254283).
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Figure 18: Unique Region of Chromatin Accessibility Within Foxp3 Locus by UCBDerived CD4+ Foxp3+ T Cells. CD4+CD25+ cells were sorted from male UCB-derived
Foxp3+ T cells (CBT) after induction culture as described in Figure 9 was sent for ATACsequencing transposase reaction, library preparation, and sequencing at NuSeq Core,
Northwestern University. Preprocessed sequencing data were visualized using the Integrative
Genomics Viewer for chromatin accessibility. Tracks show ATAC signals at the human foxp3
locus and the promoter and CNS regions are indicated in colored boxes. Red boxes indicate
regions that are accessible in CBT but not in adult tTregs and are annotated as 1, 2 and 3.
Using NCBI Blast, region 1 was not conserved in the mouse Foxp3 locus nor within
chromosome X, while two ranges within regions 2 (79% and 80% homology, Figure 19) and 3
(69% and 74% homology, Figure 20) are conserved in the mouse Foxp3 locus. Furthermore, like
human Foxp3, region 2 ranges from exon 6 and 7 in mouse Foxp3 and region 3 spans exon 8 and
9 (Figure 18 and 21).
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Figure 19: Sequence Alignment of CBT Region 2 Against Mouse Foxp3. Sequence alignment
and statistics between UCB-derived Foxp3+ T cell (CBT) region 2 from Figure 18 with mus
musculus scurfin (Foxp3) gene using NCBI Blast (NC_000086.8:7445915-7461482 Mus
musculus strain C57BL/6J chromosome X, GRCm39, discontiguous megablast program). Two
separate alignments were found between CBT region 2 and mouse Foxp3. A) Range 1 consists of
239-431 nucleotide of region 2, B) Range 2 consists of 566-758 nucleotide of region 2.
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Figure 20: Sequence Alignment of CBT Region 3 Against Mouse Foxp3. Sequence alignment
and statistics between UCB-derived Foxp3+ T cell (CBT) region 3 from Figure 18 with mus
musculus scurfin (Foxp3) gene using NCBI Blast (NC_000086.8:7445915-7461482 Mus
musculus strain C57BL/6J chromosome X, GRCm39, discontiguous megablast program). Two
separate alignments were found between CBT region 3 and mouse Foxp3. A) Range 1 consists of
407-974 nucleotide of region 3, B) Range 2 consists of 1205-1402 nucleotide of region 3.
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Figure 21: Graphics of blast results for CBT region 2 and region 3 against mouse Foxp3.
CBT region 2 spans from exon 6 and 7 in mouse Foxp3 and region 3 spans exon 8 and 9.
These findings could allow the generation of transgenic mice to study if these regions can
regulate Foxp3 expression, particularly in perinatal T cells. However, the identification of UCBderived Foxp3+ T cells murine counterpart has yet to be identified.
Foxp3 Stability by UCB-derived Foxp3+ T Cells under Inflammatory Conditions
Several studies in the inflammatory settings suggested that Foxp3 expression by Tregs
can be lost during inflammatory responses. For instance, IL-6 led to a decrease in Foxp3
expression from sorted CD4+CD25+ Tregs and subsequently increases IL-17 production in these
cells in vitro536. Tumor necrosis factor (TNF) has been shown to decrease Foxp3 mRNA and
protein expression by the Tregs537. TNF and IL-6 led to Foxp3 degradation and subsequent loss
of function in Tregs538. We asked if ex vivo generated UCB-derived Foxp3+ T cells lose Foxp3
expression when subjected to anti-human CD3 and anti-human CD28 coated beads (10ug/ml)
and 10ng/ml IL-2 restimulation in the absence or presence of other inflammatory cytokines. We
added 10ng/ml IL-4, 50ng/ml IL-6, 10ng/ml IL-1β, or 10µM TGF-β receptor kinase inhibitor
SB431542 in the presence of IL-2 and harvested the cells after 5 days of restimulation.
We found that Foxp3 frequency in both CD4+ and CD8+ T cell subsets did not
significantly change in the presence of the indicated cytokines compared to controls (NT). The
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addition of SB431542, TGF-β receptor 1 kinase inhibitor, showed a decreasing trend in Foxp3
frequency within CD4 T cells (Figure 22). This is plausible because TGF-β1 has been shown to
maintain Foxp3 expression in Tregs and a defect in TGF-β1 signaling in Tregs is associated with
a decrease in Foxp3 expression and suppressive capability133. These data demonstrated that
Foxp3 expression by ex vivo generated UCB-derived Foxp3+ T cells are stable in the presence of
inflammatory cytokines.

Figure 22: Foxp3 Frequency Within CD4+ And CD8+ UCB-Derived Foxp3+ T Cells After
Restimulation in the Absence or Presence of Other Cytokines. Representative FACS plot of
CD25 and Foxp3 expression and summary of Foxp3 frequency by UCB CD4+ and CD8+
Foxp3+ T cells after restimulation in the absence or presence of other cytokines. After Foxp3+
induction culture as described in Figure 9, UCB-derived Foxp3+ T cells were harvested and
cultured in the presence of beads coated with 10ug/ml anti-human CD3 and anti-human CD28
for 5 days in the presence of 10ng/ml IL-2 and in addition to other indicated cytokines (NT= IL2 alone, SB=SB431542). After 5 days, cells were harvested and intracellularly stained for Foxp3.
Each dot indicates one donor (N=3), analyzed by one-way ANOVA, Dunnett’s multiple
comparisons test.
Effects of Alcohol on UCB-derived Foxp3+ T Cell Generation
Next, we sought to determine if Foxp3 induction by UCB T cells will be inhibited under
inflammatory conditions early in the differentiation process. So far, we found that UCB T cells
differentiate into Foxp3+ T cells upon antigen receptor stimulation and carry suppressive
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functions in vitro and in vivo. Foxp3 expression by these UCB T cells is epigenetically regulated
differently from those of adult tTregs. Foxp3 expression by these ex vivo generated UCB Foxp3+
T cells are also stable even after restimulation in the presence of inflammatory cytokines.
One of the factors that can promote an overall inflammatory state in the fetus is prenatal
alcohol exposure505. Chronic alcohol usage by mothers causes an increase in serum
proinflammatory cytokines such as IL-1β, IL-6, and TNF in the fetus. Alcohol is a known
environmental factor that causes immune dysfunctions in infants. Alcohol consumption during
pregnancy can lead to fetal alcohol spectrum disorders (FASDs), which include abnormalities in
development and cognitive function, as well as immune dysfunction498,539,540. Limited alcohol
use during gestation increases the risk for neonatal infection by 2.5 fold, while excessive alcohol
abuse further increases this predisposition another 3-4 fold488. This immune deficit may induce
significant and long-term defects in immunity and increase the susceptibility of individuals with
fetal alcohol exposure (FAE) to autoimmune diseases and bacterial infections 486–488,490. Notably,
in animal models, FAE increases susceptibility to autoimmune diseases such as rheumatoid
arthritis and type 2 diabetes486,487. Since Foxp3+ T cells are important for maintaining tolerance
and preventing autoimmune disease, we hypothesized that alcohol impairs the immune functions
of neonates by blocking the development of Foxp3+ T cells from UCB and enhancing
proinflammatory conditions among infants.
To determine the effects of alcohol exposure in fetal tolerance, we tested if the presence
of ethanol (EtOH) affects Foxp3+ T cell induction from total UCB mononuclear cells. Using the
same culture system established as described in Figure 9, we added increasing concentrations of
EtOH during the first 5 days of the UCB Foxp3+ induction culture. The addition of EtOH did not
cause apparent toxicity or cell death as the total number of cells in the wells with or without
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EtOH are comparable at the end of the 2-week culture (Figure 23). To test if EtOH may cause
cell death earlier in the culture, we also counted cell numbers on days 3 and 5. Total cell
numbers were not significantly different in the absence or presence of 100mM EtOH at both
days 3 and 5 (Figure 24).
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Figure 23: Total Cell Number After UCB Foxp3+ T Cell Induction Culture in the Absence
or Presence of Ethanol. Total umbilical cord blood mononuclear cells were subjected to
Foxp3+ induction culture as described in Figure 9, with or without ethanol at the indicated
concentrations for the first five days of the culture. On days 13-14, the culture was harvested,
and cell counts were obtained. N=6 UCB donors.
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Figure 24: Total Cell Number from Day 3 And Day 5 Of UCB Foxp3+ T Cell Induction
Culture in the Presence or Absence of Ethanol. Total umbilical cord blood mononuclear cells
were subjected to Foxp3+ induction culture as described in Figure 9, with or without ethanol at
the indicated concentrations for the first three or five days of the culture. Ethanol was added
daily up to the day of harvest (3- or 5-days total spike treatment) to achieve the indicated EtOH
concentration. At days 3 or 5, cell numbers were calculated. N=3 UCB donors.
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When we assessed the frequency of CD25+Foxp3+ within CD4+ and CD8+ T cell
population after Foxp3+ T cell induction culture as described in Figure 9, there was a significant
decrease in CD25+Foxp3+ frequency when 100mM EtOH was added in the induction culture in
comparison to media alone in both CD4+ and CD8+ T cell subsets (Figure 25).

Figure 25: Frequency of CD25+Foxp3+ Within CD4+ And CD8+ T Cells at The End of
UCB Foxp3+ Induction Culture in the Absence or Presence of Ethanol. Left: Representative
FACS plot of CD25 and Foxp3 within CD4+ and CD8+ T cells after UCB Foxp3+ induction
culture in absence or presence of indicated EtOH concentration for first five days of culture.
Right: Frequency plots of CD25+Foxp3+ within CD4+ and CD8+ T cells after UCB Foxp3+
induction culture in absence or presence of indicated EtOH concentration. Total umbilical cord
blood mononuclear cells were cultured in the presence of anti-human CD3 and IL-2 for 13-14
days with or without EtOH of the indicated concentration. N=6 independent UCB donors.
*p<0.05 paired t test.
Next, we ask if the presence of EtOH affects the total cell number of CD25+Foxp3+ T
cells after the induction culture. We observed a significant decrease in total CD4+CD25+Foxp3+
T cell number but did not see a significant decrease in CD8+CD25+Foxp3+ T cells at 100mM
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EtOH concentration (Figure 26). Due to donor variability in cell number, we normalized each
treatment cell number to its media control counterpart.
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Figure 26: Total Cell Number of CD4+CD25+Foxp3+ And CD8+CD25+Foxp3+ Tregs at
the end of UCB Foxp3+ Induction Culture With or Without EtOH. Total umbilical cord
blood mononuclear cells were cultured in the presence of anti-human CD3 and IL-2 for 13-14
days with or without ethanol of the indicated concentrations for the first five days of the culture.
On days 13-14, the culture was harvested and stained CD4, CD8, CD25, and Foxp3. Cell number
is reflected as a ratio to respective media control of the same donor. N=6 UCB donors. **p<0.01,
One-way ANOVA, Dunnett’s multiple comparisons test.
Furthermore, 100mM EtOH significantly decreased Foxp3 expression in both CD4+ and
CD8+ T cells as seen by a decrease in mean fluorescence intensity (MFI) at the end of the
Foxp3+ T cell induction culture (Figure 27). Therefore, the presence of 100mM ethanol
decreased Foxp3 protein expression within the cells. Altogether, these data demonstrate that
EtOH can inhibit UCB Foxp3+ T cell induction.
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Figure 27: Mean Fluorescence Intensity (MFI) Of Foxp3 at the End of Foxp3+ Treg
Induction Culture With or Without EtOH. Total umbilical cord blood mononuclear cells were
cultured in the presence of anti-human CD3 and IL-2 for 13-14 days with or without ethanol of
the indicated concentrations for the first five days of the culture. On days 13-14, the culture was
harvested and stained for CD4, CD8, CD25, and Foxp3. MFI is reflected as a ratio of ethanol
treatment to media control (NT). N=6 umbilical cord blood donors, *p<0.05, paired t-test.
A Potential Mechanism Underlying UCB-derived Foxp3+ T Cells Induction Inhibition by
EtOH
It has been shown previously that IL-2 is required for TGF-β to induce naïve
CD4+CD25- T cells to become CD25+ and express Foxp3105. IL-2 signaling is initiated by
binding with high affinity to the trimeric IL-2R that consists of CD25, also known as IL-2
receptor alpha (IL-2Rα), IL-2Rβ, and common γ chain541–543. IL-2Rβ and the common γ chain
can also form a dimer and bind IL-2 with low affinity. CD25-/- mice develop severe
autoreactivity and develop autoimmune disorders544. This lymphoproliferative syndrome was
partly attributed to a deficiency in Treg cells545. We hypothesized that EtOH inhibits UCBderived Foxp3+ induction by blocking CD25 expression early in the culture.
To determine if the presence of EtOH changes CD25 expression on UCB T cells, total
UCB mononuclear cells were cultured with beads coated with anti-human CD3 for 1 day in the
presence and absence of EtOH without exogenous IL-2 (as IL-2 can promote CD25 expression).
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After 1 day, the cells were harvested and stained for CD25 expression on both CD4 and CD8 T
cells.
In the presence of anti-CD3 stimulation, CD25 expression is induced in both CD4+ and
CD8+ T cells after 1 day (NT, Figure 28). EtOH produces a significant dose-dependent decrease
in both CD25 frequency and expression (gMFI) within CD4+ and CD8+ T cell population
especially in the presence of 100mM EtOH. The expression of CD25 appears to be more
sensitive to EtOH treatment in the CD8+ T cell subset, where 50mM EtOH led to a significant
decrease in both CD25 frequency and expression (Figure 28). These data suggest that EtOH
inhibits UCB-derived Foxp3+ T cell induction by blocking CD25 expression early on during
Foxp3+ T cell induction culture.
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Figure 28: CD25 Frequency and Expression in UCB T Cells in the Absence and Presence of
EtOH After CD3 Stimulation. A) Representative histogram of CD25 expression by CD4+ and
CD8+ T cells 1 day after CD3 stimulation. B) CD25 frequency within CD4+ and CD8+ T cells.
C) CD25 expression as reflected by geometric mean fluorescent intensity within CD4+ and
CD8+ T cells. Total UCB were cultured in the presence of anti-CD3 coated beads for 1 day.
Ethanol was added to achieve indicated final concentration at the time of culture. After 1 day, the
cells were harvested and stain for CD25 within CD4+ and CD8+ T cells. NT= media control,
50mM, and 100mM indicate the final concentration of EtOH in the media. N=6 independent
UCB donors. Analyzed with one-way ANOVA, Dunnett’s multiple comparisons test, *p<0.05.
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Section II: Helios Expression in Perinatal T Cells
The perinatal immune system is phenotypically and functionally distinct from the adult
immune system, which is highly tolerantly biased. In murine models, one of the main differences
is murine neonatal T cells appeared to be heavily biased toward a Th2 profile against both
primary and secondary responses in vitro and in vivo compared to adult T cells307,546. A Th2
biased response is critical for tolerance establishment, especially during the first few days of
birth, while a Th1 response has been associated with allograft rejection547,548. This Th2 biased
response by neonates rapidly declines to adult T cell levels by day 5 after birth308. In human
perinatal T cells, we have previously shown that UCB naïve CD4+ T cells differ from adult
naïve CD4+ T cells in terms of surface antigen expression as well as cytokine production 309.
Freshly isolated UCB naïve CD4+ T cells do not exhibit a Th2 biased response but produce less
IFN-γ compared to adult naïve CD4+ T cells309. Furthermore, UCB T cells produce higher levels
of IL-10, an anti-inflammatory cytokine, upon antigen receptor stimulation compared to adult T
cells310. These data demonstrate that perinatal T cells are biased towards a tolerant and antiinflammatory response.
Helios Expression in Human Perinatal and Adult T Cells
To investigate if there are transcription factors that could contribute to the tolerant nature
of the perinatal immune system, we screened for transcription factors known to regulate T cell
function and cytokine productions. As Helios is generally considered a transcription factor
expressed by a subset of CD4+ Foxp3+ Tregs, and plays a critical role in maintaining Treg
stability and suppressive function372,384–386, we investigated if UCB has a higher frequency of
Helios+ T cells.
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We previously found that our ex vivo generated UCB-derived Foxp3+ T cells co-express
Helios after our 14-day induction culture, like freshly isolated adult CD4+ Foxp3+ tTregs
(Figure 9)512. However, when we analyzed Helios and Foxp3 expression in freshly isolated UCB
and APB total mononuclear cells, a significantly higher frequency of UCB CD4+ T cells
(46.9±27.2%) express Helios without Foxp3 co-expression, in comparison to APB CD4+ T cells
(8.1±4.1%). About 3±3.8% of UCB CD4+ T cells express both Foxp3 and Helios while about
15±7.6% adult CD4+ T cells are Foxp3+Helios+ (Figure 29). This demonstrates that a majority
of Helios+ UCB CD4+ T cells do not express Foxp3, while a majority of adult CD4+Helios+ T
cells are Foxp3+. This is in agreement with previous findings, where fetal naïve CD4+ T cells
express higher levels of Helios compared to adult naïve CD4+ T cells327. Additionally, a
significantly higher frequency of UCB CD8+ T cells express Helios compared to APB CD8+ T
cells (79.3±8.43% and 25.5±12.35% respectively, Figure 29).

Figure 29: Helios and Foxp3 Expression in UCB And APB CD4+ and CD8+ T Cell
Population. A) Representative FACS plot of Helios and Foxp3 expression by UCB and APB
CD4+ and CD8+ T cell population. B) Helios+Foxp3- frequency summary by UCB and APB
CD4+ and CD8+ T cells. C) Helios+Foxp3+ frequency summary by UCB and APB CD4+ T
cells. Freshly isolated UCB and APB mononuclear cells were stained for Helios and Foxp3
frequency within CD3+CD4+ and CD3+CD8+ T cells. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001 unpaired t test. Each dot represents individual donors (APB N=5, UCB N=6)
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The striking difference in Helios frequency between UCB and APB T cells led us to
hypothesize that Helios+ T cell frequency decreases with age. In collaboration with the Loyola
Neonatal Intensive Care Unit, we obtained blood samples from 8 pre-term (<30 weeks’
gestation) donors and tracked their Helios expression during the first three weeks of life during
their routine blood work. Helios+Foxp3- by CD4+ T cells started at a relatively high frequency
(26.0±20.3%) and showed a decreasing trend of significantly lower at 3 weeks after birth
(5.8±3.2%). The Helios+Foxp3- by CD8+ T cells also started at a relatively higher frequency
(48.7±27.0%) and decreased significantly by 3 weeks after birth (15.1±19.1%, Figure 30).

Figure 30: Frequency of Helios Within CD4 and CD8 T Cells from Preterm Neonate’s
Peripheral Blood Collected Up To 3 Weeks After Birth. A) Representative FACS plot of
Helios and Foxp3 expression by preterm neonates CD4 and CD8 T cells. B) Summary plot of
Helios+Foxp3- frequency by CD4 and CD8 T cells in preterm neonate’s peripheral blood.
Freshly isolated mononuclear cells were harvested from pre-term donors and stained for Helios
and Foxp3 frequency within CD4 and CD8 T cells. *p<0.05, **p<0.01 unpaired t-test comparing
to week 0. Each dot represents an individual donor, and the line tracks the same donor. N=5-8
each week, depending on the donor.
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Helios Expression in Mouse Splenic T Cells
To determine if we observe a similar phenotype in mice, we analyzed Helios and Foxp3
expression of splenic CD4+, CD8+ αβ T cells of different ages ranging from 0 to 5-day old
neonates, 7 weeks (50 days) after birth as well as >6 months old. In agreement with previous
reports, the detection of Foxp3+ Tregs started to appear in the periphery around 3 days after
birth93,94. These CD4+ Foxp3+ T cells also express Helios and increase gradually from 2.8±0.4
to 11.1±0.5% at 7 weeks old. Billingham and Medawar demonstrated that tolerance against
foreign antigens could be established in utero241. These data suggest that other Foxp3- T cells
could contribute to the tolerant nature of the perinatal immune system prior to the appearance of
Tregs in the periphery. As observed in humans, most CD4+ and CD8+ T cells from 0-day old
neonate splenocytes express Helios do not co-express Foxp3 (34.7±11.4% and 76.6±15.5%
respectively). Helios+ T cell frequency rapidly decreases after birth by 2-4 days, reaching to
adult levels for both CD4+ and CD8+ T cells (7.2±0.6% and 7.5±1.3% respectively, Figure 31).
These data demonstrate that neonates have a higher frequency of Helios+ T cells that do
not co-express Foxp3 in both CD4+ and CD8+ T cell subset and this frequency decreases with
age in both humans and mice. Furthermore, these Helios+ T cells are detected in the periphery
before the appearance of Helios+Foxp3+ Tregs, suggesting that these Helios+Foxp3- T cells may
be a non-Treg mechanism that promotes perinatal tolerance.
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Figure 31: Helios and Foxp3 Expression Within Splenic CD3+γδTCR- CD4+ and CD8+ T
Cell Population in Mice. Splenocytes were harvested from mice of indicated ages and stain for
Helios and Foxp3 within CD4+ and CD8+ αβ T cells. αβ T cells were gated as CD3+γδTCRpopulation. A) Representative FACS plots of indicated age group. B) Plot represents mean and
standard deviation of N=3-7 individual mice or pooled neonatal mice. At earlier neonatal days,
splenocytes were pooled from littermates to obtain enough cells for staining and is counted as
one donor. All value on the x-axis indicates days except for >6mo where it represents >6-monthold adult. Analyzed by ordinary one-way ANOVA, Dunnett’s multiple comparisons test
comparing each age against 0-day old *p<0.05, ****p<0.0001.
In mice,  T cells are more highly represented in neonatal stage compared to  T
cells353.  T cells are disproportionately important for immune protection in younger mice
compared to adult mice in an age-dependent manner. As a majority of peripheral T cells in mice
before 5 days of age are  T cells, we next determined if murine  T cells express Helios and
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also display an age-dependent decrease in Helios frequency as observed in  T cells. In fact, we
observed a high frequency of  T cells in the spleen express Helios but not Foxp3 by 0-day old
neonates (91±13.4%). The frequency of Helios+Foxp3-  T cells rapidly decreases to adult
levels between 2-4 days after birth (37.4±3.9% at 50 days old, 15.7±3.4% at 6 months old,
Figure 32C). The majority of splenic γδ T cells are CD8+ or CD4-CD8- DN (Figure 32A). When
we further investigated Helios+ Foxp3- frequency within the different splenic γδ T cell subset,
we found that Helios frequency decreases in both CD8+ and DN γδ T cells after birth. Strikingly,
we found that while adult CD8+ γδ T cells express a very low frequency of Helios, they express
significantly higher frequency of Foxp3+ without co-expression of Helios compared to perinatal
CD8+ γδ T cells in the spleen. This phenomenon is unique to CD8+ γδ T cells, as Foxp3 is not
detected by CD4-CD8- DN γδ T cells at any time points (Figure 32D).
In summary, we found that a higher frequency of  and  T cells express Helios in
neonatal mice, and Helios frequency rapidly decreases a few days after birth to adult levels.
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Figure 32:Helios and Foxp3 Expression Within Splenic CD3+γδTCR+ T Cell Population in
Mice. A) Gating strategy for total CD3+TCR+ T cells, CD8+ CD3+ TCR+ and CD4-CD8(DN) CD3+TCR+. The same gating strategy is applied for all indicated age groups. B)
Representative FACS plots for Helios and Foxp3 by adult total CD3+TCR+ T cells, CD8+
CD3+ TCR+ and CD4-CD8- (DN) CD3+TCR+ in the spleen. C) Kinetics of Helios+Foxp3by total CD3+TCR+ T cells, DN CD3+TCR+ T cells and CD8+ CD3+TCR+ T cells in
the spleen from neonates through adulthood. D) Kinetics of Helios-Foxp3+ by CD8+ and DN
CD3+TCR+ T cells in the spleen. Splenocytes were harvested from mice of indicated ages and
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stained for Helios and Foxp3. The plot represents the mean and standard deviation of N=3-7
individual mice or pooled neonatal mice. At earlier neonatal days, splenocytes were pooled from
littermates to obtain enough cells for staining and counting as one donor. All value on the x-axis
indicates days except for >6mo where it represents >6-month-old adult. Analyzed by ordinary
one-way ANOVA, Dunnett’s multiple comparisons test comparing each day against 0-day old
**p<0.01, ***p<0.001, ****p<0.0001.
Helios Expression in Mouse Thymocytes
These Helios differences between perinatal and adult T cells may be pre-determined at
the hematopoietic stem cell (HSC) level, as hypothesized by the concept that the immune system
develops in a “layered” fashion. This hypothesis suggests that unique hematopoietic stem cells
(HSCs) give rise to distinct lymphocyte lineages at different stages of development. These
distinct populations of cells may co-exist for a period of time323,356. This prompted us first to
examine if the rapid reduction of Helios+ T cells we observed in the spleen in neonatal mice has
a developmental origin in the thymus. To test this, we obtained thymocytes from fetuses in
embryonic days (E) 17.5/18.5, 0, 1, 3, and 5-day old neonates and compared their Helios and
Foxp3 expression to adult mice (>6 months of age). Figure 33 demonstrates the gating strategy
to examine Helios and Foxp3 expression in CD4+ and CD8+ single-positive (SP) population in
the thymus.
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Figure 33: Gating Strategy of Helios and Foxp3 Expression in Different Thymocyte
Population. This strategy is applied for all thymocyte analyses for the different age groups.
The frequency of Helios+Foxp3- expressing CD4+ and CD8+ SP thymocytes is highest
at E17/18.5 (75.32±3.71% and 96.1±1.08% respectively). We observed a significant decrease in
Helios+Foxp3- CD4+ SP thymocytes starting at birth (day 0, 43.73±2%) and rapidly decline to
adult levels (35.28±12.88%) by day 1 after birth (32.56±2.27%). Like previous reports, we
detected the emergence of Foxp3+ CD4+ Tregs in the thymus around 3 days after birth. These
Foxp3+ CD4+ Tregs also express Helios and can be detected through adulthood (2.17±0.66%at
day 3, 3.44±0.77% at >6 months old, Figure 34A).
In contrast, the frequency of Helios+ CD8+ SP thymocytes significantly decreased only
by 3 days after birth (78.28±2.17%) and is the lowest in adults (60.13±10.93%, Figure 34B).
These data demonstrate that Helios expression in both CD4+ and CD8+ thymocytes is the
highest before birth and rapidly declines after birth, like what we observed in the periphery
(Figure 31 and 34).
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Figure 34: Helios and Foxp3 Frequency and Kinetics in Murine Perinatal and Adult
CD4+CD3+ SP And CD8+CD3+SP Thymocytes At the Indicated Ages. A) Helios+Foxp3and Helios+Foxp3+ frequency by CD4+ SP thymocytes. B) Helios+Foxp3- frequency by CD8+
SP thymocytes. CD4 and CD8 SP are gated as CD4+CD3+ and CD8+CD3+ after gating for live
and single cells. Analyzed by ordinary one-way ANOVA, Dunnett’s multiple comparisons test
comparing each timepoints to E17.5/E18.5, **p<0.01, ***p<0.001, ****p<0.0001. Each data
point represents mean and standard deviation of N=3-4 pooled samples or individual mice. All
value on the x-axis indicates days except for >6mo where it represents >6-month-old adult.
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To determine if perinatal  T cells in the thymus also express Helios, we analyzed
Helios and Foxp3 expression by  T cells in the thymus at the indicated ages.  T cells in the
thymus are predominantly DN but a minor population of CD8+  T cells have been reported549.
Therefore, we analyzed Helios frequency by total  T cells (CD3+TCR+), DN  T cells
(CD4-CD8-CD3+TCR+) as well as CD8+  T cells. In our hands, we detected CD8+ T
cells in the thymus, especially in fetal and neonatal thymocytes, but almost undetectable in
adults. Within total  T cells, the highest Helios frequency was detected before birth, E17.5/18.5
(96.2±2.72%). The frequency of Helios expressing total  T cells significantly decreases at day
0, 3 and 5 after birth. Helios frequency within adult (>6mo) total  T cells is significantly lower
(60.1±12.9%) compared to fetal thymocytes. When we assessed Helios expression within
CD8+ T cells, we saw a significant decrease in Helios frequency by 3 days after birth. Lastly,
looking within CD4-CD8- DN  T cells population, Helios frequency is only significantly lower
in adults compared to perinatal thymocytes (Figure 35C).
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Figure 35: Helios Kinetics in Murine Perinatal and Adult CD3+γδTCR+ Thymocytes at the
Indicated Ages. A and B) Gating strategy for Helios and Foxp3 expression by total
CD3+TCR+, CD8+ CD3+TCR+ and DN CD3+TCR+ in the thymus. FACS plots are from
0-day old thymus sample. The same strategy is applied for all analysis of different age groups. C)
Helios+Foxp3- frequency by total  T cells (CD3+TCR+), DN  T cells (CD4-CD8CD3+TCR+) and CD8+  T cells (CD8+CD3+TCR+) in the thymus of indicated ages.
Analyzed by ordinary one-way ANOVA, Dunnett’s multiple comparisons test comparing each
time point to E17.5/E18.5, **p<0.01, ****p<0.0001. Each data point represents the mean and
standard deviation of N=3-4 individual mice. All value on the x-axis indicates days except
for >6mo where it represents >6-month-old adult.
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Overall, the frequency of Helios in CD4+ SP, CD8+ SP and  TCR+ thymocytes are
higher than the spleen across all the time points, but the kinetics of Helios+ T cells are similar
between both the spleen and the thymus. Both newborn splenocytes and thymocytes started with
high Helios frequency and their Helios frequency rapidly decreased to adult levels within the
first week of birth (Figure 36). Altogether, these data demonstrate that perinatal αβ and γδ T cells
express a higher frequency of Helios and the frequency of Helios+ T cells decreases with age
both in the thymus and the spleen.

Figure 36: Helios+Foxp3- Frequency Comparison by Splenic and Thymic αβ T Cells and
γδ T Cells of Perinatal and Adult Mice. A) Helios+Foxp3- frequency by CD4+ and CD8 αβ T
cells and total γδ T cells in the spleen and thymus. B) Helios+Foxp3- frequency by CD8+ and
CD4-CD8- DN γδ T cells in the spleen and thymus. Each data point represents mean and
standard deviation of N=3-7 individual mice or pooled neonatal samples. All value on the x-axis
indicates days except for >6mo where it represents >6-month-old adult. C) Summary schematics
of Helios expression by αβ and γδ T cells in the spleen and thymus from perinatal stage to
adulthood.
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Helios Expression in Gut Associated T Cells
The intestinal immune surveillance network is an integrated part of the organ, enabling it
to balance host protection against pathogens and maintain tissue homeostasis. T cells reside in
three main compartments in the intestine, namely gut-associated lymphoid tissue (GALT),
lamina propria (LP), and the epithelium (IEL). These frontline T cells are primarily heterogenous
and can be distinguished into two major subsets (type a and type b) based on T cell receptor and
co-receptor expression550,551. “Type a” cells consist of conventional thymus-selected antigenexperienced T cells that can also be found in the peripheral blood, spleen, and secondary
lymphoid organs. These T cells express TCRαβ+ and are MHC class I or class II restricted CD4+
and CD8αβ+ T cells. “Type b” T cells consist of unconventional T cells that express CD8αα
homodimer and can express either TCRαβ+ or TCRγδ+ (Figure 37). A large proportion of the
gut IEL compartment consists of these CD8αα TCRαβ+ or TCRγδ+ “type b” T cells.

Figure 37: Type A and B Gut Associated T Cells.
“Type b” T cells have been implicated to be of perinatal origin. These “type b” T cells
can be detected at fetal stages, but major colonization of the gut epithelium by these cells
occurred perinatally. The detection of Vγ7+ γδ T cells in the gut IEL fraction suggests that γδ
TCR+ IELs originate from the fetal origin as Vγ7 is detected in the thymus at E1351. It is also
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implicated that αβ TCR+ IELs are of fetal origin as αβ TCR+ can be detected in both IEL and
LPL of human fetal intestine552,553. Furthermore, grafting of adult thymi into athymic nude mice
led to virtually no γδ TCR+ IELs and relatively less CD8αα αβ TCR+ IELs compared to fetal
thymi554. These data suggest that progenies of fetal thymocytes are the major source of CD8αα
γδ and αβ T cell subsets in the intestinal IELs. Since we observed a higher frequency of Helios+
 and αβ T cells in both the spleen and thymus of neonatal mice, we seek to determine if gutassociated “type b” + and αβ+ T cells express Helios due to their implicated fetal origin.
The gut immune system undergoes significant changes throughout life in terms of
numbers and subset compositions since it is exposed to a wide variety of food and microbial
antigens555. First, we wanted to determine if we could detect “type a” and “type b” gut T cells in
both neonates and adult mice. We isolated LPL and IEL fractions from small intestines (SI) of 5day old neonates and adult mice (6-12 weeks old) and assessed their cell proportions. Due to the
isolated mononuclear cell number, panel design, and fluorophore restrain, we stained for γδ TCR
and CD3 and gated CD3+ γδTCR- as CD3+αβ T cell population. We verified that majority of
CD3+ γδTCR- contains cells that stained for αβ TCR population in both the gut IEL and LPL
fraction (Figure 38). Therefore, from here onwards, αβ T cell population in the gut will be
represented under CD3+ γδTCR- fraction.
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Figure 38: TCRαβ and γδ Expression by CD3+ T Cells within SI LPL, SI IEL and Spleen
of Adult Mice.
When we compared the frequency of αβ T cells and γδ T cells in the SI IEL and SI LPL
between 5-day old neonates and adults, we observed that the frequency of αβ T cells (CD3+
γδTCR-) is similar in the SI IEL but significantly higher in 5-day old neonatal SI LPL compared
to adult SI LPL (Figure 39A). In contrast, the frequency of γδ T cells (CD3+ γδTCR+) is
significantly higher in adult SI IEL than 5-day old neonates, while it is similar in the SI LPL
(Figure 39B).
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Figure 39: Frequency of αβ and γδ T cells Among CD45+ Cells in Neonatal and Adult SI
LPL and IEL. A) Frequency of αβ T cells reflected by the frequency of CD3+ γδTCR- gated
within CD45 population in the SI IEL and LPL of 5-day old neonates and adult. B) Frequency of
γδ T cells as reflected by the frequency of CD3+ γδTCR+ gated within CD45 population in the
SI IEL and LPL of 5-day old neonates and adult. The small intestine intraepithelial layer and
lamina propria are processed to isolate mononuclear cell subsets and stained for different surface
antigen markers to determine their frequency. Each dot represents an individual experiment with
either individual or pooled SI of the indicated age group. Analyzed by unpaired t-test, **p<0.01,
***p<0.001. N=4 individual experiments.
It was previously reported that gut-associated αβ TCR+ and γδ TCR+ IELs predominantly
express CD8αα homodimer170,556. In the human fetal intestine, nearly 50% of fetal IELs express
an antigen-experienced and CD8αα phenotype552. We further stained adult and neonatal LPL and
IEL for other surface markers, including CD4, CD8α, and CD8β. Gating strategies are depicted
in Figure 40.
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Figure 40: Gating Strategy of CD4, CD8αα, CD8αβ, and CD4-CD8- Subsets Within
CD3+γδTCR+ and CD3+γδTCR- Population. The same gating strategy was applied to both SI
IEL and SI LPL.
Within the αβ T cell subsets, both SI IEL and LPL in 5-day old neonates are
predominantly enriched with CD4+ subsets (46.7±15.48% and 64.27±6.59% respectively).
Neonatal SI IEL CD4+ frequency within αβ T cell subsets is significantly higher than adult SI
IEL (14.15±3.81%). Still, it is not significantly different between neonatal SI LPL and adult SI
LPL (50.24±11.59%). The population of CD8αα αβ T cells is significantly lower in 5-day old SI
IEL (7.15±4.07%) and LPL (2.64±1.64%) in comparison to adult SI IEL (60.64±11.65%) and
LPL (24.43±8.5%). On the other hand, CD8αβ subset frequency within αβ T cells is not
significantly different between neonates (22.48±9.43%) and adult SI IEL (14.41±8.11%). Lastly,
5-day old neonate SI IEL has significantly lower CD4-CD8- αβ T cell frequency compared to
adult SI IEL (3.4±2.32% and 6.55±1.76% respectively). At the same time, they are not
significantly different in the SI LPL compartment (Figure 41). In addition to that, there is also a
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clear difference between SI IEL and LPL fraction particularly in the adult gut CD8αα αβ T cells
where there was an enrichment in the SI IEL fraction but not as prominent in the LPL fraction.

Figure 41: Proportion of CD4, CD8αα, CD8αβ and CD4-CD8- Within αβ T Cells in 5-day
Old and Adult SI IEL and LPL. The small intestine intraepithelial layer and lamina propria is
processed to isolate mononuclear cell subsets and stained for different surface antigen markers to
determine their frequency. αβ T cells are gated as CD3+ γδTCR- within CD45 population in the
SI IEL and LPL of 5-day old neonates and adults. Within the αβ T cells subset, the average
frequency of each subset is obtained from N=4-7 individual experiments and plotted as a pie
chart. Analyzed by unpaired t-test comparing each subsets between 5-day old neonates and adult,
*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001.
Within the γδ T cells subset in the gut, the SI IEL are predominantly enriched with
CD8αα expressing cells in both neonates and adults. However, the frequency of CD8αα subset is
significantly higher in adult SI IEL (86.33±3%) in comparison to 5-day old neonates
(71.13±3.32%). Gut CD8αα and CD4-CD8- γδ T cells have been the most studied population,
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but a novel CD8αβ γδ T cell subset has just been recently identified and characterized in the
human gut. This CD8αβ γδ T cell subset has cytotoxic potential and is negatively correlated with
disease severity in inflammatory bowel disease (IBD), suggesting a potential regulatory role in
IBD557. We detected CD8αβ γδ T cells in both neonates and adult gut, with a significantly higher
frequency in 5-day old neonates SI IEL and LPL (11.05±2.92% and 7.6±2.07% respectively)
compared to adult SI IEL and LPL (2.94±1.12% and 2.94±1.95% respectively). Both neonatal SI
IEL and LPL has a higher frequency of CD4-CD8- γδ T cell subsets (12.52±2.87% and
41.54±1.64% respectively) compared to adults SI IEL and LPL (6.41±1.4% and 10.22±2.43%
respectively) where strikingly in the neonatal SI LPL, CD4-CD8- subsets reconstitute almost half
of all γδ T cells. We detected a minimal frequency of CD4 expressing γδ T cells in both neonates
and adults SI IEL and LPL (Figure 42).
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Figure 42: Proportion of CD4, CD8αα, CD8αβ, and CD4-CD8- Within γδ T Cells in 5-day
Old and Adult SI IEL and LPL. The small intestine intraepithelial layer and lamina propria
were processed to isolate mononuclear cell subsets and stained for different surface antigen
markers to determine their frequency. γδ T cells are gated as CD3+ γδTCR+ within CD45
population in the SI IEL and LPL of 5-day old neonates and adults. Within the γδ T cells subset,
the average frequency of each subset is obtained from N=4-7 individual experiments and plotted
as a pie chart. Analyzed by unpaired t-test comparing each subsets between 5-day old neonates
and adults, *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001.
Helios expression in gut-associated “type a” and type b” T cells. After we demonstrated
that we could successfully detect the different types of gut mucosal T cells in both 5-day old
neonates and adults SI IEL and LPL fractions, we next checked Helios expression within the
different gut T cell subsets. Since gut-associated “type b” + and αβ+ T cells has implications
of perinatal origin, we hypothesized that “type b” + and αβ+ T cells express the high frequency
of Helios throughout adulthood while “type a” CD4 and CD8 αβ+ T cells do not.
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In the SI IEL “type a” T cell fraction, we found that the frequency of Helios+Foxp3within CD4+ T cells of 5-day old neonates and adults are not significantly different
(20.1±20.83% vs 9.43±4.1%). In contrast, Helios+Foxp3- frequency within the CD8αβ αβ T
cells are significantly higher in 5-day old IEL in comparison to adult SI IEL (54.87±10.5% vs
17.06±9.77%). On the other hand, within the SI IEL “type b” T cell fraction, which compromises
of CD8αα γδ and αβ T cells, the frequency of Helios+Foxp3- is not significantly different
between neonates and adults CD8αα γδ T cells (89.03±14.76% in neonates vs. 69.3±20.61% in
adults). There is no significant difference between neonatal and adult CD8αα αβ T cells in their
Helios+Foxp3- frequency (95.7±5.73% in neonates vs. 71.26±20.32% in adults) in the SI IEL
fraction (Figure 43). However, it is important to note that the frequency of CD8αα αβ T cell
subset in the gut of 5 day old neonates is very low as observed in Figure 41 and in agreement
with previously published studies558.
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Figure 43: Helios and Foxp3 Expression Within “Type A” and “Type B” SI IEL Associated
T Cells. A) Representative flow plots of Helios and Foxp3 expression within CD4, CD8αβ αβ T
cells and CD8αα αβ and γδ T cells from small intestine IEL fraction isolated from 5-day old
neonates or adult. B) Summary plots comparing the frequency of Helios+Foxp3- expression
within CD4, CD8αβ αβ T cells (type a) and CD8αα αβ and γδ T cells (type b) from small
intestine IEL fraction isolated from 5-day old neonates or adult. αβ T cells are gated as CD3+
γδTCR- gated within CD45 population and γδ T cells are gated as CD3+ γδTCR+ within CD45
population in the SI IEL. N=3 individual experiments of pooled neonatal gut (6-9 pups per
experiment) and N=7 individual experiments for adult gut samples. They were analyzed by
unpaired t test ***p<0.001.
In the SI LPL “type a” T cell fraction, the frequency of Helios+Foxp3- within CD4+ T
cells of 5-day old neonates and adult are not significantly different (9.33±5.39% vs

118
10.39±5.32%). Helios+Foxp3- frequency within the CD8αβ αβT cell subset is significantly
higher in 5-day old SI LPL in comparison to adult SI LPL (39.4±8.46% vs 10.02±4.47%).
Within the SI LPL “type b” T cell fraction, the frequency of Helios+Foxp3- is not significantly
different between neonates and adults CD8αα γδ T cells (93.6±5.43% in neonates vs
86.65±8.12% in adults). There is also no significant difference in Helios+Foxp3- frequency
between neonates and adult SI LPL CD8αα αβ T cells. (86.73±7.34% and 87.93±9.68%
respectively, Figure 44). Like the SI IEL fraction, neonatal SI LPL CD8αα αβ T cells frequency
is very low (Figure 41)558.
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Figure 44: Helios and Foxp3 Expression Within “Type A” and “Type B” SI LPL
Associated T Cells. A) Representative flow plots of Helios and Foxp3 expression within CD4,
CD8αβ αβ T cells and CD8αα αβ and γδ T cells from small intestine LPL fraction isolated from
5-day old neonates or adult. B) Summary plots comparing the frequency of Helios+Foxp3expression within CD4, CD8αβ αβ T cells (type a) and CD8αα αβ and γδ T cells (type b) from
small intestine LPL fraction isolated from 5-day old neonates or adult. αβ T cells are gated as
CD3+ γδTCR- gated within CD45 population and γδ T cells are gated as CD3+ γδTCR+ within
CD45 population in the SI LPL. N=3 individual experiments of pooled neonatal gut (6-9 pups
per experiment) and N=6 individual experiments for adult gut samples. Analyzed by unpaired t
test ***p<0.001.
When we compared Helios+Foxp3- frequency between “type a” and “type b” T cell
subsets in the SI IEL and LPL, “type b” T cells (both CD8αα αβ and γδ T cells) express
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significantly higher frequency of Helios+Foxp3- than “type a” T cells (CD8αβ and CD4 αβ T
cells) in both neonates and adults (Figure 45). These data suggest that Helios expression is
limited to T cells of perinatal origin and is not induced by the gut microenvironment as not all
gut-associated T cells express Helios.

Figure 45: Comparison of Helios+Foxp3- Frequency Between “Type A” and “Type B” T
Cells in SI IEL and LPL by Neonates and Adults. Summary plots comparing the frequency of
Helios+Foxp3- between “type a”: CD8αβ αβ T cells, CD4 αβ T cells and “type b”: CD8αα γδ T
cells and CD8αα αβ T cells by 5 day old and adult SI IEL and LPL. αβ T cells are gated as CD3+
γδTCR- gated within CD45 population, and γδ T cells are gated as CD3+ γδTCR+ within CD45
population in the SI IEL and LPL. N=3 individual experiments of pooled neonatal gut (6-9 pups
per experiment) and N=6-7 individual experiments for adult gut samples. Analyzed by 2way
ANOVA, Tukey’s multiple comparisons test, *p<0.05, ****p<0.0001.
Helios expression in “type c” gut T cells. We detected the presence of a less studied γδ
T cell subset both in the SI IEL and LPL of neonates and adults. These γδ T cells express CD8αβ
and will be categorized as “type c” gut-associated T cells hereinafter (Figure 42). This group of
CD8αβ γδ T cells carries a striking phenotype where neonates express a higher frequency of
Helios+Foxp3- in both SI IEL and LPL and significantly decreases in both adult SI IEL and
LPL. However, there is a significant increase in the frequency of Helios and Foxp3 coexpression by these CD8αβ γδ T cells, particularly in adult SI IEL and a trend of increase by
CD8αβ γδ T cells in adult SI LPL in comparison to neonates (Figure 46).
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Figure 46: Helios and Foxp3 Expression by CD8αβ γδ “Type C” Gut Associated T Cells.
The small intestine intraepithelial layer and lamina propria are processed to isolate mononuclear
cell subsets and stained for Helios and Foxp3 expression. CD8αβ+ subset was gated within
CD3+ γδTCR+ population in the SI IEL and LPL of 5-day old neonates and adults. Within
CD8αβ+γδ T cells subset, the average frequency of Helios-Foxp3+, Helios+Foxp3+,
Helios+Foxp3- and Helios-Foxp3- is obtained from N=6-7 adult mice and N=3 individual
experiments for 5-day old, pooled neonate samples and plot as a pie chart. They were analyzed
by unpaired t-test comparing each subsets between 5-day old neonates and adult SI IEL or SI
LPL, *p<0.05, **p<0.01, and ***p<0.001.
Helios expression in fetal gut T cells. It was previously demonstrated that gut
intraepithelial γδ T cells can be detected in rat intestines as early as 1 day after birth559. Next, we
asked if we could also detect Helios+Foxp3- T cells in fetal gut IEL and LPL fraction (whole
intestine). To test this, we set up timed pregnancies and obtained gut tissue from fetuses between
E17.5 and 18.5. During this period, the majority of fetal gut αβ T cells are CD4-CD8- while the
majority of γδ T cells express CD8αα (Figure 47).
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Figure 47: Proportion of CD4, CD8αα, CD8αβ and CD4-CD8- Within αβ and γδ T Cells in
E17.5/18.5 Fetal IEL and LPL. The whole intestine (small and large) intraepithelial layer and
lamina propria is processed to isolate mononuclear cell subsets and stained for different surface
antigen markers to determine their frequency. αβ T cells are reflected as CD3+ γδTCR- while γδ
T cells are gated as CD3+ γδTCR+ within CD45 population in the fetal IEL and LPL fraction.
The average frequency of each subset is obtained from N=4 individual experiments and plotted
as a pie chart. Fetal gut was pooled from the same litter (N=7-11 pups).
Next, we analyzed Helios expression by “Type b” CD8αα γδ T cells in both the fetal IEL
and LPL. We found that both fetal IEL and LPL CD8αα γδ T cells express a high frequency of
Helios+Foxp3- (80.84±18.83% and 78.72±12.23% respectively, Figure 48). We are unable to
analyze CD8αα αβ T cells in the fetal gut due to low cell number.
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Figure 48: Helios and Foxp3 Expression Within CD8αα γδ T Cells in E17.5/18.5 Fetal IEL
and LPL. A) Representative FACS plot of Helios and Foxp3 expression by CD8αα γδ T cells in
the IEL and LPL. B) Summary plot reflecting Helios+Foxp3- frequency within CD8αα γδ T cells
in the IEL and LPL. Whole intestine (small and large) intraepithelial layer and lamina propria is
processed to isolate mononuclear cell subsets and stained for different surface antigen markers to
determine their frequency. γδ T cells are gated as CD3+ γδTCR+ within CD45 population in the
fetal IEL and LPL fraction. N=5 individual experiment, fetal gut was pooled from the same litter
(N=7-11 pups).
In summary, Helios+Foxp3- can be detected in gut CD8αα γδ T cells as early as
E17.5/18.5 fetal stage. Helios+Foxp3- frequency is higher in “type b” T cells than “type a” T
cells in both SI IEL and LPL in both neonates and adults. Altogether, these data suggest that
“type b” perinatal origin gut T cells in both SI IEL and LPL express high Helios+Foxp3frequency and maintains throughout adulthood. On the other hand, within the “type a” T cells,
neonatal gut associated CD8αβ αβ T cells express higher frequency of Helios+Foxp3- but
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significantly decreases in adult, while CD4+ T cells express similar Helios+Foxp3- frequency
between 5-day neonates and adult. Lastly, “type c” CD8αβ γδ T cells highly express
Helios+Foxp3- during the neonatal stage, at levels similar to those of “type b” gut associated T
cells. However, their Helios+Foxp3- frequency significantly decreases in adults with the
subsequent emergence of Helios+Foxp3+ and Foxp3+ populations instead (Figure 49).

Figure 49: Helios+Foxp3- Frequency and Kinetics by “Type A”, “Type B” and “Type C” T
Cells in SI IEL and SI LPL in 5-day old Neonates and Adult. A) Helios+Foxp3- frequency by
“type a”, “type b” and “type c” T cells in SI IEL and LPL by 5-day old neonates and adults. B)
Summary diagram of Helios and Foxp3 kinetics by indicated gut-associated T cell subsets from
perinatal stage to adulthood.
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Ikaros Transcription Factor Family Expression in Gut Associated T Cells
The Ikaros zinc finger (IKZF) transcription factors are known regulators of immune cell
development. Furthermore, these transcription factors are differentially expressed by different T
cell subsets and can play a prominent role in T cell differentiation. For instance, Ikaros
expression has been shown to negatively regulate Th1 differentiation by silencing T-bet
expression and IFNγ production398,399. Helios expression has been shown to maintain the
function and stability of Foxp3+ Tregs. One of the mechanisms is by repressing IL-2 expression
in Tregs, which is one of Treg’s suppressive mechanisms to compete for IL-2 secreted by
responder T cells388,560. Aiolos has also been shown to directly repress IL-2 expression in CD4 T
cells under Th17 differentiation conditions405.
We observed that perinatal T cells express a higher frequency of Helios while adult T
cells do not. Furthermore, gut-associated “type b” T cells implicated in perinatal origin also
highly express Helios and maintained Helios expression through adulthood. However, if other
IKZF transcription factors such as Ikaros and Aiolos follows similar kinetics as Helios is
unknown. We next seek to compare Ikaros, Aiolos, and Helios expression in “type a”, “type b”
and “type c” gut-associated T cells by 5-day old neonates and adult mice.
Within “type a” gut-associated T cells, the predominant IKZF transcription factor
combination is Aiolos+ Helios- and Ikaros+ (A+H-I+). We do not observe a significant
difference in any of the IKZF transcription factor combination by CD8αβ αβ T cells between 5day old neonates and adult SI IEL. Due to fluorophore constraints, we analyzed CD8- αβ T cell
fraction to include both CD4 and CD4-CD8- population. Based on our previous findings, the
majority of CD8- cells consist of CD4+ T cell subset (Figure 40). In the CD8- αβ T cell fraction,
the Aiolos+ Helios- Ikaros+ (A+H-I+) IKZF transcription factor combination is significantly
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higher in neonates than their adult counterpart (59±20.4% and 33.25±13.23% respectively,
Figure 50).
Within “type b” gut associated T cells, the predominant IKZF transcription factor
combination is Aiolos+ Helios+ and Ikaros+ (A+H+I+) for both CD8αα αβ and γδ T cells. The
frequency of Aiolos+ Helios+ Ikaros+ (A+H+I+) within CD8αα γδ T cells is significantly higher
in neonates than adults SI IEL (70.3±15.5% and 53.5±11.27% respectively). Additionally, there
is a significantly higher frequency of Aiolos+ Helios+ but Ikaros- (A+H+I-) in adult SI IEL.
CD8αα γδ T cell population in adults (23±6%) compared to neonates (3.67±1.53%). Like their
“type b” CD8αα γδ T cell counterpart, about 22±4.32% of adult SI IEL CD8αα αβ T cells
express Aiolos+ Helios+ (A+H+I-) alone (Figure 50). Analysis for 5-day old neonates was
unavailable due to the low frequency of CD8αα αβ T cells.
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Figure 50: Ikaros Transcription Factor Proportions Within “Type A” and “Type B” Gut
Associated T Cells in 5-day Old Neonates and Adult SI IEL. Pie charts reflecting the average
frequency of transcription factor combination (A: Aiolos, H: Helios and I: Ikaros). Small
intestines were processed to isolate mononuclear cell subsets from the IEL fraction and stained
for different surface and intracellular markers to determine their frequency. αβ T cells are gated
as CD3+ γδTCR- and γδ T cells are gated as CD3+ γδTCR+ within CD45 population. Within αβ
and γδ T cells subset, the average frequency of each subset is obtained from N=3-6 individual
experiments and plot as a pie chart. Neonates were pooled from the same litter of 6-9 pups and
adults are individual mouse. Analyzed by 2way ANOVA, Sidak’s multiple comparisons test,
comparing each individual combination between 5-day old neonates and adult, **p<0.01,
***p<0.001.
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In summary, we found that “type b” gut associated T cells predominantly express the
combination of Aiolos, Helios, and Ikaros (A+H+I+) IKZF transcription factors in both neonates
and adults. On the other hand, “type a” gut associated T cells predominantly express Aiolos and
Ikaros (A+H-I+) in both neonates and adults. Consistent with our previous findings, the major
difference between “type a” and “type b” gut T cells is that Helios is mainly expressed by “type
b” T cells in both neonates and adult.
The second predominant IKZF transcription factor combination in adult “type b” gut
associated T cells is Aiolos+ Helios+ Ikaros- (A+H+I-). This population is significantly lower in
5-day old neonate “type b” T cells. On the other hand, a big proportion of “type a” T cells also
express Ikaros alone without Helios and Aiolos. This population demonstrates a trend of higher
frequency in adult in comparison to 5-day old neonates. A summary depiction of the changes in
the major IKZF transcription factor combination by type a and type b T cells are shown in Figure
51.
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Figure 51: Summary Diagram of Aiolos, Ikaros and Helios Expression by “Type A” and
“Type B” Gut Associated T Cells in 5-Day Old Neonates and Adult SI IEL. Within “type a”
T cells, one of the predominant IKZF transcription factor combination is Aiolos+ Ikaros+ in both
neonates and adult gut. A smaller subset of Ikaros+ “type a” T cells can be detected in neonates,
with increasing frequency in adults. On the other hand, “type b” T cells were more enriched with
Aiolos+ Ikaros+ Helios+ T cells that maintained through adulthood. A smaller subset of Aiolos+
Helios+ “type b” T cells can be detected in neonates and can be found at a higher frequency in
the adult gut.
Ikaros Transcription Factor Family Expression in Splenic T Cells
We observed that Helios expression in splenic T cells started high in newborns and
rapidly decrease a few days after birth. Since we observed differences in between “type a” and
“type b” gut T cells in Ikaros transcription factor family expression, we next investigate IKZF
transcription factor profile in splenic T cells. We hypothesized that splenic T cells expresses
similar IKZF transcription factor profile as gut associated “type a” T cells.
In the spleens of 5-day old neonates and adults, majority of CD8+ αβ T cells and γδ T
cells express CD8αβ heterodimer co-receptor and not CD8αα as we observed in gut associated
“type b” T cells (Figure 52A). Due to fluorophore constraints, CD8- population will consists of
CD4 and CD4-CD8- populations for αβ T cells and mainly CD4-CD8- population for γδ T cells
(Figure 52B).
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Figure 52: Gating Strategy for CD8αβ and CD8- for αβ T Cells and γδ T Cells in the
Spleen. A) Gating strategy for IKZF transcription factor profile in the spleen αβ (CD3+γδTCR-)
and γδ T cells (CD3+γδTCR+) for 5-day old neonates and adult. B) CD4+ and CD4-CD8- (DN)
profile gated within CD8- population of αβ and γδ T cells in neonatal and adult spleen.
Within splenic αβ T cells, neonatal CD8αβ and CD8- αβ T cells express the IKZF
combination Aiolos+ Helios- and Ikaros+ (A+H-I+), with a significant higher frequency than
adults. Neonatal CD8αβ T cells also express significantly higher frequency of Aiolos+ Helios+
and Ikaros+ (A+H+I+) combination in comparison to adults. Another major proportion of splenic
αβ T cells express Ikaros alone, with no significant difference between neonates and adults.
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Both neonatal CD8αβ and CD8- γδ T cells express a significantly higher frequency of the
IKZF transcription factor combination Aiolos+ Helios+ and Ikaros+ (A+H+I+) in comparison to
adults. In both adult splenic αβ and γδ T cells, there is a significant higher frequency in cells that
do not express any of the Ikaros transcription factor tested (A-H-I-) in comparison to neonatal
splenic αβ and γδ T cells (Figure 53).
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Figure 53: Ikaros Transcription Factor Proportions by Splenic αβ and γδ T Cells. Pie charts
reflecting the average frequency of transcription factor combination (A: Aiolos, H: Helios and I:
Ikaros). Splenocytes were harvested and stained for different surface and intracellular markers to
determine their frequency. αβ T cells are gated as CD3+ γδTCR- and γδ T cells are gated as
CD3+ γδTCR+ within CD45 population. Within αβ and γδ T cells subset, the average frequency
of each subset is obtained from N=3-6 individual experiments and plot as a pie chart. Neonates
were pooled from the same litter of 2-3 pups and adults are individual mouse. Analyzed by 2way
ANOVA, Sidak’s multiple comparisons test, comparing each individual combination between 5day old neonates and adult, ***p<0.001, ****p<0.0001.
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This prompted us to investigate if Aiolos- Helios- and Ikaros- phenotype is enriched
within the memory T cell population in adult spleen. When we stained for CD44 and CD62L
along with Aiolos, Helios and Ikaros, we did not observe a correlation between Aiolos- Heliosand Ikaros- with memory T cell population as assessed by CD44 and CD62L expression (Figure
54).

Figure 54: Frequency of Aiolos- Helios- and Ikaros- Within Splenic Naïve and Memory αβ
T Cell Subsets. Representative FACS plot of CD44 and CD62L and frequency of AiolosHelios- and Ikaros- by A) CD4+ and B) CD8αβ+ αβ T cells in adult spleen. Splenocytes were
harvested and stained for different surface and intracellular markers to determine their frequency.
αβ T cells are gated as CD3+ γδTCR- within live and single cells. Tn= naïve T cells as reflected
by CD44-CD62L+, Tcm= T central memory as reflected by CD44+CD62L+ and Tem= T
effector memory as reflected by CD44+CD62L-. N=3 individual mouse.
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In summary, like what we observed with “type a” T cells in the neonatal gut, the
predominant IKZF transcription factor combination is Aiolos+ Helios- and Ikaros+ (A+H-I+) in
neonatal splenic αβ T cells. Unlike the gut, there is a significant increase in adult αβ T cells that
do not express any of the three IKZF transcription factors tested. On the other hand, neonatal γδ
T cells in the periphery were more enriched with Aiolos+ Ikaros+ Helios+ (A+H+I+) cells and
these cells significantly decreases in adults. Unlike the gut, there is an increase in a subset of
peripheral splenic γδ T cells that do not express any of the three IKZF transcription factor tested
in adults. Summary diagram depicted in Figure 55.

Figure 55: Summary Diagram of Aiolos, Ikaros and Helios Expression by αβ and γδ T cells
in 5-day old Neonates and Adult Splenocytes.
Helios Expression in UCB HSC-derived T Cells using Humanized Mouse Model
Since we observed that T cells of perinatal origin express higher Helios+Foxp3frequency in both human and mice, we next asked if Helios+ T cells may arise from perinatal
origins. It is known that fetal and adult HSC can give rise to different types of T cells that differ
in their phenotype and function323,356,357. To test this, we generated humanized mice by
transferring CD34+Lineage- hematopoietic stem cells (HSC) isolated from UCB into NSG-S
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mice after sublethal total body irradiation. Human hematopoietic cell reconstitution was checked
by staining cheek bleed samples collected from the mice at 4-, 9- and 19/20-weeks post HSC
transfer with anti-human CD45. We demonstrated that UCB HSC can successfully reconstitute
NSG-S mice and human CD45+ cells can be detected in the periphery as early as 4 weeks post
transfer and maintained up to 19 weeks post transfer prior to sacrifice. Similar to previous
reports, the transfer of UCB CD34+ HSC can successfully reconstitute the different
hematopoietic lineages (Figure 56)561.

Figure 56: Detection of Human CD45, CD4, CD8, CD19 and CD33 in Peripheral Blood of
NSG-S mice that Received UCB HSC. NSG-S mice received sublethal total body irradiation
and CD34+Lin- sorted HSC from UCB 24 hours later. A, B) Representative FACS plot and
frequency of human CD45 cells were measured by staining peripheral blood for anti-hCD45 at
indicated weeks post HSC transfer. C) Representative FACS plot of the different human
hematopoietic lineages within human CD45+ cells in the peripheral blood at 4 weeks post UCB
HSC transfer.
After establishing this humanized mouse model, we sought to determine if CD4+ and
CD8+ T cells generated in vivo in UCB-HSC humanize mice express Helios. We found that both
UCB HSC-derived CD4+ and CD8+ T cells express Helios in splenocytes harvested from
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humanized mice between 10-21 weeks post UCB HSC transfer (Figure 57). UCB HSC-derived
CD4+ T cells express around 49.92±30% Helios+Foxp3-, like what we observed in our UCB
samples (46.9±27.2%, Figure 29B). About 83.18±11.84% of UCB HSC-derived CD8+ T cells
express Helios without co-expressing Foxp3 like what we observed previously with freshly
isolated UCB mononuclear samples (79.3±8.43%, Figure 29B). These data demonstrates that
UCB HSC-derived T cells express and maintain Helios in vivo using NSG-humanized mouse
model. This implicated that Helios+ T cells arise from perinatal progenitor origin and potentially
the low frequency of Helios+ T cell observed in adults is due to a switch in HSC pool after birth.

Figure 57: Helios and Foxp3 Expression by CD4+ and CD8+ T Cells in UCB-HSC
Humanized Mice. NSG-S mice received sublethal total body irradiation and CD34+Lin- sorted
HSC from UCB 24 hours later. Mice were checked for human CD45 reconstitution and
harvested between 10-21 weeks post HSC transfer. A) Representative FACS plot of Helios and
Foxp3 by CD4+ and CD8+ T cells gated within anti-human CD45 and CD3 population in the
spleen. B) Summary plot for Helios and Foxp3 frequency within CD4 and CD8 T cells in the
spleen of UCB-HSC humanized mice.
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Section III: Potential Function of Helios in Perinatal T Cells
Helios and IL-10 Expression by CD4+ T Cells Under Th1 Polarizing Conditions
The neonatal immune system is phenotypically and functionally distinct from the adult
immune system. The overall response of the neonatal immune system is high tolerogenic, with
reduced alloantigen recognition and poor responses against foreign antigens 238,241,257–259. This
propensity for tolerance is important in preventing excessive inflammation when neonates are
first exposed to benign antigens such as food and maternal antigens 511.
One mechanism that accounts for this increased tolerance is the Th2-biased response
generated by the neonatal immune system. Murine neonatal T cells differentiate into IL-4
producing Th2 cells in the presence of allogeneic cells, while IL-2 and IFN-γ production by Th1
cells are defective562. While human UCB T cells do not show a Th2 biased response, they
demonstrated a defective Th1 response. For instance, under neutral conditions, UCB T cells
produce lower levels of the proinflammatory cytokine IFN-γ while producing higher levels of the
anti-inflammatory cytokine interleukin-10 (IL-10) compared to APB T cells309,310.
In our previous studies, we demonstrated that UCB naïve T cells differ in their surface
antigen expression compared to APB naïve T cells309. Our lab also demonstrated that UCB naïve
CD4+ T cells are capable of producing Th1 and Th2 type cytokine to levels comparable to adult
naïve CD4+ T cells and they are not preprogrammed to produce Th2 cytokines under nonpolarizing conditions309. However, strikingly we found that UCB naïve CD4+ T cells produce
significantly higher levels of IL-10 in the presence of Th1 polarizing conditions compared to
APB naïve CD4+ T cells, particularly without PMA and ionomycin restimulation. This is not
because UCB naïve CD4+ T cells are incapable of producing IFN-γ when subjected to Th1
conditions, as UCB naïve CD4+ T cells produce higher IFN-γ than APB naïve CD4+ T cells
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upon PMA and ionomycin restimulation (Figure 58). These data demonstrated that under Th1
inflammatory conditions, UCB naïve CD4+ T cells produce high levels of IL-10. This was also
demonstrated in studies that looked at newborns with mothers infected with Malaria, a Th1
predominant response, during pregnancy563. These data suggest intrinsic differences between
UCB T cells and APB T cells in their effector differentiation processes.

Figure 58: IL-10 and IFN-γ Production by APB and UCB Naïve CD4+ T Cells After Th1
Polarization. Naïve CD4+ T cells were cultured in the presence of Th1 polarizing conditions for
5 days. After 5 days, cells were harvested and restimulated with or without PMA and Ionomycin
for 4 hours. After 4 hours, supernatants were collected, and cytokine levels such as A) IL-10 or
B) IFN-γ were assayed using the Human Th cytokine Legendplex Panel and analyzed by
unpaired t test, *p<0.05, **p<0.001. These data were generated by Ramiah Jacks Ph.D.
To determine if we also observe IL-10 production by mouse neonatal T cells under Th1
inflammatory conditions, total splenocytes from 5-day old neonates were subjected to Th0, Th1
and Th2 conditions for 5 days. After Th polarization, the cells were harvested and restimulated
with PMA and ionomycin in the presence of monensin and stained for IL-10 expression by
CD4+ T cells. We found that neonatal CD4+ T cells produce IL-10 after PMA and Ionomycin
restimulation in Th0, Th1 and Th2 conditions. However, a significantly higher frequency of
neonatal CD4+ T cells express IL-10 under Th1 and Th2 conditions even without PMA and
ionomycin restimulation than neutral Th0 conditions. These data demonstrate that murine
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neonatal CD4+ T cells produce IL-10 under both Th1 and Th2 inflammatory conditions (Figure
59).

Figure 59: IL-10 Expression by Neonatal CD4+ T cells After Th0, Th1 and Th2 Conditions.
A) Representative histogram of IL-10 expression and B) summary of IL-10 frequency within 5day old neonatal CD4+ T cells in the absence or presence of PMA and Ionomycin stimulation
with monensin for 4 hours after 5 days of Th0, Th1 or Th2 culture condition. Each dot represents
individual mouse (N=3), analyzed by 2way ANOVA, Sidak’s multiple comparisons test.
*p<0.05, **p<0.01.
We observed that a higher frequency of perinatal T cells expressed Helios without coexpression of Foxp3 in both mice and humans and the frequency of these Helios+ T cells rapidly
declines early on in life to adult levels in the periphery. In humans, UCB naïve CD4+ T cells
differ in IL-10 production under Th1 conditions compared to adults. We also found a
significantly higher frequency of IL-10 producing CD4+ T cells under inflammatory conditions
in neonatal mice. Furthermore, other IKZF transcription factors such as Ikaros and Aiolos have
been reported to promote IL-10 production by CD4+ T cells400,406. While Helios has been
reported to form heterodimers with Ikaros, it is unknown if Helios promotes IL-10 production in
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T cells368. With these data, we hypothesized that high Helios expression in perinatal T cells
contributes to tolerance by promoting IL-10 production under inflammatory conditions.
To determine if there is a correlation of Helios expression and IL-10 production under
inflammatory conditions, we checked for Helios and IL-10 expression after subjecting 5-day old
total splenocytes to Th0, Th1 and Th2 culture conditions. We observed a significantly higher
frequency of Helios expressing CD4+ T cells after Th1 polarizing conditions than Th0 and Th2
(Figure 60).

Figure 60: Helios Frequency Within CD4+ T Cells from 5-day old Neonatal Splenocytes. A)
Representative histograms and B) summary plot of Helios frequency within CD4+ T cells from
5-day old neonate splenocytes after indicated Th culture conditions for 5 days. Blue line
indicates isotype control and red line indicate fully stained samples. Each dot represents
individual mouse (N=6), analyzed by one-way ANOVA, Tukey’s multiple comparisons test,
*p<0.05, **p<0.01.
Next, we compared the frequency of IL-10 producing CD4+ T cells within CD4+Helios+
and CD4+Helios- populations. After indicated Th polarization culture, the cells were harvested
and subjected to PMA and Ionomycin restimulation. Upon PMA and ionomycin restimulation,
there is a significantly higher frequency of IL-10 producers within CD4+ T cells that express
Helios than those that do not express Helios after Th1 polarizing conditions (Figure 61). These
data demonstrated that under Th1 conditions, expression of Helios in CD4+ T cells that
correlates with IL-10 production.
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Figure 61: IL-10 Frequency Within Helios+ and Helios- CD4+ T Cells from 5-day Old
Neonatal Splenocytes. A) Representative IL-10 histogram gated within Helios+ or HeliosCD4+ T cells in the absence or presence of PMA and Ionomycin restimulation after Th1
polarization. Blue lines indicate isotype control, and red lines indicate fully stained samples. B)
Summary plot of IL-10 producing CD4+ T cells by Helios- and Helios+ subsets under indicated
Th conditions in the presence or absence of PMA and Ionomycin restimulation. Total
splenocytes were isolated from 5-day old neonates and subjected to Th0, Th1 or Th2 culture
conditions for 5 days. After 5 days, cells were harvested and subjected to PMA and Ionomycin
restimulation in the presence of monensin. Each dot indicates individual mouse (N=6), analyzed
by 2way ANOVA, Sidak’s multiple comparisons test, *p<0.05.
It was previously reported that Helios is upregulated in both CD4+ and CD8+ T cells
after activation in both humans and mice373. To investigate whether the higher IL-10 frequency
by CD4+ Helios+ T cells is due to Helios representing more activated cells and producing
cytokines, we compared IFN-γ frequency by Helios+ and Helios- CD4+ T cells in the same
culture. Without PMA and Ionomycin restimulation, there is a significantly higher frequency of
IFN-γ producing CD4+ T cells by the Helios+ subset compared to Helios- subset in both Th1
and Th2 polarizing culture conditions. However, after Th1 polarizing conditions, both Helios+
and Helios- CD4+ T cells contain a similar frequency of IFN-γ producing cells after PMA and
Ionomycin restimulation. There is a significantly higher IFN-γ producing CD4+ T cell frequency
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within the Helios+ subset under Th2 polarizing conditions after PMA and Ionomycin
restimulation. These data indicate Helios expression correlates with IL-10 producing CD4+ T
cells under Th1 inflammatory conditions after PMA and Ionomycin restimulation and is not
because Helios negative cells are incapable of producing cytokines under Th1 conditions (Figure
62).

Figure 62: IFN-γ Frequency Within Helios+ and Helios- CD4+ T Cells From 5-day old
Neonatal Splenocytes. A) Representative IFN-γ histogram gated within Helios+ or HeliosCD4+ T cells in the absence or presence of PMA and Ionomycin restimulation after Th1
polarization. Blue lines indicate isotype control, and red lines indicate fully stained samples. B)
Summary plot of IFN-γ producing CD4+ T cells by Helios- and Helios+ subsets under indicated
Th conditions in the presence or absence of PMA and Ionomycin restimulation. Total
splenocytes were isolated from 5-day old neonates and subjected to Th0, Th1 or Th2 culture
conditions for 5 days. After 5 days, cells were harvested and subjected to PMA and Ionomycin
restimulation in the presence of monensin. Each dot indicates individual mouse (N=3), analyzed
by 2way ANOVA, Sidak’s multiple comparisons test, *p<0.05.
Requirement of Helios in IL-10 Production Under Th1 Polarizing Conditions
Since we observe that there is a correlation in Helios expression and IL-10 production by
CD4+ T cells in mice, we next tested if Helios promotes IL-10 production under Th1 polarizing
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conditions by knocking out Helios in human UCB T cells. We designed guide RNAs (gRNA)
against Helios or non-target as a control. We found that guide 3 (g3) against human ikzf2
successfully knockout Helios at efficiency between 15-30% by both CD4+ and CD8+ UCB T
cells. After checking that Helios is successfully knockout in these cells, the transfected cells were
harvested and subjected to Th1 polarizing conditions for 5 days to test if Helios promotes IL-10
production under Th1 conditions. While Helios was knockout in a proportion of both CD4+ and
CD8+ T cells, we did not consistently observe a decrease in IL-10 production by these cells
(Figure 63).

Figure 63: Helios Knockout in UCB T Cells and its Effect in IL-10 Production Under Th1
Conditions. A) Representative histogram and B) summary frequency plots for Helios expression
by CD4+ and CD8+ T cells 2 days after electroporation with NT, guide 2 (g2) or guide 3 (g3)
against human ikzf2. C) IL-10 levels in supernatants from unstimulated or PMA and Ionomycin
restimulated conditions from cells transfected with NT gRNA or Ikzf2 g3 after being subjected to
5 days of Th1 culture conditions. Total T cells were isolated from UCB and stimulated for 3 days
with anti-CD3 and CD28 in the presence of IL-2. After three days, the cells were harvested and
transfected with NT or ikzf2 gRNA with Cas9 protein using Neon electroporation system. The
cells were allowed to rest for two days before checking knockout efficiency for Helios and then
subsequently cultured under Th1 polarizing conditions for 5 days. After 5 days, the cells were
harvested and restimulated with PMA and Ionomycin for 4 hours and supernatants were
collected and analyzed for cytokine production using Legendplex kit and analyzed by paired ttest *p<0.05, **p<0.01.
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Since we did not observe a decrease in IL-10 production in the UCB total T cell culture
even when we observed a reduction in Helios expression, we next tested our hypothesis using
purified naïve CD4+ T cells isolated from UCB. Similarly, while we observed a decrease in
Helios expression after CRISPR cas9, IL-10 production was not affected in knockout conditions
(Figure 64). These data demonstrate that while Helios correlates with IL-10 expression under
Th1 inflammatory conditions, it is not required for IL-10 production.

Figure 64: Helios Knockout in UCB Naïve CD4+ T Cells and its Effect in IL-10 Production
Under Th1 Conditions. A) Summary frequency plot for Helios expression by CD4+ T cells 2
days after electroporation with NT or guide 3 (g3) against human ikzf2. B) IL-10 levels in
supernatants from unstimulated or PMA and Ionomycin restimulated conditions from cells cells
transfected with NT gRNA or Ikzf2 g3 and subjected to 5 days of Th1 culture conditions. Naïve
CD4+ T cells were isolated from UCB and stimulated for 3 days with anti-CD3 and CD28 in the
presence of IL-2. After three days, the cells were harvested and transfected with NT or ikzf2
gRNA with Cas9 protein using Neon electroporation system. The cells were allowed to rest for
two days before checking knockout efficiency for Helios and then subsequently cultured under
Th1 polarizing conditions for 5 days. After 5 days, the cells were harvested and restimulated
with PMA and Ionomycin for 4 hours and supernatants were collected and analyzed for cytokine
production using Legendplex kit. Analyzed by ratio paired t test *p<0.05.
Helios Suppresses Effector Cytokine Production by Perinatal T Cells
Most of the studies related to the function of Helios have been focused on within the Treg
subset. Treg-specific Helios knockout subsequently increased effector cytokine production such
as IFN-γ, TNF, and IL-17376. Fetal iTregs differentiated from cells that are Helios deficient also
demonstrate concurrent increased levels of IFN-γ and IL-2327. We previously demonstrated that
freshly isolated UCB naïve CD4+ T cells produce significantly lower levels of IFN-γ compared

145
to adult naïve CD4+ T cells309. With these data, we hypothesized that perinatal T cells express
high levels of Helios to suppress effector cytokine production to promote an overall tolerant
state. To test this, we knockout Helios from UCB naïve CD4+ T cells using CRISPR-cas9 gene
editing system and restimulated them with PMA and Ionomycin to assess the effect of Helios in
cytokine productions by UCB CD4+ T cells. We found that compared to cells that received nontarget (NT) gRNA control, Helios knockout led to a significant increase in IFN-γ (638.4pg/ml ±
773.7pg/ml vs 910.5pg/ml ±785.6pg/ml) and IL-13 (339.3pg/ml ± 134pg/ml vs 555.9pg/ml ±
172.1pg/ml) production (Figure 65). In agreement with our data from Th1 polarization, we did
not see a difference between NT gRNA and ikzf2 gRNA (g3) in IL-10 production (Figure 63-65).
These data demonstrate that Helios expression in UCB T cells suppresses effector cytokine
production such as IFN-γ and IL-13 but is not required for IL-10 production.

Figure 65: Cytokine Production by Helios Knockout UCB CD4+ T Cells After PMA and
Ionomycin Restimulation. A) Representative histogram and summary of Helios frequency
within CD4+ T cells 2 days after electroporation. B) Cytokine levels by cells that received NT or
IKZF2 g3 after PMA and Ionomycin restimulation 2 days post electroporation. Naïve CD4+ T
cells were isolated from UCB and stimulated for 3 days with anti-CD3 and CD28 in the presence
of IL-2. After three days, the cells were harvested and transfected with NT or ikzf2 gRNA (g3)
with Cas9 protein using Neon electroporation system. The cells were allowed to rest for two days
before checking knockout efficiency for Helios and then subsequently restimulated with PMA
and Ionomycin for 4 hours. Supernatants were collected and analyzed for cytokine production
using Legendplex kit. N=4 individual donors, analyzed by paired t-test *p<0.05, **p<0.01.

CHAPTER FOUR: DISCUSSION
Summary of Results
It is well established that the perinatal immune system is highly tolerogenic. This tolerant
nature allows fetuses and newborns to tolerate benign antigens such as food, maternal antigens,
and commensal bacteria. However, it also increases a newborn’s susceptibility to life-threatening
infections. My dissertation aims to investigate how perinatal T cells can contribute to immune
tolerance in infants. A better understanding of the perinatal immune system will provide pivotal
knowledge to develop strategies to protect infants from infectious diseases while establishing
immune homeostasis with commensal microbes.
Using UCB as a source for full-term immune cells to study perinatal tolerance, we
demonstrated that UCB CD4+ and CD8+ T cells differentiate into Foxp3+ T cells upon antigen
receptor stimulation without the addition of exogenous TGF-β. In contrast, adult CD4+ and
CD8+ T cells have a significantly lower frequency of Foxp3+ T cell differentiation even though
they were subjected the same culture system set up (Figure 9). One of the main functions of
Foxp3+ Tregs is to suppress conventional T cell proliferation to prevent an excessive
inflammatory response. This prompted us to investigate if these ex vivo generated Foxp3+ T cells
from UCB also carry regulatory functions. We demonstrated that ex vivo generated UCB CD4+
and CD8+ Foxp3+ T cells carry suppressive functions comparable to their preexisting UCB
tTreg counterpart using an in vitro suppression assay system (Figure 10). Furthermore, these
UCB-derived Foxp3+ T cells also significantly delayed xGVHD mediated by the transfer of
autologous total UCB mononuclear cells, demonstrating regulatory functions in vivo (Figure 12).
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Interestingly, we found that the pre-treatment of ex vivo generated UCB Foxp3+ T cells did not
decrease any other proinflammatory cytokines in the serum except for a significant decrease in
anti-inflammatory cytokine, IL-10, in this xGVHD model (Figure 14, 15).
We also found that these ex vivo generated UCB-derived Foxp3+ T cells maintain
relatively stable Foxp3 expression up to 62 days in culture, and Foxp3 expression is stable upon
restimulation in the presence of inflammatory cytokines (Figure 22). We demonstrated that
Foxp3 expression in UCB-derived Foxp3+ T cells is relatively stable after differentiation when
the cells were subjected to restimulation in the presence of inflammatory cytokines such as IL1β, IL-4, and IL-6. However, we observe a decreasing trend in Foxp3 expression when we block
TGF-β signaling using TGF-β receptor 1 kinase inhibitor SB431542 (Figure 22). These data
suggest that TGF-β signaling is involved in Foxp3 maintenance in UCB-derived Foxp3+ T cells,
similar to previous reports regarding the role of TGF-β1 signaling in Treg Foxp3 expression and
suppressive functions133.
We next investigated if these UCB-derived Foxp3+ T cells resemble preexisting tTregs or
peripherally induced pTregs by assessing their epigenetic status of Foxp3. It was previously
shown that the CNS2 region of Foxp3 is highly demethylated to allow stable expression of
Foxp3 by tTregs137,138. In contrast, the CNS2 region of Foxp3 is highly methylated in Foxp3+ in
vitro induced Tregs (iTregs) and Foxp3- effector T cells as well. Consequently, Foxp3
expression in iTregs is very unstable and is lost when TGF-β is removed135. Using genomic
bisulfite sequencing, we found that the CNS2 region of Foxp3 by UCB-derived CD4+ Foxp3+ T
cells is highly methylated like CD4+ effector T cells and their iTreg counterpart (Figure 16).
These data suggest that although UCB-derived Foxp3+ T cells maintain stable Foxp3 expression
like preexisting tTregs, their maintenance of Foxp3 expression may not come from Foxp3 CNS2
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demethylation. This prompted us to investigate other epigenetic mechanisms that could
contribute to the Foxp3 stability by our ex vivo generated UCB-derived Foxp3+ T cells. We next
conducted ATAC-seq on UCB-derived Foxp3+ T cells to assess genomic chromatin accessibility
at the Foxp3 locus compared to tTregs. We found that UCB-derived CD4+ Foxp3+ T cells have
less chromatin accessibility than CD4+ tTreg samples at the promoter, CNS1, CNS2 and CNS3
regions of Foxp3 (Figure 17). We further found UCB-derived Foxp3+ T cell unique region in
Foxp3 locus that is more accessible than tTregs (Figure 18). These unique regions potentially
could be regions that regulate Foxp3 expression and maintenance in these cells. Altogether, our
bisulfite sequencing and ATAC-seq data demonstrate that UCB-derived Foxp3 T cells are
epigenetically regulated differently from preexisting tTregs.
Fetal alcohol exposure is one of the factors that can promote an overall inflammatory
state in the fetuses and can led to persistent immune deficit into adulthood486–488,490,505. While we
demonstrated that Foxp3 expression by UCB-derived Foxp3+ T cells is stable after
differentiation, previous lab members demonstrated that UCB-derived Foxp3+ T cell
differentiation could be inhibited in the presence of proinflammatory cytokines IL-4 and IL-12
(Jessica Lee MD, Ph.D.). Therefore, we hypothesized that the presence of EtOH would block
UCB-derived Foxp3+ T cell differentiation. Indeed, we observed that the presence of 100mM
EtOH for the first five days of the induction culture significantly inhibits both CD4+ and CD8+
UCB-derived Foxp3+ T cell differentiation without causing apparent toxicity or cell death
(Figure 23-25). Mechanistically, EtOH inhibits IL-2Rα (CD25) expression in both UCB CD4+
and CD8+ T cells early during the culture (Figure 28). IL-2 signaling is required for TGF-β
mediated Foxp3 induction by naïve CD4+ T cells105. Our data demonstrated that EtOH can
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inhibit CD25 expression and block IL-2 signaling, subsequently decreasing Foxp3+ T cell
differentiation in our induction culture.
While Foxp3+ T cells are one of the contributing factors of the tolerant biased perinatal
immune system, we next investigated if other transcription factors expressed by perinatal Foxp3
negative conventional T cells also contribute to perinatal tolerance. We found that a higher
frequency of UCB CD4+ and CD8+ T cells expresses the Ikaros transcription factor family
protein, Helios, without co-expression of Foxp3 compared to adult CD4+ and CD8+ T cells
(Figure 29). Helios is generally considered a transcription factor expressed by Foxp3+ Tregs and
is essential for Treg stability and function372,384–386. Subsequently, we found that the high
frequency of Helios+Foxp3- expressing CD4+ and CD8+ T cells decreased by 3 weeks after
birth (Figure 30).
Next, we investigated if this phenotype also occurs in mice. We found that the frequency
of Helios+Foxp3- CD4+ and CD8+  T cells is significantly higher in the spleen of newborn
mice compared to the adult. The frequency of Helios rapidly decreases by 2-3 days after birth to
adult levels. Furthermore, the appearance of Helios+Foxp3+ Tregs in mice did not appear in the
periphery until three days after birth (Figure 31). These data demonstrate that the presence of
Helios+  T cells in the periphery predates the appearance of Tregs in mice and may contribute
to perinatal tolerance establishment prior to Treg development in the periphery.
Additionally, it is known that  T cells are highly represented in the neonatal stage
compared to  T cells in mice353. We next investigated if peripheral  T cells also express
Helios. Strikingly, we found a significantly higher frequency of (T cells in newborn mice express
Helios without Foxp3 co-expression than adults (Figure 32). This high frequency of Helios in the
periphery also rapidly decreases to adult levels between 2-3 days after birth, as we observed with
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αβ T cells. Majority of splenic  T cells are CD8+ or DN. While Helios is highly express by
both subsets during the perinatal stage and decreases by 2-3 days after birth, we found a striking
increase in Foxp3 expression by adult CD8+  T cells compared to neonates (Figure 32).
Next, we investigated if the differences in Helios between perinatal and adult T cells has
a developmental origin in the thymus. We found that the frequency of Helios+Foxp3- of CD4+
SP, CD8+ SP as well as total γδ TCR+ thymocytes is significantly higher before birth
(E17.5/18.5) and decreases by 3 days after birth (Figure 34, 35). We also observed that the
frequency of Helios+Foxp3- by CD4+SP, CD8+SP, as well as γδ TCR+ thymocytes, are higher
than splenic T cells across all timepoints even though the kinetics of Helios+ T cell frequency is
similar (Figure 36).
Our data so far demonstrated that the frequency of Helios+Foxp3- expression started high
in the perinatal stage and rapidly decreased after birth in both αβ and γδ T cells in the periphery.
These data suggest that high Helios expression is limited to perinatal T cells in both humans and
mice. Next, we sought to investigate if Helios expression is maintained in T cells that have been
shown to have a fetal developmental origin. These T cells consist of gut-associated “type b”
CD8αα γδ T cells as well as CD8αα αβ T cells51,554. We found that Helios was highly expressed
by these “type b” gut-associated T cells compared to “type a” gut-associated T cells that mainly
consists of conventional CD4+ and CD8αβ+ αβ T cells in both neonate and adult SI IEL and
LPL fraction (Figure 45).
Furthermore, Helios expression can be detected by “type b” T cells as early as fetal stage
E17.5 and maintained through adulthood (Figure 48). Additionally, we found a different γδ T
cell subset expressing CD8αβ and categorized them as “type c” gut-associated T cells based on
their Helios and Foxp3 kinetics. These “type c” γδ T cells in the gut are different from “type a”
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and “type b” gut T cells because neonatal CD8αβ+ γδ T cells express a high frequency of Helios
without co-expression of Foxp3. However, the adult CD8αβ+ γδ T cells have a significantly
higher frequency of Helios+Foxp3+ as well as a trend of higher frequency of Foxp3+ alone
population compared to neonates (Figure 46). We also observed a similar phenotype by adult
splenic CD8αβ+ γδ T cells where they express significantly higher Foxp3 compared to neonates
(Figure 32).
It is known that Helios can form homodimer or heterodimers with other Ikaros
transcription factor proteins. We next investigated if other Ikaros transcription factors such as
Aiolos and Ikaros follow Helios kinetics or if this is specifically unique to Helios. We found that
gut-associated “type b” T cells predominantly express all three IKZF transcription factors Helios,
Aiolos, and Ikaros, while “type a” T cells predominantly express Aiolos and Ikaros without
Helios. These data further suggest that Helios expression is unique to perinatal origin “type b” T
cells (Figure 50). When we assessed the IKZF transcription factor profile in the periphery, we
found that 5-day old neonatal splenic αβ T cells predominantly express Aiolos and Ikaros
without Helios, like those of “type a” gut-associated T cells. This follows our previous finding
where splenic αβ T cells lose Helios expression significantly by 3 days after birth.
Furthermore, splenic γδ T cells in 5-day old neonates have a significantly higher
frequency of Aiolos+ Helios+ and Ikaros+ expression compared to adults. The observation of
Helios+ γδ T cells at 5 days after birth is consistent with our previous findings where splenic γδ
T cells have a higher frequency of Helios compared to both CD4+ and CD8+ splenic αβ T cells 5
days after birth (Figure 36). Strikingly, we observed a significant increase in both splenic αβ and
γδ T cells that do not express any of the IKZF transcription factors tested in adults (Figure 53).
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Our data demonstrate that Helios expressing T cells is developmentally controlled and
limited to those developing during the perinatal stage. To test this hypothesis, we generated
humanized mice by transferring UCB isolated HSCs into immunodeficient NSG-S mice. We
found that CD4+ and CD8+ T cells generated from UCB HSCs retain high levels of Helios
expression (Figure 57). These data suggest that Helios expressing T cells are derived from fetal
HSCs.
We next sought to investigate the function of Helios in perinatal T cells. Our previous
studies demonstrate that UCB naïve T cells carry self-intrinsic differences phenotypically and
functionally compared to adult naïve T cells309. UCB naïve CD4+ T cells produce significantly
higher levels of IL-10 in the presence of Th1 polarizing conditions compared to adult naïve
CD4+ T cells, and this is not due to the lack of Th1 differentiation by UCB naïve CD4+ T cells
as they produce significantly higher levels of IFN-γ after Th1 polarization in the same culture
compared to adult naïve CD4+ T cells (Figure 58). We hypothesized that Helios promotes IL-10
production under Th1 polarizing conditions in neonatal T cells. We found that Helios frequency
is the highest among CD4+ T cell subsets after Th1 polarization (Figure 60).
Furthermore, Helios expression correlates with CD4+ T cells that produce IL-10 under
Th1 polarizing conditions after PMA and Ionomycin restimulation while IFN-γ frequency is
similar between Helios+ and Helios- CD4+ T cells (Figure 61, 62). To test if Helios is required
for Th1 mediated IL-10 production by perinatal T cells, we designed guide RNA against human
IKZF2 to knockout Helios in UCB T cells. We found that while Helios can successfully be
knocked out in UCB T cells, IL-10 production was not affected in Helios knockout conditions
after Th1 polarization (Figure 63, 64). These data suggest that Helios correlates with IL-10
production under Th1 conditions but is not required for IL-10 production. Previous literature
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suggested that Helios expression by Foxp3+ Tregs may suppress effector cytokine production
such as IFN-γ, TNF and IL-17376. We hypothesized that perinatal T cells express Helios to
suppress their effector cytokine production as well. Indeed, we found that when we knockout
Helios from UCB naïve CD4+ T cells, certain effector cytokine production increases in
comparison to non-target guide RNA controls (Figure 65).
Regulatory Functions of UCB-derived Foxp3+ T Cells In Vitro and In Vivo
We demonstrated that both CD4+ and CD8+ T cells from UCB differentiate into Foxp3+
T cells upon antigen receptor stimulation. When we assess if these UCB-derived Foxp3+ T cells
carry suppressive function in vitro, we found that both UCB CD4+ and CD8+ ex vivo generated
Foxp3+ T cells suppress effector T cell proliferation in a dose-dependent manner comparable to
autologous UCB preexisting CD4+CD25+ tTreg population.
Traditionally, Tregs have been considered a stable T helper lineage, carrying suppressive
functions and a terminally differentiated phenotype. However, many studies have indicated that
Tregs retain some degree of plasticity and acquire different transcriptional programs similar to
the effector T cell population to regulate Th1, Th2, or Th17 responses564. For example, Th1-type
Treg express chemokine receptors CXCR3 and transcription factor T-bet, while Th17-type Treg
express CCR6 and RORγ565,566. The acquisition of T-bet by Tregs is necessary to control Th1
inflammation in vivo126. T-bet+ CXCR3+ Tregs are required to control type 1 diabetes, a Th1
predominant autoimmune disease567. These responses are associated with the expression of
specific Th-associated transcription factors and chemokine receptor expression568.
Characterization conducted by previous lab members demonstrated that these UCB ex vivo
generated Foxp3+ T cells differ in their surface chemokine receptor phenotype from those of preexisting adult tTregs. A majority of both UCB-derived CD4+ and CD8+ Foxp3+ T cells express
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Th1-type phenotype, CXCR3+ and T-bet+ while majority of adult tTregs are Th17-like Tregs
that express CCR6+569. Therefore, although UCB-derived Foxp3+ T cells carry comparable
suppressive functions like their autologous tTregs counterparts in vitro, potentially in vivo, these
UCB Foxp3+ T cells may be generated in the periphery upon antigen receptor stimulation to
localize to Th1 inflammation sites and regulate Th1 responses specifically. Furthermore, human
neonates are deficient in their Th1 responses (as reviewed above)309. A Th2 biased response in
mice during the first week of life is critical for tolerance establishment, while Th1 response
contributes to allograft rejection547,548. We demonstrated that adult CD4+ and CD8+ T cells have
a significantly lower Foxp3+ T cell differentiation frequency than UCB, even though they were
subjected to the same Foxp3+ T cell induction culture set up (Figure 9). Therefore, these UCBderived Foxp3+ T cells may be explicitly generated during the perinatal stage as an additional
mechanism to suppress Th1 response and promote tolerance establishment.
Using xGVHD model, we demonstrated that pre-treatment of UCB-derived Foxp3+ T
cells significantly delayed xGVHD development mediated by total autologous UCB
mononuclear cell transfer. The transfer of human PBMC in the xGVHD model is a Th1
predominant response with the majority of CD4+ T cells expressing IFN-γ530,531. These data
demonstrated that UCB-derived Foxp3+ T cells carries suppressive functions in vivo in a Th1type predominant response xGVHD model. Like previous reports, we observed high levels of
IFN-γ in the serum with our xGVHD model. However, while the transfer of UCB-derived
Foxp3+ T cells significantly delays xGVHD development, we did not observe any significant
suppression of Th1 type cytokine levels in the serum (Figure 14). This could be because the
serum was collected when mice hit criteria (lost <15% of original weight after cell transfer).
Potentially we might see a difference between total UCB mononuclear cell transfer vs. UCB-
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derived Foxp3+ T cell pretransfer group if we collect serum earlier on before the mice hit
xGVHD criteria.
Strikingly, we observed that the UCB-derived Foxp3+ T cell pretreatment group has a
significantly lower level of IL-10 in the serum than the group that received autologous UCB
mononuclear cells alone. This result was counterintuitive because IL-10 is known to be an antiinflammatory cytokine. However, patients with GVHD have been reported to have elevated
serum levels of IL-10 and were significantly associated with fatal outcomes532. Furthermore, IL10 administration accelerates GVHD in mice while IL-10 neutralization diminishes GVHD
mediated by allogeneic donor grafts570. Using an xGVHD model, Abraham et al demonstrated
that IL-10 overexpression leads to expansion of human T cells and subsequent exacerbation of
xGVHD development in these mice571. It is still unclear how UCB-derived Foxp3+ T cells
suppress IL-10 levels in our xGVHD model.
Rapid Kinetics of UCB Mononuclear Cells-mediated xGVHD
Numerous studies have utilized the xGVHD model to investigate new clinical regimens
to decrease GVHD. It is one of the significant causes of morbidity and mortality following
allogeneic bone marrow transplantation in patients. Typically, human adult PBMCs were
transferred into NSG mice, and a range of cell numbers was transferred (2x106 to 3x107). The
median survival in NSG mice that receive 2x106 adult PBMC is 56 days530. In our xGVHD
model, we used total UCB mononuclear cells instead. We consistently observed that mice that
received 1x106 total UCB mononuclear cells hit criteria no later than 18 days post transfer
(Figure 12). This is not due to the type of NSG mice we used (NSG-S instead of NSG for better
human cell engraftment) because the transfer of the same amount of adult PBMC into NSG-S
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mice did not manifest xGVHD as rapidly as total UCB mononuclear cell transfer in our hands
(data not shown).
GVHD is known to be initiated by donor T cells; the rapid induction of xGVHD by UCB
transfer may be due to these factors by UCB T cells572: First, UCB contained a higher frequency
of CD45RA naïve T cells compared to APB517–519. It was previously demonstrated that the
transfer of allogeneic naïve T cells led to a more severe GVHD development in mice573. Second,
we demonstrated that UCB naïve CD4+ T cells have enhanced effector cytokine production than
adult naïve CD4+ T cells under Th polarizing conditions. UCB naïve CD4+ T cells produce
significantly higher levels of IFN-γ than adult naïve CD4+ T cells under Th1 polarizing
conditions309. It is known that proinflammatory Th1 cytokines such as IL-2 and IFN-γ can
exacerbate GVHD by promoting T cell expansion as well as enhancing cellular damage574.
Lastly, we also found that UCB naïve CD4+ T cells produce significantly higher levels of IL-10
under Th1 polarizing conditions than adult naïve CD4+ T cells (Figure 58). Overexpression of
recombinant IL-10 in NSG mice that receive 1x107 adult PBMC succumbed to xGVHD between
15 to 21 days compared to control mice that received adult PBMC alone are free from GVHD for
around 30 days571. It is interesting to note that overexpression of IL-10 exacerbates adult PBMC
mediated xGVHD to the kinetics like what we observed when we transfer total UCB
mononuclear cells in our xGVHD model (median survival 18 days). Therefore, the transfer of
total UCB mononuclear cells potentially initiates xGVHD more rapidly due to their higher IL-10
production by CD4+ T cells under Th1 inflammatory conditions. However, it is still unclear
what is the cellular source of IL-10 production in our xGVHD model.
Our data demonstrated that antigen receptor stimulation of total UCB leads to the
generation of suppressive Foxp3+ T cells in vitro in the presence of IL-2 after 14 days of culture.
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However, the transfer of total UCB into NSG-S mice causes xGVHD manifestation in vivo. One
potential explanation could be that the generation of UCB Foxp3+ T cells is slower than the
activation of UCB T cells that produces IL-10. In our hands, UCB naïve CD4+ T cells can
produce high levels of IL-10 (Figure 65) upon antigen receptor stimulation in the presence of IL2 as early as day 5 in culture. These data suggest that under similar culture conditions, UCB
naïve CD4+ T cells can produce IL-10 earlier than the generation of stable Foxp3+ T cells that
carries suppressive functions. It has been demonstrated that APB mononuclear cells activated
with anti-CD3 in the presence of IL-10 led to an initial inhibition of CD8+ T cell proliferation
followed by a proliferative phase between days 4 to days 9 in culture. These CD8+ T cells are
biased towards a type 2 response and produce IL-4575. Previous lab member (Jessica Lee M.D.,
Ph.D.) also demonstrated that IL-4 could further inhibit Foxp3+ T cell induction by UCB.
Therefore, potentially in our xGVHD model mediated by total UCB transfer, UCB CD4+ T cells
produce high levels of IL-10 upon alloreactive activation in vivo. The high levels of IL-10
subsequently lead to the expansion of UCB CD8+ T cells that produce IL-4 and inhibit UCB
Foxp3+ T cell generation in vivo.
Epigenetic Regulation of FOXP3 by UCB-derived Foxp3+ T Cells
We demonstrated that UCB-derived Foxp3+ T cells could be generated upon antigen
receptor stimulation without adding exogenous TGF-β in our induction culture system. We
further demonstrated that a subset of CD14+CD36hi monocytes is important in generating these
Foxp3+ T cells and acts as the cellular source of TGF-β and retinoic acid569. This is similar to the
requirement for mature naïve T cells in the periphery to differentiate into pTregs 103,104.
Furthermore, we also demonstrated that UCB-derived Foxp3+ T cells from our induction culture
are not coming from the expansion of preexisting tTregs, as depletion of CD4+CD25+ prior to
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culture set up still generate the same frequency for Foxp3+ T cells569. This prompts us to
investigate if Foxp3 regulation in UCB-derived Foxp3+ T cells is like that of tTregs or pTregs.
Using bisulfite sequencing and ATAC-seq, we found that the epigenetic landscape of
Foxp3 by UCB-derived CD4+ Foxp3+ T cells are different from tTregs (Figure 16,17). Bisulfite
sequencing demonstrated that Foxp3 CNS2 region of UCB-derived Foxp3+ T cells is highly
methylated like those of CD4+ effector T cells or in vitro differentiated Tregs (iTregs). Highly
methylated CNS2 contributes to the instability of Foxp3 expression in iTregs 137,138. However, we
observed that UCB-derived Foxp3+ T cell maintain their Foxp3 expression for a long time in our
culture system (up to 62 days in culture)512. Together with our ATAC-seq data, Foxp3 expression
by UCB-derived Foxp3+ T cells is regulated differentially than tTregs. Our ATAC-seq data
further demonstrate unique chromatin open regions found in the Foxp3 locus of UCB-derived
Foxp3+ CD4+ T cells compared to adult CD4+ Foxp3+ tTregs. These gene regions were
conserved in mouse Foxp3 locus as well. These findings could allow the generation of transgenic
mice to study if these regions can regulate Foxp3 expression, particularly in perinatal T cells.
However, UCB-derived Foxp3+ T cells murine counterpart has yet to be identified.
One potential mechanism that maintains Foxp3 stability in our ex vivo generated Foxp3+
T cells from UCB is the transcription factor Helios. Helios has been previously reported to be
important for Treg Foxp3 stability and function372,384–386. Treg-specific Helios knockout
subsequently leads to a decrease in Foxp3 expression376. Interestingly, Helios does not bind to
the Foxp3 locus in both CD4+ and CD8+ Tregs, while Foxp3 is found to occupy the Ikzf2 locus
in CD4+ Tregs376,389. T cell-specific Helios deletion did not affect Foxp3 induction,
demonstrating that Helios is not required for Foxp3 expression372. These data suggest that while
Helios is not required for Foxp3 induction, it may be maintaining Foxp3 expression through
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some other unknown mechanisms. After the 14-day induction culture, we found that both UCB
CD4+ and CD8+ Foxp3+ T cells also highly express Helios (Figure 9F).
Further testing will be required if Helios indeed supports Foxp3 stability in these cells.
Potentially, Helios could be knockout using the CRISPR-Cas9 system after the induction culture
to test if Helios is required to maintain Foxp3 expression in UCB-derived Foxp3+ T cells.
Additionally, the role of Helios in Foxp3 expression by CD8+ T cells is unknown.
Helios has been reported previously to enhance differentiation of human fetal naïve
CD4+ T cells into Foxp3+ Tregs without the addition of exogenous TGF-β. They demonstrated
that Helios knockout impairs the capability of fetal naïve CD4+ T cells to differentiate into
Foxp3+ Tregs, and this impairment is rescued with the addition of TGF-β327. One difference with
this study is they differentiate Foxp3+ Tregs using purified naïve CD4+ T cells stimulated in the
presence of anti-CD3/CD28/CD2 tetramers and check Foxp3 induction by 6 days of culture. In
our hands, bead stimulation with UCB purified T cells yields a lower frequency of Foxp3+ T
cells at the end of the 14-day induction culture. Future studies to dissect if different types of
Foxp3+ T cells are generated from perinatal T cells based on culture conditions (i.e., the
presence of other cell subsets such as APCs) and their subsequent requirement for Helios to
express and maintain Foxp3 are needed.
Alcohol Effects on UCB-derived Foxp3+ T Cell Differentiation
Implications of the Inhibition of UCB-derived Foxp3+ T Cell Differentiation by Alcohol
Our data demonstrated that EtOH presence during the first five days of culture
significantly inhibits Foxp3+ T cells induction from both UCB CD4+ and CD8+ T cells as
reflected by the significant decrease in CD25+ Foxp3+ frequency within CD4+ and CD8+ T
cells. This aligns with previous reports where FAE promotes an overall inflammatory state in the
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fetus. In animal models, FAE increases the development of autoimmune diseases such as
rheumatoid arthritis and type 2 diabetes486,487. FAE also subsequently leads to an increase in
proinflammatory cytokine levels in the fetus505. Foxp3+ Tregs play a significant role in
regulating allergic reactions by inducing and maintaining immune tolerance against allergens.
The percentage of Foxp3+ Tregs is significantly decreasing in allergic children (atopic dermatitis
and/or food allergy) compared to healthy controls576. In humans, alcohol consumption during
pregnancy was associated with a dose-dependent increased risk of atopic dermatitis during early
infancy577. Since Foxp3+ T cells play a vital component in peripheral immune tolerance, our data
demonstrated that it is plausible that prenatal alcohol exposure inhibits the generation of Foxp3+
T cells in vivo during the perinatal stage and subsequently leads to an increase in allergies and
autoimmune disease development.
Potential Mechanisms Underlying the Inhibition of UCB-derived Foxp3+ T Cell Induction
by Alcohol
When we assessed if EtOH induces toxicity in the culture and leads to cell death, we did
not see any significant differences in total UCB mononuclear cell numbers early on or at the end
of the culture (Figure 23 and 24). This suggests that EtOH may be altering important pathways
that are required for Foxp3+ T cell differentiation. We observed that EtOH also significantly
decreases Foxp3 expression as reflected by the mean fluorescent intensity in both CD4+ and
CD8+ T cells (Figure 27). Levels of Foxp3 expression have been previously shown to reflect
their regulatory functions in transplantation settings. Foxp3 expression levels are directly
associated with their potential in preventing allograft rejection through the production of
regulatory cytokines and suppressing effector T cell activation578.
While the mechanism for Foxp3 induction in CD4+ T cells has been heavily studied,
there is still a lot to explored regarding CD8+ Foxp3+ T cell differentiation. In the absence of
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DCs, it was shown that murine splenic CD8+ T cells upregulate Foxp3 most optimally in the
presence of antigen, IL-2, TGF-β, and retinoic acid579. In our hands, induction of Foxp3 is
significantly inhibited in both CD4+ and CD8+ UCB T cells in the presence of a TGF-β receptor
I kinase inhibitor, demonstrating that TGF-β signaling is also required for Foxp3 induction by
CD8+ T cells in humans512. Furthermore, it has been shown previously that IL-2 signaling is
required for TGF-β to induce naïve CD4+CD25- T cells to become CD25+ and express
Foxp3105. Indeed, we found that EtOH significantly inhibits CD25 (IL-2Rα) expression, a
component of the IL-2 receptor important for IL-2 signaling, in both CD4+ and CD8+ UCB T
cells early on in the culture (Figure 28).
One potential mechanism by which EtOH is inhibiting CD25 expression is through its
modulation of Phospholipase D (PLD) signaling. PLD is a phosphodiesterase that catalyzes the
hydrolysis of phosphatidylcholine, a major phospholipid in the plasma membrane, into
phosphatidic acid (PA) and choline. There are two closely related members in the PLD family,
PLD1 and PLD2, with different subcellular localizations 580. Primary alcohol such as 1-butanol
and EtOH are excellent substrates for PLD and are preferred over water by at least 400-fold581.
In the presence of primary alcohol, PLD favors transphosphatidylation over hydrolysis,
significantly reducing the production of PA while yielding phosphatidyl alcohol (i.e.,
phosphatidyl ethanol, PEth). In early TCR signaling studies using Jurkat T cell lines, PLD is
induced in the presence of TCR cross-linking and PMA activation, subsequently inducing
transcription factor AP-1, a transcription factor involved in the regulation of growth and
proliferation582–585. Jurkat treated with EtOH produce PEth upon activation, and anti-CD3
induced AP-1 activity is blocked585. PA has been shown to induce CD25 expression on T cells
with equal potency as saturating doses of IL-2586. Additionally, PLD1 and PLD2 double KO
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CD4+ T cells have less CD25 upregulation after stimulation than WT CD4+ T cells587.
Therefore, in the presence of EtOH, it is possible that the reduction of PA production by UCB T
cells decreases their CD25 expression. This decrease in CD25 expression early in our UCB
culture subsequently inhibits Foxp3 induction by CD4+ and CD8+ UCB T cells.
CD25 Expression Differences between CD4+ and CD8+ T Cells
Upon antigen receptor stimulation, CD25 is induced in both CD4+ and CD8+ T cells.
However, we found that consistently across all our donors, the frequency and gMFI of CD25 is
higher in CD4+ than those of CD8+ UCB T cells 24 hours after stimulation. This could be due to
intrinsic intracellular signaling differences between CD4+ and CD8+ T cells. Both CD4 and
CD8 molecules acts as coreceptors to enhance antigen responsiveness mediated by TCR. It is
found that TCR/CD4 cross-linking led to greater tyrosine phosphorylation of intracellular
substrates compared to TCR/CD8 cross-linking. Cross-linking CD4 also initiated greater kinase
activity compared with CD8 cross-linking in an in vitro kinase assay588. Furthermore, TCR/CD8
signaling is implicated to depend more on a PKC-mediated signaling pathway, as the addition of
PKC specific inhibitor significantly attenuated IL-2 production by CD8+ T cells, whereas CD4+
T cells were far less affected588. Hence, it is plausible that the overall lower CD25 induction by
CD8+ T cells after activation is due to intrinsic signaling differences between CD4+ and CD8+ T
cells.
Implications of High Helios Expression in Perinatal T Cells
The Role of Helios in Tolerance
It is well established that the perinatal immune system is tolerance biased. We found that
perinatal T cells in both humans and mice highly express Helios without the expression of
Foxp3. The frequency of these Helios+ T cells rapidly decreases after birth (Figure 29-32).
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Furthermore, Helios+ αβ T cells and γδ T cells can be detected in the periphery prior to the
appearance of Foxp3+ Tregs in neonatal mice. Helios-/- mice also present significant fatality
within the first week of postnatal life383. This suggests that Helios+ αβ T cells and γδ T cells may
contribute to perinatal tolerance prior to existence of Tregs in the periphery since autoimmunity
does not develop prior to Treg appearance at 3 days after birth in mice87,93,94. The absence of
autoimmunity in the first few days of life was not due to the impaired function of perinatal T
cells, as perinatal T cells can generate appropriate immune responses under certain conditions 276–
279

.
γδ T cells predate the development of αβ T cells, leading to a predominance of γδ T cells

in the periphery the first few days after birth in mice192. In Billingham and Medawar’s seminal
perinatal tolerance experiment, allogeneic cells were injected into the fetus at E 15-16241. They
observed subsequent tolerance against skin graft specific to that mouse strain but rejected skin
graft from an unrelated strain (not previously exposed). At E15-16, the frequency of γδ
thymocytes reaches its peak192. Foxp3+ Tregs were not detected in mice until around three days
after birth93,94. These data suggest that tolerance establishment against allogeneic cells introduced
during E15-16 are predominantly mediated by γδ T cells prior to the appearance of Foxp3+
Tregs. While γδ T cells are considered unconventional T cells where they can recognize antigens
in a non-MHC restricted manner, they possess a large diversity of complementary determinant
region 3 (CDR3) of their TCR due to germline VDJ rearrangement589. αβ T cells undergo
endogenous ligand driven positive and negative selection in the thymus before entering the
periphery. However, the role of ligand-mediated selection in γδ T cells is still unclear.
Furthermore, Allogeneic cells injected within 24 hours after birth homes to the thymus,
suggesting a role in the thymocyte selection process590. Therefore, the introduction of allogeneic
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cells during the fetal stage in Billingham and Medawar’s model may lead to the selection and
expansion of γδ T cells expressing TCR specific to the injected allogeneic cells and establish
tolerance.
While most of the Helios related studies are focused in Foxp3+ Treg populations, several
studies have suggested the association of Helios with tolerogenic T cell responses in both the
thymus and periphery. Helios+ T cells have also been shown to be induced in the periphery
against self-antigen and food antigens. Using an autoimmune gastritis mouse model, Ross et al.
demonstrated Helios was expressed in H+/K+ ATPase-specific CD4+Foxp3- T cells in the
periphery following H+/K+ ATPase presentation in the paragastric lymph nodes. These
CD4+Helios+ cells have less survival and proliferation in response to peptide in vitro and
produce very little IL-2 compared to CD4+Helios- cells591. Another study observed that
Helios+Foxp3- CD4 T cells are generated predominantly in Peyer patches (PP) upon
physiological uptake of dietary proteins and exhibited a proapoptotic phenotype with coexpression of programmed cell death protein 1 (PD-1). They also showed that patients with
Crohn’s disease have lower Helios+Foxp3- CD4 T cell frequency in their PP compared to
healthy controls, implicating the importance of these cells to maintain intestinal homeostasis in
response to food antigens592. These studies demonstrate that Helios expression in non-Tregs can
contribute to maintaining immune tolerance against food or autoantigen. Our observation of
Helios+ αβ and γδ T cells in the perinatal stage may be cells that are specific to self-antigen and
generated before Treg appearance to maintain tolerance against self. Future studies investigating
the TCR repertoire and specificity of Helios+ αβ and γδ T cells is needed to determine if
perinatal Helios+ T cells are limited to self-antigen specific T cells.
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Additionally, the perinatal immune system is thought to be Th2 biased, particularly in
mice. For instance, neonatal T cells produce higher levels of IL-4 compared to adult T cells, and
this Th2 biased response rapidly declines by 5 days after birth to adult levels307,308. A Th2 biased
response is also critical for establishing tolerance, especially during the first few days of birth. In
contrast, Th1 cytokines have been associated with allograft rejection547,548. Using a neonatal
model of tolerance where allogeneic splenocytes were injected into mice within 24 hours after
birth, allospecific Th2 biased response with high IL-4 and low IFN-γ levels was observed, and
antigen-specific tolerance was established593. On the other hand, alloantigen exposure during
adulthood triggers a Th1 biased response593. Furthermore, redirecting the priming response into
Th1 biased response by injecting IFN-γ during neonatal alloantigen exposure subsequently led to
antigen rejection in this model51. These data demonstrated that Th2 biased response is important
for establishing perinatal tolerance. The generation of tolerance against foreign antigen was not
due to the generation of Foxp3+ Tregs. Helios expression was induced in CD4+ T cells
differentiating into Th2 in vivo without parallel upregulation of Foxp3374. It is plausible that the
high frequency of Helios in perinatal T cells is associated with the Th2 biased response in
perinatal mice prior to the appearance of Foxp3+ Tregs in the periphery to promote tolerance.
Helios+ T cells are Limited to Perinatal Origin
The “layered immune system” hypothesis states that perinatal T cells and adult T cells
differ in their ontogeny and arise in succession from different waves of HSCs. This concept is
applied to the observation that  T cells and B cells lineages in mice have different ontogeny
and arise from different waves in succession352,353. It was also demonstrated that HSCs from fetal
and adult give rise to T cells with different functions and phenotype323,356. Fetal-derived CD4+ T
cells have been shown to preferentially become Tregs and made Th2 cytokines upon
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stimulation323,594. Our observation that Helios is highly expressed in both human and mouse
perinatal T cells compared to adults suggests that Helios+ T cells may be generated from HSC of
perinatal origin. In fact, we demonstrated that Helios+ CD4+ and CD8+ αβ T cells could be
generated in vivo using humanized mouse model by transferring UCB HSCs into NSG-S mice
(Figure 57). These Helios+ T cells were maintained in the periphery for up to 21 weeks post
HSC transfer. One caveat of a humanized mouse model is the development of human T cells in a
mouse thymic environment. It is still unknown if there are thymic factors that regulates the
generation of Helios+ T cells and contribute to the Helios differences we observed between
perinatal and adult T cells. Additionally, further testing is required to compare if AB-HSC
humanized mice can also generate Helios+ T cells.
The next evidence that suggests Helios expression is limited to perinatal origin is the
detection of Helios specifically within “type b” CD8αα αβ and γδ T cells in the gut. Helios
expression in “type b” T cells can be detected in the perinatal stage and is maintained through
adulthood (Figure 45). “Type b” gut-associated T cells have been demonstrated to arise from
perinatal progenitor cells Helios expression is maintained through adulthood 51,554. These data
suggest that Helios+ T cells are limited to those coming from perinatal origin.
When we investigated if the kinetics of Helios+ T cells we observed in the spleen is also
reflected in the thymus, we saw that both αβ and γδ thymocytes also express high frequency of
Helios and is significantly lower in adults. However, one striking observation is that Helios
expression in the thymus across all stages is consistently higher than the spleen. This suggests
that there may be extrathymic factors that further regulates Helios+ T cells that exit into the
periphery. Alternatively, Helios+ T cells may also migrate to non-lymphoid organs after they
exit the thymus. Further testing by transferring fetal liver HSC or adult BM HSC into
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immunodeficient neonate and adult Rag2-/- mice will allow us to test the hypothesis whether
Helios discrepancy between perinatal and adult T cells is due to progenitor cell differences or
extrathymic factor.
The Role of Helios in Self-renewal
In acute myeloid leukemia, Helios drives leukemia stem cell self-renewal and inhibits
myeloid differentiation595. γδ T cells of perinatal origin such as murine dendritic epidermal T
cells (DETCs) and γδ IEL have the capability for life-long self-renewal in tissues independently
of circulating precursors596. It was demonstrated that “type b” gut-associated T cells, consisting
of CD8αα αβ and γδ T cells, arise from progenitor cells of perinatal origin51,554. We only observe
high Helios expression specifically in “type b” gut-associated T cells and their expression
maintained through adulthood. Helios expression by these “type b” T cells may contribute to
their self-renewal properties. Furthermore, we do not observe high expression of Helios by “type
a” conventional T cells in the gut. These data demonstrated that Helios is not required for T cell
localization to the gut, or the gut microenvironment induces its expression.
TCR Repertoire by Helios+ T Cells
It was previously reported that the perinatal TCR repertoire in human and mice are
skewed towards those with higher self-reactivity based on higher CD5 detection, a surrogate
marker for TCR avidity for self-pMHC346,597. This was due to thymocytes bearing TCR with low
affinity against self-peptide are not efficiently selected into the neonatal repertoire, while
stronger TCR signals accompany both conventional and Treg selection. TCR with high selfreactivity has been linked to more promiscuous binding to different foreign peptide-MHC
complexes and higher affinity binding against foreign antigens 347–349. Thus, the limited TCR
repertoire in neonates endows them with a greater ability to respond to multiple foreign antigens.
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In the thymus, Helios is shown to differentiate CD4+ thymocytes' response to weak or strong
self-pMHC stimulation. Helios is expressed at low levels in the DP stage but was further
downregulated during positive selection of CD4+ thymocytes that bind self-pMHC weakly. On
the other hand, Helios was upregulated in strongly self-reactive CD4+ single positive thymocytes
particularly when elimination of self-reactive thymocytes was inhibited in Bim deficient mice598.
TCR repertoire analysis comparing Helios+ and Helios- Treg demonstrate very little overlap599.
We observe that Helios expression is restricted to T cells of perinatal origin (both in the
periphery and the gut). The IEL population appears to be enriched with T cells that bear
autoreactive TCR. Although no specific self-peptide ligand has yet been identified, several lines
of evidence support the idea that this population is autoreactive. For instance, IEL CD8αα αβ T
cells express Vβ TCR that recognizes endogenous antigen (Mls antigen in mice bearing Mls
allele)600. Recognition of self-antigen in the context of class I MHC is required for the selection
and differentiation of CD8αα αβ T cells in the IEL using TCR transgenic mice601. Autoreactive
γδ T cells have been shown to escape negative selection in the neonatal thymus, but not in adults,
and undergo extrathymic differentiation in the intestinal epithelium602. Hence, the high
frequency of Helios+ perinatal T cells in the spleen and the gut may reflect T cells with higher
self-reactivity, and this was due to the differences in thymic selection in the perinatal versus
adult stage.
Additionally, not 100% of “type b” gut-associated T cells express Helios especially in the
adult gut (around 70%, Figure 45). This observation could be attributed to “induced” IELs
instead of naturally arising IEL, where CD8αα can be upregulated by conventional CD8αβ+ and
CD4+ αβ T cells in the intestine603,604. Furthermore, the detection of Vγ2 and Vγ4 chain in
addition to Vγ7 on the IEL γδ T cells suggests that γδ IELs consist of γδ T cells from different
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developmental waves based on their Vγ chain usage49,20. Potentially Helios+ γδ IELs may be
confined to certain Vγ chain usage. Future studies to investigate the TCR repertoire differences
between Helios+ and Helios- perinatal T cells (both in the periphery and the gut) will be needed.
Helios Renders Perinatal T Cells to be Less Reactive
As reviewed above, the perinatal immune system is functional where they can generate
inflammatory responses like their adult counterpart. This suggests that strong and redundant
mechanisms must exist to preserve a tolerogenic biased immune response. Some of the known
cell intrinsic mechanisms to promote tolerance response are such as the increased capacity of
fetal T cells to differentiate into Tregs, due to higher sensitivity to respond to TGF-β324. Helios
expression by fetal naive T cells has been suggested to generate a poised epigenome for
enhanced Treg differentiation327.
Another implication of high Helios expression in perinatal T cells is to suppress effector
cytokine production by perinatal T cells. Freshly isolated UCB naïve CD4+ T cells have been
shown to produce significantly lower levels of IFN-γ compared to adult naïve CD4+ T cells309.
Neonatal CD8+ T cells also produce significantly less granzyme B, IFN-γ, and IL-2 compared to
adult CD8 T cells316. In Tregs, Helios deficiency led to increased effector cytokine production
such as IFN-γ, TNF and IL-17376. Helios expression is also found to suppress IL-2 gene
transcription in Tregs388. Hence it is possible that perinatal T cells and gut-associated “type b” T
cells express high levels of Helios to prevent excessive inflammatory cytokine production
against foreign antigen when establishing tolerance is critical. Our data suggest a novel function
of Helios in perinatal T cells where it suppresses effector cytokine production upon T cell
activation (Figure 65).
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Furthermore, we also demonstrated that mouse neonatal CD4+ T cells subjected to Th1
polarizing conditions express significantly higher Helios frequency than Th0 or Th2 conditions
(Figure 60). Helios expression also correlated with IL-10 producing CD4+ T cells under Th1
polarizing conditions in neonates (Figure 61). These data suggest that neonatal T cells may also
upregulate Helios under Th1 inflammatory condition as a feedback mechanism to limit
inflammation.
We initially hypothesized that Helios is required for IL-10 production under Th1
inflammatory conditions as we observed a correlation of Helios with IL-10 producing CD4+ T
cells under Th1 polarization in mice (Figure 61). However, when we knockout Helios in UCB
naïve CD4+ T cells and subjected them to Th0 or Th1 conditions, we did not observe a decrease
in IL-10 production (Figure 63, 64). Additionally, we also did not observe any effect on Helios
knockout when UCB T cells were restimulated immediately without further culturing in Th0 or
Th1conditions (Figure 65). This suggests that Helios is not required for IL-10 production by
human CD4+ T cells. Alternatively, the Ikaros transcription factor family is known to form
heterodimers with other proteins in the family368,371,400.
Ikaros and Aiolos have been reported to promote IL-10 production by CD4+ T cells400,406.
Helios-null mice have minimal impact on T cell development and function, in contrast to
hyperproliferative T cell response and T lymphomas development observed with dominantnegative Helios overexpression381,383. This suggests that other Ikaros family members can
compensate for Helios in T cells. Therefore, the lack of apparent IL-10 effects by Helios
knockout may be compensated by other family members. Future experiments will be needed to
test the effect of double and triple knockouts using gRNA against Helios, Aiolos, and Ikaros.
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In gut mucosal tissue, we found that perinatal origin “type b” T cells expressed Helios
since fetal stages and maintained it throughout adulthood. “Type b” gut-associated γδ and αβ IEL
demonstrates an “activated yet resting” phenotype where expression of conventional cytokines
such as IFN-γ, IL-I2, IL-4 and IL-10 are very low605. An increase in effector cytokine production
by Helios deficient UCB CD4+ T cells further suggests that “type b” gut-associated T cells may
also express Helios as a mechanism to suppress effector cytokine production to prevent
excessive inflammation. This is important because the epithelial tract of the gut is constantly
confronted with a plethora of foreign and potentially harmful antigens. The gastrointestinal tract
immune system must constantly distinguish harmless dietary proteins and commensal microbes
and respond accordingly to harmful pathogens. Hence it is plausible that these perinatal origin
“type b” T cells reconstitute the gut early on to promote the establishment of immune
homeostasis against commensal microbes and harmless food antigens that the newborns are
exposed after birth.
It has been reported that Ikaros transcription factor family of proteins can both repress
and activate gene expression by the formation of higher-order chromatin binding complexes.
Helios has been reported to be associated with proteins of the Mi-2β/NuRD complex369.
Depending on the context in the chromatin, Mi-2/NuRD complexes can either activate or repress
gene transcription606,607. We observed that when we knockout Helios in UCB CD4+ T cells, there
is a significant increase in certain effector cytokines such as IFN-γ and IL-13 production upon
PMA and ionomycin restimulation. It was previously reported that intracellular pathogens like
Toxoplasma gondii could repress STAT1 transcription and block IFN-γ dependent transcription
by recruiting Mi-2/NuRD to STAT1-dependent promoters608. Furthermore, inactivation of NuRD
by knocking out a NuRD-specific component, metastasis-associated protein 2 (Mta2), led to
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hyper induction of IL-2, IL-4, and IFN-γ by T cells609. Altogether, these data suggest that Helios
may suppress IFN-γ production in UCB T cells via NuRD complexes.
Why Does Helios+ T Cells Decrease Rapidly After Birth in the Periphery?
We observed that the frequency of Helios+ T cells rapidly decrease in the periphery by 23 days after birth in mice, and by 3 weeks after birth in humans to adult levels. While we do not
have human fetal T cell Helios data, Ng et al demonstrated that fetal naïve T cells from 18-23
gestational week expressed Helios. This enhances the preferential differentiation of fetal naïve T
cells towards a Treg cell fate327. Together with our data, this demonstrates that Helios+ T cells
are present as early as 18-23 gestational weeks in fetuses and progressively decline by 3 weeks
after birth in human. After birth, the decline of Helios+ T cells may be essential for the gradual
switch from the tolerant biased perinatal immune response into an immune system capable of
generating effector functions.
One potential explanation for this progressive decrease of Helios+ T cells is that Helios+
perinatal T cells arise from distinct HSC lineage from adult T cells. Their frequency decreases in
the periphery when they are superseded by “adult-type” T cells. In fact, phenotypically similar
immune cells of the developing fetal immune system and those from adults have been shown to
be functionally and transcriptionally different327,356,357,360,361. Immune cell phenotype has also
been shown to drastically change between birth (UCB) and postnatal peripheral blood 610. Using
single-cell mapping, Bunis et al demonstrated that lymphoid cells, myeloid cells as well as HSCs
from fetal, perinatal and adult transition occur progressively along a continuum of maturity
instead of the layering of fetal lineage alongside a distinct adult lineage611. Their study also
provides evidence that T cell populations of different developmental stages are characterized by
a progressive downregulation of fetal genes and upregulation of adult genes from fetal through
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adulthood. It is plausible that Helios+ T cells are confined in the perinatal stage of development
and subsequently replaced by Helios- T cells in the periphery as part of the perinatal to the adult
immune system transition process.
Another potential explanation is the presence of steroid hormones estrogen and
progesterone that has potent immunomodulatory effects throughout gestation and shortly after
birth in newborns. Estrogen and progesterone are implicated to be critical to maternal tolerance
against the fetus while little is known about their effects on fetal T cells 612. Estrogen has been
shown to promote Treg induction and expansion in vitro and in vivo613,614. Progesterone also
promotes differentiation of UCB naïve T cells into Tregs while it has little effect on adult T cells,
suggesting that sensitivity to progesterone is lost in adults. Estrogen and progesterone have been
detected in UCB plasma615,616. The highest concentration of progesterone was noted during the
first 24 hours of life and progressively decreases by 72 hours after birth to 0-16ng/ml615.
Estrogen can regulate HSC homeostasis and affect their number and mobilization. During
pregnancy, estrogen can increase HSC self-renewal in the bone marrow to support
extramedullary hematopoiesis to support a rapid expansion of maternal blood volume617. Overall,
the presence of estrogen and progesterone during pregnancy and the rapid decrease of estrogen
and progesterone right after birth in newborns, it is possible that these hormones may influence
the generation of Helios+ T cells, specifically in the perinatal stage. While most studies
regarding progesterone and estrogen have been focused on maternal side of the maternal-fetal
interface of pregnancy, future investigations are required to understand how exposure of these
hormones can affect the perinatal immune system development and their role in perinatal
tolerance.
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Implications of “Type C” γδ T Cells
In the gut, we found a subset of less characterized γδ T cells that express CD8αβ receptor,
which we categorize as “type c” gut-associated T cells. Neonatal SI IEL and LPL CD8αβ γδ T
cells express a high frequency of Helios+Foxp3-, and this frequency significantly decreases in
adults. These “type c” T cells subsequently express Helios+Foxp3+ or Foxp3+ alone in adults
(Figure 46). In the spleen, γδ T cells are either DN or express CD8αβ (Figure 52). While the
Helios+Foxp3- frequency in both splenic DN and CD8αβ γδ T cells decreases from neonates to
adulthood, splenic CD8αβ γδ T cells in adults also demonstrate a subsequent increase in Foxp3+
expression alone (Figure 32). The increase in Foxp3 frequency by gut and splenic CD8αβ γδ T
cells suggests that Foxp3 expression is induced in the periphery and accumulates with age.
Not much is known about Foxp3 expressing γδ T cells and how these cells can be
generated. However, many studies have reported in vitro generated Foxp3+ γδ T cells can carry
immunoregulatory functions. One study reported that freshly isolated mouse splenic total γδ T
cells do not express Foxp3. However, the addition of TGF-β in the presence of anti-γδTCR
stimulation subsequently lead to the induction of Foxp3 by these γδ T cells618. These in vitro
generated Foxp3+ γδ T cells carriy suppressive functions, where it inhibits proliferation of
responder T cells and decreases their IL-2 production618. In humans, the induction of suppressive
Foxp3+ γδ T cells in the presence of TGF-β and IL-15 upon antigen receptor stimulation has
been reported619. Another report demonstrated that Vitamin C further increased TGF-β-induced
Foxp3 expression, stability, and suppressive capability of human γδ T cells. These Foxp3+ γδ T
cells has hypomethylation at their Foxp3 CNS2 region620. The detection of CD8αβ γδ T cells
have also been reported in the human gut mucosa and was implicated to play an important role in
gut homeostasis as their frequency is negatively correlated with inflammatory bowel disease
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severity557. Potentially, the “type c” CD8αβ γδ T cells we observe may induce Foxp3 expression
in vivo upon antigen receptor stimulation and necessary cytokine signals and reflect a population
of antigen experienced γδ T cells in adults. Further studies are required to determine if these
Foxp3+ CD8αβ γδ T cells carry suppressive functions.
Implications of IKZF Transcription Factor Profile
The majority of gut “type b” associated T cells express Helios, Aiolos, and Ikaros from
neonates and maintain through adulthood (Figure 50). While all three transcription factors have
been described individually in T cell differentiation, their expression in gut-associated T cells
remained unexplored. To the best of our knowledge, a comprehensive analysis of these three
transcription factors together in neonates and adult T cells has not been conducted. In addition to
the role of Helios in tolerance as discussed above, some of the known functions by Ikaros and
Aiolos in T cells implicates some contribution to perinatal tolerance. For instance, Ikaros inhibits
Th1 differentiation by suppressing T-bet expression and IFN-γ production398,399. Furthermore,
Ikaros deficiency also decreases GATA-3 expression, a Th2 associated transcription factor, as
well as Th2 cytokines such as IL-4, IL-5 and IL-13, under Th2 polarizing conditions398.
Furthermore, T cells with Ikaros deficiency also produce lower levels of anti-inflammatory
cytokine, IL-10 and an increase in Th1 cytokines such as IL-2 and IFN-γ upon antigen receptor
stimulation621. These data suggest that Ikaros is important an important regulator in Th2 cell
differentiation and responses. Aiolos may contribute to neonatal tolerance where it is associated
with IL-10 production by CD4+ T cells406. Aiolos is shown to be able to form heterodimers with
Ikaros, which is known to bind the Il10 locus371,400,406.
The main difference between gut associated “type a” vs “type b” T cells is the expression
of Helios, where “type a” predominantly express Aiolos and Ikaros while “type b” T cells
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express Helios, Aiolos and Ikaros (Figure 50). This further suggests that Helios expression is
restricted to T cells of perinatal origin. Within the “type b” T cells, the adult gut has a significant
increase in a population that expresses Aiolos and Helios without Ikaros. Based on known
function of Ikaros in CD4+ T cells, it is possible that this proportion of Helios+ Aiolos+ Ikaros“type b” T cells are the “induced” IEL and carry different function than those of Helios+ Aiolos+
Ikaros+ “type b” T cell population. Future experiments using single cell RNA-seq will allow us
to elucidate how the different Ikaros transcription family factor combinations may regulate the
function of these T cells in the gut. Additionally, it will be interesting to test if Helios+ Aiolos+
Ikaros+ “type b” T cells arise from perinatal origin by transferring fetal liver HSCs vs adult BM
HSCs into Rag2-/- mice to assess if solely perinatal HSCs will give rise to Helios+ Aiolos+ and
Ikaros+ “type b” T cells.
When we investigate the Ikaros transcription factor family profile in the spleen between
neonates and adults, we observe that in neonates αβ and γδ T cells, we can still detect a
proportion of cells that express Helios+ Aiolos+ and Ikaros+ in 5-day old neonates. Like “type
a” T cells in the gut, a big proportion of 5-day old neonatal splenic αβ T cells express Aiolos and
Ikaros without Helios (Figure 53). This corresponds to our observation where the frequency of
Helios+ CD4+ and CD8+ αβ T cells rapidly decreases by 2-3 days after birth. It would be
interesting to investigate if other Ikaros transcription factor profiles differ prior to 5 days after
birth.
A significant larger proportion of neonatal γδ T cells express Helios+ Aiolos+ and
Ikaros+ and this population significantly decreases in adult γδ T cells in the spleen (Figure 53).
This suggests that there may be a switch in the γδ T cell pool in the periphery from perinatal
origin vs adult origin. In humans, γδ V gene usage is different between UCB and adult304.
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Additionally, UCB and adult γδ T cells display differences in cytokine production regardless of
V gene usage where UCB γδ T cells produce higher levels of IL-10 in comparison to adults306. In
mice, while both Vγ1 and Vγ4 γδ T cells can be detected in the adult spleen and LN 44,52,53, they
are implicated in carrying different functions. Vγ1+ γδ T cells are shown to promote CD4+ T
cells into a Th2 type response while Vγ4+ γδ T cells promote a Th1 type response following
Coxsackievirus B3 infection622. In a different study, Vγ1+ γδ T cells enhance allergic airway
inflammation by promoting Th2 cytokines in the airway while Vγ4+ γδ T cells suppress allergic
airway inflammation623. Future testing will be required to determine if there is an association
with Ikaros family protein expression profile with Vγ chain usage by neonates and adult γδ T
cells in the spleen.
Another striking observation is the appearance of both αβ and γδ T cells that do not
express Aiolos, Helios or Ikaros in the adult spleen. This is not correlated to the naïve and
memory proportions in the adult spleen (Figure 54). We do not observe a significant emergence
of this population in adult gut-associated “type a” or “type b” T cells, suggesting that it is unique
to αβ and γδ T cells in the periphery.
It is known that the Ikaros transcription factor family proteins can form homodimer with
themselves or heterodimer with each other to carry out their regulatory functions. While we
detected Helios, Ikaros and Aiolos mostly in perinatal origin gut “type b” T cells in both
neonates and adults, we do not know the level of expression, as well as if these transcription
factors are functioning in these T cells as homodimers or heterodimers. Further experiments will
be needed to determine their mRNA and protein levels via RT-PCR or western blots from
purified “type b” T cells in the gut. To determine if Helios, Ikaros and Aiolos are forming
homodimers or heterodimers in these T cells, co-immunoprecipitation can be performed. One
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limitation for these experiments is the low cell number after sorting for “type b” T cells in the
gut.
Concluding Remarks
The tolerogenic biased nature of perinatal immune system is beneficial for infants to
establish immune homeostasis against an onslaught of harmless antigens they encounter after
birth. The tolerance against harmless foreign antigens such as food and commensal bacteria is
established during a critical time window of development. Failure to establish tolerance can
cause allergic disease or inflammation in adulthood. However, increased tolerance renders
newborns highly susceptible to life-threatening infections, which cause 40% of the 3 million
annual worldwide neonatal deaths260. Therefore, understanding the mechanisms that contribute to
perinatal immune tolerance is important to develop strategies for better vaccines development
and establishing immune homeostasis against harmless antigens to prevent atopic diseases.
In this study, we demonstrated that there are multiple mechanisms by which T cells can
contribute to immune tolerance in newborns. Firstly, most perinatal T cells express the
transcription factor Helios, and Helios decreases effector cytokine production upon T cell
activation. Second, perinatal T cells differentiate into a unique subset of Foxp3+Helios+ T cells
that carries immunoregulatory functions but are epigenetically and phenotypically distinct from
canonical adult Foxp3+ tTregs. These Foxp3+ T cells differentiation requires the presence of
CD36hi monocytes. Our data also suggest that Helios+ T cells are limited to perinatal origin as:
1) UCB HSC-derived T cells generated in a humanized mouse model express and maintained
Helios, and 2) perinatal origin “type b” gut-associated T cells, important for the maintenance of
gut homeostasis, express Helios in the fetal stage and maintained their expression through
adulthood (Figure 66).
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Altogether, both cell-intrinsic (Helios) and extrinsic (CD36hi monocytes) mechanisms
promote the tolerogenic nature of the perinatal immune system.

Figure 66: Working Model of Helios+ T Cells in Perinatal Immune Tolerance.
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